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SUMMARY
It is now clear that the major protective immune mechanisms to the 
erythrocytic stages of Plasmodium chabaudi chabaudi AS require the presence of 
CD4+ T lymphocytes. Both ThI and Th2 malaria-specific, cloned T cell lines can 
protect immunocompromised mice upon adoptive transfer. Infection with P. c. 
adamiy however, another subspecies of P. chabaudi, is thought to be resolved solely 
by antibody-independent mechanisms. In different host/parasite combinations, 
therefore, CD4-bearing lymphocytes mediate cellular protective functions and/or act 
as helper cells in protective antibody production. In addition, one report suggests that 
infection with P. c. chabaudi CB is controlled in an antibody-independent manner. 
Experiments were performed, therefore, to define further the role of T cells in 
immunity to rodent malaria using the CB strain of P. c. chabaudi in NIH mice. 
Although this strain is a virulent but usually resolving mouse malaria, it is often 
necessary to treat mice at the peak parasitaemia with subcurative doses of 
chloroquine. Such treatment, therefore, also allowed the effect of chemotherapy on 
the development of an immune response to be investigated.
Using the P. c. chabaudi CB/NIH mouse system, selective depletion of T cell 
subsets by treatment with rat monoclonal antibodies to murine CD4 and CD8 
determinants revealed that the CD4-bearing population of lymphocytes is critically 
required for protection against erythrocytic infection. Mice lacking a CD4+ cell 
compartment suffered very high primary parasitaemias, that recurred despite 
treatment of the mice with chloroquine on days 8 and 9 post infection. For 30 days 
post infection (DPI) parasitaemias were never reduced below 3% and mice developed 
complications of infection such as ascites and subcutaneous oedema. In contrast, the 
parasitaemias of mice after removal of CD8-bearing lymphocytes did not deviate 
from the parasitaemias of immunocompetent control animals, although in mice 
lacking both CD4+ and CD8+ T cells the parasitaemias were higher than in mice 
depleted of CD4+ cells alone. This experiment demonstrated the crucial role that is 
played by P. c. chabaudi CB-specific CD4+ lymphocytes in the protective immune 
response to the asexual erythrocytic stages of this malaria parasite.
Adoptive transfer experiments in vivo were carried out to determine if 
protection could be transferred with specific populations of enriched splenic 
lymphocytes, alone or in combination. Sublethally irradiated mice that received 
splenic cells taken from donor mice after clearance of a malarial infection (75 DPI) 
demonstrated a reduced level and quickened remission of primary parasitaemia and 
more rapid clearance of pRBCs from the bloodstream without recrudescence of 
infection, compared to control mice receiving unprimed splenic lymphocytes.
Transfers carried out 21 DPI when the primary patent parasitaemia was subpatent, 
resulted in the same pattern of protection by T cells and a population of 
unfractionated cells, although the transfer of B cells did not prevent a recrudescence 
from occurring. Splenic T cells, therefore, from donor mice 21 DPI produced a 
sterilising immunity which appeared to transcend antigenic variation. When donor 
mice were treated with a subcurative dose of chloroquine 10 DPI the ability of 75 DPI 
spleen cells to confer a similar level of protection was not affected. When T, B and 
unfractionated cells were taken from chloroquine treated donor mice at the time of 
subpatency (14 DPI) and adoptively transferred into irradiated recipients, they were 
able to confer a level of protection which was demonstrated by a reduced peak 
parasitaemia, quickened pRBC remission and a prolonged subpatent period compared 
to the transfer of naive spleen cells, but in each case a recrudescence did occur.
In all the transfers carried out, although it was possible to transfer immunity 
with preparations enriched for either T or B cells, optimal protection was conferred by 
an unfractionated population containing both lymphocyte phenotypes, suggesting that 
there was a degree of synergistic activity between parasite-primed T and B cells in the 
control of malarial infection. Examination of serum antibody titres for recipients of 
T, B and unfractionated (T + B) spleen cells from donor mice 75 DPI, however, did 
not support this view, as titres did not differ significantly between recipients of 
enriched cells or a mixed splenic population.
Titration of the number of 21 DPI T lymphocytes necessary to produce a 
sterilising immunity showed that decreasing the number of cells below 2 x 107 
cells/ml resulted in effective transfer of immunity upon adoptive transfer but a 
recrudescence occurred, the height and timing of which changed as the number of T 
cells decreased. Mice receiving 2 x 107 21 DPI T cells produced IFN-y and NO, but 
not at levels significantly different from recipients of a smaller number of T cells or 
naive T cells, although an earlier and prolonged secretion of IFN-y was detected. T 
cell recipients produced higher levels of malaria-specific antibody compared to naive 
T cell recipients but as the number of transferred T cells was decreased the level and 
pattern of antibody production was not affected.
The passive transfer of serum collected during subpatency in naturally 
recovering or chloroquine treated animals resulted in a delayed onset in patency in 
recipient mice. Recrudescent parasites collected from the former were equally 
susceptible to the antiparasite effects of subpatent serum as the infecting population, 
but recrudescent parasites collected from chloroquine treated mice were insensitive to 
14 DPI subpatent serum. Whereas recrudescent parasites from naturally recovering 
mice did not differ with respect to the course of infection in naive mice compared to 
the infecting parasite population, recrudescences from chloroquine treated mice
showed a course of infection with a delayed onset and lower recrudescence. This 
indicated that following subcurative chloroquine treatment antigenic variation was 
demonstrated by serum sensitivity but this could not be demonstrated in untreated 
animals. Analysis of the recrudescent populations by live IF AT showed that all 
recrudescent populations from chloroquine treated mice were antigenic variants of the 
infecting parasite population, while only two out of four of the recrudescences from 
naturally recovering mice were shown to be antigenic variants.
The production of nitric oxide (NO) was examined during a P. c. chabaudi CB 
infection by measurement of the levels of nitrate in the serum of infected mice. A 
large peak of NO production coincident with the peak parasitaemia was produced in 
infected mice with background levels remaining throughout the rest of infection. In 
both chloroquine treated and naturally recovering mice there was no subsequent 
elevation of NO associated with the recrudescences. These results suggest that at the 
peak of infection with P. c. chabaudi CB non-specific immune mechanisms are 
operative to control a rapidly escalating acute parasitaemia. Chloroquine treatment 
during the ascending primary parasitaemia, one or two days prior to the peak 
parasitaemia, prevented any elevation in NO levels. Chloroquine treatment, in vivo at 
these times, did not appear to inhibit the pattern of IFN-y production. In vitro, 
chloroquine inhibited the production of NO from J774 macrophage-like cells in a 
dose-dependent manner.
To dissect further the protective immune response in both naturally recovering 
and chloroquine treated mice, splenic T lymphocytes were taken from P. chabaudi 
CB strain-infected NIH mice at different time points during an infection. Each of 
these preparations was established as a cell line in vitro using pRBCs as the source of 
antigenic stimulation and irradiated spleen cells as antigen presenting cells (APCs). 
This was somewhat problematic and only one cell line was successfully raised. This 
line, prepared from mice at 60 DPI, was phenotypically characterised by surface 
immunofluorescence as CD4+ i.e. belonging to the helper/inducer T cell subset. This 
line proliferated specifically in vitro in response to P. c. chabaudi CB antigen 
processed and presented by syngeneic APCs, although it also proliferated in response 
to nRBCs. In vivo, adoptive transfer of this CD4+ line was effective in conferring 
protective immunity to immunocompromised mice. This was demonstrable, 
compared to control mice that were given naive splenic T cells, as both a reduced 
level and shortened duration of primary parasitaemia, and as a quicker parasite 
remission.
CHAPTER ONE 
GENERAL INTRODUCTION
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1.1 Historical Outline
The history of malaria is rooted in antiquity. The writings of the Sumerians and 
ancient Chinese, Homer, Aristotle, Plato and Shakespeare all described the 
intermittent fevers characteristic of malaria. In the 5th century B.C., Hippocrates, the 
great Greek physician, recognised the distinct features of the disease and linked it to 
the proximity of stagnant waters. Rome, ancient and modem, was one of the most 
malarious places in the world until the Pontine marshes were drained in the 1930's. 
St. Augustine, Dante, the Holy Roman Emperor Charles V, as well as Pope Sixtus V 
and his successor Urban VII, are all believed to have died from malaria. The Italians 
called the disease "Roman fever" and maVaria - literally meaning bad air - on the 
theory that its cause was related to the foul air common near marshy areas.
No progress was made in the aetiology of malaria until 1847, when Meckel 
observed black pigment in the blood and spleen of a patient who died of the disease 
(Harrison, 1978). The critical finding that not only pigment but also the parasite itself 
was present in the blood of infected individuals was made by Major Louis Alphonse 
Laveran, a French army physician. In 1880, Laveran first described the crescent­
shaped bodies now known to be the gametocytes of Plasmodium falciparum  in the 
blood of a malarious patient. This finding was followed by the discovery in 1898 by 
Dr Ronald Ross that the parasite was transmitted through the bite of a mosquito. The 
same year the renowned Italian zoologist Giovanni Battista Grassi found that malaria 
was transmitted only by the "dapple-winged" female Anopheles mosquito (reviewed 
by Gamham, 1966; Harrison, 1978). These discoveries marked the beginning of one 
of the most prolonged research efforts in the history of modem science.
Significant control of the disease became possible in the 1930's and 1940's with 
the development of new synthetic antimalarial drugs and modern-day insecticides. 
Consequently, in 1955 the WHO initiated a policy of global malaria eradication. 
Large scale spraying of insecticides, the mainstay of the programme, contributed to 
the subsequent elimination of malaria for an estimated 400 million people and 
eradicated the disease in most temperate regions (Nogeur et al., 1978). However, in 
the last 20 years there has been an alarming resurgence of malaria as mosquito vectors 
became resistant to DDT and malaria parasites developed resistance to prophylactic 
and therapeutic drugs. There has been an estimated 2.3-fold increase in prevalence, 
and it now appears that the potential for transmission may be close to its original level 
(Bruce-Chwatt, 1979). Today, almost half the world's population is at risk from 
malaria, the disease remaining endemic in 103 countries (WHO, 1993). Since the 
areas involved are so vast, accurate figures regarding the levels of morbidity and 
mortality are subject to considerable errors. However, estimates suggest that 270 
million people are infected with malaria each year with over 2.5 million deaths,
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mostly of children and infants (Stiirchler, 1989).
1.2 Classification
Malaria parasites are protozoans and members of the family Plasmodiidae 
within the order Coccidia, sub-order Haemosporina, which comprises various 
parasites found in the blood of reptiles, birds and mammals. The zoological family of 
Plasmodiidae includes the parasites which undergo two types of multiplication by 
asexual division (schizogony) in the vertebrate host and a single sexual multiplication 
(sporogony) in the mosquito host. The genus Plasmodium has been defined on the 
basis of one type of the asexual multiplication by division occurring in the 
parenchymal cells of the liver of the vertebrate host (pre-erythrocytic schizogony); the 
other characteristic of this genus is that the mosquito hosts are various species of 
Anopheles.
There are nearly 120 species of plasmodia, including at least 22 species found in 
primate hosts and 19 in rodents, bats or other mammals. About 70 other plasmodial 
species have been described in birds and reptiles. Four species of Plasmodium  
commonly infect man: P. falciparum, P. vivax, P. malariae and P. ovale. Of these, 
the first is the most important as it is responsible for malignant tertian or falciparum 
malaria, which causes the most fatalities and morbidity.
1.3 Life cycle
Infection with Plasmodium is initiated by the bite of an infected female 
anopheline mosquito. Motile sporozoites contained in the insect's saliva are 
inoculated into the bloodstream during the taking of a blood meal. The inoculum size 
is small, averaging 15 sporozoites in one study (Rosenberg et al., 1990). The 
sporozoites remain in the peripheral blood for between 15-60 mins (Fairley, 1947; 
Sinden & Smith, 1982) before sequestering to the liver, where they enter hepatocytes, 
either directly (Shortt, 1948; Shin et al., 1982), or indirectly after uptake by 
phagocytic Kupffer cells (Smith et al., 1981). Within the hepatocyte, the parasites 
develop into pre-erythrocytic schizonts (Garnham et al., 1966) by asexual 
multiplication. When mature, each schizont and its host cell rupture, releasing around 
30,000 haploid merozoites in the case of P. falciparum. Mammalian malaria parasites 
are thought to undergo only one cycle of pre-erythrocytic multiplication, this taking 
between 5.5 and 15 days for human malarias, depending on the species. Tissue 
schizogony directly follows sporozoite invasion in P. falciparum  and P. malariae 
infections, while for P. vivax and probably P. ovale infections, a proportion of the 
sporozoites first develop into the latent hypnozoite form which is responsible for 
producing relapses (Krotoski et al., 1982 a,b). The stimulus for resumption of growth
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of hypnozoites is unknown but is thought to be predetermined (Bray & Garnham,
1982).
The released merozoites enter the bloodstream, where they rapidly invade RBC 
and begin a cycle of asexual parasite multiplication. The merozoite attaches to a RBC 
and orientates itself so that the apical complex comes into contact with the RBC 
membrane, probably via a species-specific receptor. For the human malarias P. 
falciparum and P. vivax, these receptors are known to be associated with glycophorin 
(Miller et al., 1977; Perkins, 1981) and the Duffy blood group Ags (Miller et al., 
1975b), respectively. After attachment of the merozoite, the RBC membrane thickens 
and forms a junction with the merozoite's plasma membrane (Aikawa et al., 1978). 
The parasite releases material from its rhoptries and micronemes, causing the RBC 
membrane to invaginate, when the junction moves over the parasite which enters the 
invagination until it lies completely enclosed within the parasitophorous vacuole 
(Dvorak et al., 1975, Aikawa et al., 1978). During the entry process (reviewed by 
Mitchell & Bannister, 1988), the surface coat of the merozoite is sloughed off 
(Bannister et al., 1975; Miller et al., 1975a). After uptake into the RBC, the parasite 
develops a vacuole and becomes a ring stage, so called because of the signet ring-like 
morphology upon examination of Giemsa's stained bloodsmears. The ring stage feeds 
on host cell cytoplasm (mostly haemoglobin), the vacuole disappears and the parasite 
enlarges, producing malarious pigment, to become an amoeboid trophozoite. Asexual 
multiplication (schizogony) begins with the repeated division of the parasite nucleus 
within the intact nuclear membrane. The parasite then segments to form a schizont 
containing between 8-32 merozoites, depending on the parasite species. In all cases, 
as many merozoites are formed as there were nuclei, each new merozoite regaining its 
surface coat (Bannister et al., 1975; 1977). After vesiculation and swelling of the 
pRBC membrane, the erythrocytic schizont bursts, releasing the merozoites which 
invade further RBCs (Dvorak et al., 1975). The length of the asexual erythrocytic 
cycle depends on the species of malaria parasite: one cycle takes 48 hrs in P. 
falciparum, P. vivax and P. ovale, and 72 hrs in P. malariae. In the rodent malaria, P. 
chabaudi chabaudi, one cycle takes 24 hrs. The asexual process is relatively 
synchronous in the natural host, and for some parasite species in laboratory adapted 
hosts; in such synchronous infections, rupture of infected cells and merozoite release 
gives rise to the clinical manifestations of alternating fever and chills characteristic of 
malaria (Hawking et al., 1968).
Rather than undergoing asexual replication, a proportion of merozoites, upon 
reinvasion, differentiate without cell division, into the sexual stages of gametocytes 
within the host RBC (gametocytogenesis). The stimulus which directs a merozoite 
into a sexual rather than an asexual cycle is not known, but both micro- and
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macrogametocytes can be found in an infection initiated with a single parasite (Carter 
& Walliker, 1975). The time for a newly invaded merozoite to mature into a ripe 
gametocyte is usually 6-12 hrs longer than that for erythrocytic multiplication, P. 
falciparum (10 d) proving an exception. Hawking et al. (1968) showed that, in 
synchronous infections of several species of Plasmodium, gametocytes matured and 
had a peak of infectivity for the anopheline mosquito during the night. They 
hypothesised that this represented a mechanism whereby their presence in the 
peripheral circulation coincided with the feeding behaviour of the nocturnal 
mosquitoes, so facilitating transmission. The sexual cycle is completed when a 
female mosquito ingests circulating gametocytes when taking a blood meal from an 
infected individual. When the mature gametocytes are taken into the mid gut of the 
vector, they lose the RBC membranes and undergo gametogenesis. Within 10 min, 
the male microgametocyte divides mitotically three times (Sinden, 1981) and 
exflagellates, releasing eight long, thin, flagellated microgametes. These swim 
towards, and ultimately fertilise, the macrogametes, so forming diploid zygotes. In 
each instance, the spherical zygote transforms into a motile ookinete which, within 24 
hrs, crosses the gut wall, usually passing intracellularly through the midgut 
epithelium, and develops into a haploid oocyst between the gut epithelial layer and 
the basal lamina of the mosquito mid gut wall (Sinden & Strong, 1978). The point at 
which meiosis takes place is unknown, but it is probably in the zygote soon after 
fertilisation, the parasites being otherwise haploid throughout the life cycle. Over the 
next 10-16 d (depending on external environmental conditions), the oocyst divides 
many times so that it ruptures, with up to 10,000 sporozoites liberated into the 
haemocoel (reviewed by Russel et al., 1963). The motile sporozoites migrate and 
penetrate into the lumen of the mosquito’s salivary glands, in doing so becoming 
infective to the vertebrate host (Vanderberg, 1975) and remaining viable indefinitely 
until discharge during one of frequent blood meals. Figure 1.3.1 illustrates 
schematically the life cycle of a mammalian malaria parasite.
P. falciparum infections tend to last no longer than 12 months in the human 
host, although infections of up to 4 years have been reported from Mauritius 
(Verdrager, 1964). Under natural conditions, the life span of P. falciparum must not 
be considered separately from immune factors, since observations of Bekessey et al. 
(1976) in Nigeria have shown that high immunity in areas with intensive malaria 
transmission increases the natural rate of recovery from infection by a factor of 10, 
and that it reduces the period of patent gametocytaemia. The life span of P. vivax is 
commonly estimated to be 3-4 years. Since the hypnozoites in vivax malaria are 
sheltered against immune attack, the host's immune response probably only affects the
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level of parasitaemia and the clinical manifestations of infection and not the survival 
of the parasite itself. The same can be expected to apply to P. ovale malaria. It seems 
that P. malariae is able to evade complete elimination by the host's protective 
immunity since its life span in man is known to reach decades.
1.4 The clinical disease
The typical symptom of malaria is a violent fever lasting 6-8 hr, recurring every 
two or three days. The different species of Plasmodium cause two types of 
intermittent fever. A tertian fever (P. falciparum, P. vivax and P. ovale) has one day 
free of fever between paroxysms; a quartan fever (P. malariae) has two. Anaemia 
and enlargement of the spleen develop as the disease progresses.
These periodic paroxysms of prostrating fever distinguish malaria from other 
infections. Each attack is abrupt and often severe. After a variable incubation period, 
the patient feels very ill, with headache and backache. A feeling of unbearable cold 
comes on rapidly, and causes violent, uncontrollable shivering. Within an hour or so 
the body temperature rises to 40-41°C (105-106°F). This is followed by the hot stage, 
when the feeling of cold gives way to one of distressing heat, this lasting for another 
1-2 hrs. Profuse sweating then ends the attack, restoring the body temperature some 
5-8 hrs after it began to rise. Each attack exhausts the victim, but between paroxysms 
the patient may feel quite normal (Kitchen, 1949).
In all types of infection the periodic febrile response is related to the time of the 
rupture of a sufficient number of mature schizonts and consequent discharge of 
merozoites and much other antigenic and altered host material into the blood stream.
Most illness and death caused by malaria infection is associated with acute 
infection, although some fatalities result from unusual chronic immunologically based 
sequelae. P. vivax and P. ovale usually cause only temporary morbidity, whilst P. 
malariae infections result in nephrosis and splenomegaly. Host mortality is almost 
entirely produced by P. falciparum. Cerebral malaria is the most important and well 
recognised manifestation of such severe disease (Spitz, 1946), which may also 
involve anaemia, jaundice, pulmonary oedema, hypoglycaemia and acute renal 
failure. Secondary infections, especially Gram negative septicaemia, are not 
uncommon (WHO, 1990) and are probably the usual cause of 'algid' malaria. Malaria 
infection has also been implicated in the incidence of tropical splenomegaly syndrome 
(reviewed by Greenwood, 1979), Burkitt's lymphoma (Dalldorf et al., 1964; Burkitt, 
1969), spontaneous abortion (Herd & Jordan, 1981) and the incomplete response to 
vaccination shown by malarious children (McGregor & Barr, 1962). However, there 
is as yet no evidence that immunosuppression by HIV leads to major complications of 
reactivations of malaria (Fleming, 1990; Lucas, 1990; Butcher, 1992). Unfortunately,
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by being a potent cause of anaemia, malaria enhances transmission of HIV to children 
through blood transfusion (Greenburg et al., 1988).
1.5 Chemotherapy
The choice of anti-malarial drug for use in man depends on whether it is for 
prophylactic or for curative purposes. In the latter case, the treatment priorities in 
severe and uncomplicated cases have to be distinguished. In life-threatening P. 
falciparum infections the objective of treatment is to save life. In uncomplicated 
malaria, prevention of late recrudescences or minor toxicity assumes the greatest 
importance, and may influence the choice of therapy. The type of infection also 
affects the selection of chemotherapy; P. vivax or P. ovale infections require the use 
of a drug effective against hypnozoites, while P. falciparum or P. malariae do not.
Drugs commonly used to treat malaria are summarised in Table 1.5.1.
GROUP COMPOUND TYPES STAGE OF LIFE 
CYCLE AFFECTED
ACTION ON 
PARASITES
ACTION ON 
MALARIAL 
PIGMENT
1 Chloroquine
Mepacrine
4-Aminoquinolines
All asexual stages Inhibition of haem 
polymerase (Slater 
& Cerami, 1992)
Rapid coarse 
clumping
2 Quinine
Mefloquine
Primaquine
8-Aminoquinolines
All stages except 
mature gametocytes of 
P.falciparum 
(but Primaquine active)
•Degeneration of 
nuclei 
•Vacuolation of 
cytoplasm
Slow, fine 
clumping
3 Antifolates:
•Proguanil
•Pyrimethamine
•Sulphonamides
Schizogony Maturation arrest 
producing large 
non viable 
parasites
4 Sesquiterpenes:
•Artemisinine
Schizogony - -
TABLE 1.5.1 Classification of antimalarial drugs (adapted from Malaria (1991), 
Edited by A J. Knell, Oxford University Press, Oxford).
Quinine in the form of Cinchona bark was introduced into Europe in the mid 
1600's and remained the standard remedy for the disease till well into this century. It 
was largely replaced by chloroquine and other synthetic compounds, during the 
1930's and 1940’s, as these were more efficacious and less toxic (Geary & Jenson,
1983). However, with increasing resistance of some malaria parasites to these 
compounds, quinine, a fast acting blood schizonticide, has returned to occupy an 
extremely important niche in malaria chemotherapy. Resistance to quinine, although
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still rare, is a potentially devastating problem.
Recently, observations by Picot et al. (1993) have suggested that chloroquine 
may help to prevent cerebral malaria, whatever the drug sensitivity of the parasite 
strain and regardless of the emergence of parasite multi-drug resistance, by inhibition 
of TNF (a cytokine implicated in having a major role in the pathology of cerebral 
malaria (Grau et al., 1989b,c; Kwiatkowski et al., 1990)). This provides an exciting 
prospect for new tools for anti-disease therapy.
1.6 Antimalarial Drug Resistance
Resistance to antimalarial drugs is spreading rapidly in most tropical areas. In 
South-East Asia, for example, strains of P. falciparum may be resistant to most or all 
conventional drugs, arising from the remarkable adaptability of this species, as well as 
the use of antimalarials for prophylaxis and for inadequate routine treatment of 
undiagnosed fevers in areas endemic for malaria.
1.7 Laboratory models for malaria research
Only in the final stages of vaccine or drug trials is research into human malarias 
involving the natural host sanctioned. Although several species of non-human 
primates are partially susceptible to infection with human plasmodia, for practical and 
ethical reasons the use of such models is difficult to justify on a regular basis. For 
this reason, various species of rodent, avian and non-human primate plasmodia are 
used as laboratory models, offering the opportunity to study the biology of the 
parasite at the cellular and molecular levels in different hosts.
The discovery of rodent malaria parasites in Katanga by Vincke and Lips was a 
major breakthrough in the study of malaria (Vincke & Lips, 1948). It was quickly 
followed by the isolation of other rodent malaria parasites from both native and rodent 
species as well as mosquitoes (reviewed by Balfort, 1971). These parasites have now 
been adapted to a range of laboratory rodents and guinea pigs which are convenient 
experimentally. In terms of their biological behaviour, the mouse malarias are 
divided into two groups: P. berghei and P. yoelii\ and P. vinckei and P. chabaudi. 
The similarities within, and distinctions between the two groups are manifest in the 
structure and behaviour of blood stage parasites, serology, isoenzyme types and 
patterns of cross-protection (Carter & Diggs, 1977). These carefully defined rodent 
models allow experimental analysis of the mechanisms of immunity to malaria, in 
experiments that cannot be undertaken in humans, although much care must be taken 
when attempting to extrapolate results from these models to the human malarias.
An important technical step forward which has facilitated research in many 
areas of malaria including immunology and vaccine development, was the elucidation
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of the conditions necessary for the continuous in vitro growth of the asexual 
erythrocytic stages of P . falciparum (Trager & Jenson, 1976; Haynes et al., 1976). 
The candle jar method (Jenson & Trager, 1977) is now used routinely for in vitro 
cultivation of P. falciparum , although several modifications of this method are 
available.
1.8 Host Resistance
A prospective host's ability to control infection may take two forms - innate and 
acquired resistance. Innate resistance, which can be parasite specific, is expressed 
regardless of any previous contact, and has no immunological specificity. It may 
relate to a requirement of the parasite (for example, either nutritional or as a 
membrane receptor for invasion) or the presence of a deleterious substance within the 
host. Acquired resistance requires previous exposure to the parasite and is 
immunologic in nature. Between these two lies non-specific resistance which is 
immunologic in nature but requires exposure to a substance or organism (eg, 
concanavalin A or Propionibacterium acnes) which is unrelated to Plasmodium spp. 
but which nevertheless stimulates the host to kill parasites.
1.8.1 Innate Resistance
Increased resistance to malaria in individuals heterozygous for 
haemoglobinopathies such as thalassaemia, was first suggested by Haldane (1949). 
Subsequently, a number of conditions have been associated with protection from 
malaria. Substitution of valine for glutamic acid at position 6 of the p-globin chain 
produces the defective haemoglobin that is responsible for sickle-cell anaemia 
(reviewed by Weatherall, 1990). Association of sickle cell haemoglobin incidence 
and hyperendemic falciparum malaria has long been noted (Allison, 1954; Luzzatto, 
1979). The mechanism of this innate resistance is related to the fact that ring-stage 
parasitized heterozygote cells have a far greater sickling rate than do non-parasitized 
cells (Luzzatto et al., 1970; Roth et al., 1978). Although no sickling occurs in cells 
with later-stage parasites abundant HbS polymer is formed and parasite development 
is retarded (Pasvol et al., 1978). Two possible mechanisms have been proposed for 
parasite killing (Nagel, 1990): polymerised HbS may be a poor substrate for parasite 
proteases, or the polymer may physically damage and/or interfere with some critical 
function of the parasites. Polymerisation of HbS may be aided by the loss of water 
from the RBCs concomitant with potassium loss during sickling. However, 
potassium loss per se may not be the crucial cause of parasite death, since it has been 
shown that the parasite grows normally in ouabain-treated RBCs with high sodium 
and low potassium content (Ginsburg et al., 1986; Tanabe et al., 1986).
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Other abnormal haemoglobin and erythrocyte phenotypes have also been 
associated with protection against malaria eg. imbalanced production of a -  and |3- 
chains (a- and p-thalassaemia), other changes in the p-globin chain structure (HbC 
and HbE), persistence of foetal haemoglobin, glucose-6-phosphate dehydrogenase 
deficiency, ovalocytosis and En(a_) erythrocytes (glycophorin A negative 
individuals). Exactly how these phenotypes exert their protective effect remains 
unclear (Luzzatto, 1979) although Weatherall (1987) suggested that the flexibility of 
the erythrocyte membrane may be involved. It has been suggested that the protection 
provided by erythrocyte abnormalities may involve interactions with the host's 
immune system. Mediation of this effect could be by increased oxidative damage to 
intra-erythrocytic parasites in these cells (Clark & Hunt, 1983) or via exposure of 
parasite-dependent erythrocyte neoantigens (Marsh et al., 1989).
At least one erythrocyte phenotype appears to be protective against malaria in 
the homozygous state. A significant proportion of African Americans are entirely 
resistant to P. vivax malaria (Young et al., 1958). Many such individuals are negative 
for the Duffy blood group determinants (Welch, 1977), a trait which is rare elsewhere. 
Resistance of Duffy negative individuals to infection when exposed to mosquitoes 
infected with P. vivax was soon established (Miller et al., 1976; 1977; Spencer et al., 
1978). These findings explain the very high frequency of the Duffy negative 
phenotype in West Africa where, consequently, P. vivax is now absent As P. vivax is 
not a lethal parasite, this fixation has probably arisen through spread of a fortuitous 
mutation rather than positive selection by the malaria parasites (Pasvol & Wilson, 
1982).
Erythrocyte age also plays an important part in malaria infections with certain 
parasites showing profound preferences for young, or old cells. Of the human 
malarias, P. vivax preferentially invades reticulocytes (young RBCs), whilst P. 
falciparum invades both reticulocytes and normocytes (mature cells). Erythrocyte age 
preferences are also seen in the rodent parasites.
The genetic background of the host has also been shown to affect predisposition 
to infection. In at least one rodent model of malaria, P. chabaudi in inbred mice, 
which is used in this study, susceptibility to infection seems to be under genetic 
control by a single, dominant, autosomal, non-H-2-linked gene (Stevenson et al., 
1982, 1988). The gene product or mechanism involved in conferring this protection 
has not been established, but it is related to the development of splenomegaly, and is 
more effective in the female sex (Stevenson et al., 1982). Recently, Hill et al. (1991) 
observed an association between certain HLA class I and II haplotypes and protection 
from severe malaria in the Gambia. Molecular analysis of the HLA B53 association 
has been studied by sequencing of peptides eluted from the B53 molecule followed by
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screening of candidate epitopes from pre-erythrocytic stage antigens of Plasmodium 
falciparum (Hill et al., 1992). Among malaria-immune Africans, HLA-B53-restricted 
cytotoxic T lymphocytes recognised a conserved nonamer peptide from liver-stage- 
specific antigen-1 (LSA-1). LSA-1, therefore, is an encouraging antigen for inclusion 
in a future subunit anti-malaria vaccine.
The effect of the host's diet, or nutritional state on malaria infections is not fully 
understood, and is little studied. A diet deficient in PABA causes a suppression of 
parasitaemia (Hawking, 1954; Gilks et al., 1988). Indeed, to overcome diet related 
suppression of malaria in experimentally infected mice and rats, where a patent 
infection is desired, some laboratories routinely add PABA to the drinking water. The 
overall nutritional status of an infected individual may affect the course and outcome 
of clinical disease. There may be a correlation between protein intake and 
parasitaemia since it is known that a protein-deficient diet can depress P. berghei 
infections in rats (Gilks et al., 1989). This may in part explain why famine relief in 
humans is sometimes accompanied by outbreaks of malaria - so called 'feeding 
malaria' (Murray etal., 1981).
1.8.2 Non-specific Immunity
Prior administration of some agents unrelated to Plasmodium has been shown to 
confer non-specific protection against malaria. Most of the experiments showing 
acquisition of non-specific immunity have been on murine malarias, and the 
protection conferred is not absolute; in many cases it is manifest as an increased 
prepatent period of the malaria infection, and the survival of animals from an 
otherwise lethal infection.
Inoculation with killed Propionibacterium acnes (formerly known as 
Corynebacterium parvum ) confers a degree of protection against subsequent 
challenge with P. berghei (Nussenzweig, 1967; Murphy, 1981), P. vincke (Lucia & 
Nussenzweig, 1969; Cottrell et al., 1977), or P. chabaudi (Clark et al., 1977). 
Previous exposure to Mycobacterium bovis (BCG) can also provide resistance to 
murine malarias (Clark et al., 1976; Murphy, 1981), although it can lessen the 
protection conferred by vaccination with P. berghei killed by formalin treatment 
(Smrkovski, 1981). The agent of rat infectious anaemia, Haemobartonella, also 
protects rats against P. chabaudi (Thoongsuwan et al., 1978).
A range of substances has been shown to affect the course of murine malaria 
infections. These include Con A, lipopolysaccharide, and diethylstilboestrol (Cottrell 
et a l., 1977), endotoxin (Martin et al., 1967), magnesium silicate in calcium 
phosphate gel (Michel et al., 1982), Coxiella burnetti extract (Clark, 1979), and 
freeze-thawed Toxoplasma gondii tachyzoites (Omata et al., 1981).
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The mechanism by which an unrelated agent can confer protection against 
malaria infection may involve the activation of macrophages, either to increase 
phagocytosis (Nussenzweig, 1967), or to release the macrophage autocrine factor, 
tumour necrosis factor (Clark et al., 1981; Taveme et al., 1981; Clark & Hunt, 1983, 
Dockrell & Playfair, 1983). This latter protective factor has been reported to mediate 
intraerythrocytic killing either through the release of superoxide ions (Allison & 
Eugui, 1982), or nitric oxide (Green et al., 1990a). The mechanisms of this parasite 
destruction will be discussed in more detail later.
Some evidence that the growth of P. falciparum in vitro can be inhibited by a 
non-Ab, non-dialysible factor has been observed by Jenson et al. (1983). As pRBC 
death was caused during the resolution or crisis period of an acute, primary malarial 
infection in laboratory models, this factor was called 'crisis form factor'. Jenson et al. 
(1982; 1983) have since identified this factor in serum samples from immune 
Sudanese adults. They showed a stronger association between clinical immunity and 
in vitro serum inhibition with this crisis form factor than with IgG.
1.8.3 Acquired immunity
The immune response and acquisition of immunity to various species of 
Plasmodium has been extensively studied. Acquired immunity is a general feature of 
the host response to malaria, and is more complex than innate immunity. It is largely 
species specific and has clear strain differences; in addition, it is stage-specific, 
affecting the sporozoite, which stays in the peripheral circulation for a brief time only, 
the pre-erythrocytic stage, the asexual erythrocytic stage (against which immunity is 
mainly directed), and gametocytes (immunity to which would interrupt transmission).
A number of aspects of the host's immune response to malaria have been 
observed and their relative importance in parasite clearance and subsequent resistance 
to re-infection investigated. Methods available to dissect the immune response 
include selective depletion of part of the host's immune system, transfer of cells, 
serum or other factors from immune to non-immune hosts, and in vitro studies - some 
of which will be discussed in subsequent chapters in relation to P. chabaudi in NIH 
inbred mice.
Evidence of acquired immunity to malaria infection in humans starts to appear 
at the beginning of the second week of patent parasitaemia and is manifest as a 
reduction in the reproduction rate and the number of pRBCs in the blood. After a 
variable period, the immunity decreases the parasitaemia to undetectable levels 
(McGregor, 1956). However, there is not a direct correlation between parasitaemia 
and symptomatology as the immune response can occasionally diminish the clinical 
manifestations of infection even in the presence of considerable blood-borne parasite
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burden. In malarious areas, acute malaria is fundamentally a disease of children, who 
suffer repeated and severe attacks that become increasingly mild with time until 
turning into frequent but low parasitaemias, with benign or no symptoms in the 
immune adult (Wilson et al., 1950; McGregor, 1960). For a long time, it was 
believed that acquired resistance to malaria was of the premunition type and that, as 
such, it waned after plasmodia were eliminated from the host. Nevertheless, the 
presence of sterilising immunity has been verified in rodents (Cox, 1964; Playfair,
1977). The presence of sterile immunity in humans has not been investigated 
experimentally, but epidemiological studies do not indicate that it exists.
(a) Sporozoite Immunity
It is now known that viable sporozoites induce a detectable Ab response in both 
man and experimental animals. Nardin et al. (1979) were able to detect rising levels 
of anti-sporozoite Abs with increasing age in serum samples from Gambian children 
and adults. This infers that repeated exposure to sporozoites over many years is 
necessary to induce Ab formation in man. There is also indirect evidence that an 
acute blood stage infection suppresses the response to sporozoites in mice (Orjih & 
Nussenzweig, 1979).
Irradiated sporozoites have been shown to be strongly immunogenic. After 
three or more immunizations with irradiated sporozoites, more than 90% of mice 
challenged with P. berghei were immune to unattenuated sporozoite challenge and the 
protection was maintained for almost two months and then declined progressively 
(Nussenzweig et al., 1969). Protection by repeated injection of irradiated sporozoites 
has also been observed in human malaria (Rieckmann et al., 1974; Clyde et al., 1975). 
Immunity was species-specific and lasted for about three months after exposure to P. 
falciparum sporozoites and up to six months after P. vivax immunization. Mice 
immunized with repeated inoculations of irradiated sporozoites clear challenge 
sporozoites from their blood more quickly than non-immunised mice (Nussenzweig et 
al., 1972). Recipients of serum collected from immunised mice showed a similarly 
increased rate of clearance, and the prepatent period of the challenge infection was 
considerably prolonged (Nussenzweig et al., 1972), implying a role for Ab in 
sporozoite immunity.
Protective mAbs have been produced against the sporozoite surface (CSP - see 
later) of P. berghei (Yoshida et al., 1980; Potocnjak et al., 1980) and the antigens to 
which they react have been separated (Vermeulen et al., 1983). The antibodies and 
their Fab fractions prevent parasite entry into cultured hepatoma cells (Hollingdale et 
a l., 1982) and the antigen which they recognise is probably involved in the 
recognition and penetration of the hepatocyte by the parasite. mAbs recognising
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similar antigens in P. knowlesi have been isolated and are protective (Cochrane et al., 
1982), while others have been produced which reduce the infectivity of P. falciparum 
sporozoites to splenectomised chimpanzees (Nardin et al., 1982).
Spitalny et al. (1976) and Spitalny & Nussenzweig (1973) suggested a role for 
cell-mediated immunity in acquired resistance to sporozoite infection. A level of 
protective immunity in the absence of detectable antibody was observed during the 
early stages of immunisation in mice, or following vaccination with irradiated 
sporozoites in splenectomised chimpanzees. Thymectomised, irradiated bone 
marrow-reconstituted mice or nude (congenically athymic) mice did not develop 
sporozoite neutralising Ab or clinical immunity after inoculation with irradiated 
sporozoites (Spitalny et al., 1977). Adoptive transfer of thymus cells restored the 
capacity of these animals to synthesise Ab and become immunised, concluding that T 
cells have at least a helper function in anti-sporozoite immunity. That there may be 
additional cell-mediated effector mechanisms was suggested by the finding that B-cell 
suppressed mice became immune after sporozoite vaccination (Chen et al., 1977) and 
that adoptive transfer of T cells could transfer immunity (Verhave et al., 1978). 
However, Tsuji et al. (1990) have reported the identification of a CD4+ cytolytic T 
cell clone effective against sporozoites and liver stage parasites, that secretes IFN-y 
and 11-2. In vitro studies performed with sporozoites of P. yoelii and murine 
hepatocytes have also demonstrated that 11-6 inhibits sporozoite penetration and 
development (Pied eta l., 1991; 1992)
(b) Immunity to pre-erythrocytic stages
It has long been held that it is only after pre-erythrocytic schizont rupture and 
merozoite release that this stage of the parasite provokes a cellular response. 
Phagocytic infiltration of infected livers and engulfment of large numbers of 
merozoites supported this view (Shortt & Gamham, 1948; Gamham & Bray, 1956; 
Lupascu et al., 1967). However, evidence of some clinical immunity was reported by 
Beaudoin et al. (1975) who demonstrated that chloroquine treated rats, with 
suppressed blood stage malaria, showed fewer pre-erythrocytic stages of P. berghei 
when viable sporozoites were administered simultaneously.
Jahiel et al. (1968a,b) were the first to demonstrate that pre-erythrocytic malaria 
parasites could be killed by non-specific immune mediators. Later recombinant IFN-y 
was shown to inhibit the in vitro growth of liver stage parasites of P. berghei, P. 
chabaudi and P. vivax (Ferreira et al., 1986; Maheshwari et al., 1986), relatively 
small quantities of IFN-y being required. Schofield et al. (1987a) showed that IFN-y 
was acting hormonally, by binding to specific hepatocyte receptors and inducing 
intracellular death. Treatment of sporozoite-immunised mice and rats with a
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neutralising mAb to rodent IFN-y abrogated pre-erythrocytic immunity, thereby 
showing that IFN-y secretion is required for this immunity (Schofield et al., 1987b). 
Moreover, immunity was abolished by depleting immunised mice of CD8+ cells 
(Schofield et al., 1987b; Weiss et al., 1988) but not CD4 cells. It is considered that 
upon parasite challenge, CD8+ T cells release IFN-y which then inhibits pre- 
erythrocytic development, although CD8+ T cells may also be directly cytotoxic for 
liver stage parasites (reviewed by Schofield, 1989).
Weiss (1990) has suggested the presence of a CD8-independent mechanism in 
cellular immunity to liver stage parasites, since host control of protective immunity to 
pre-erythrocytic stages is different in P. yoelii and P. berghei. Therefore, depending 
on the mouse strain, CD8+ cells may or may not be critical effectors, and a second, 
undefined, immune effector arm may protect infected animals (Weiss et al., 1989). In 
vivo induction of 11-6 dramatically inhibits the development of P. berghei pre- 
erythrocytic forms (Vreden et al., 1992) and in vitro studies have shown that in 
addition to 11-6, both 11-1 and TNF-a (Pied et al., 1991; Nussler et al., 1991a) inhibit 
pre-erythrocytic development. Blocking studies with mAbs showed that both TNF-a 
and 11-1 exert their effect through 11-6 (Pied et al., 1991; Nussler et al., 1991b). Acute 
phase reactants, reactive oxygen metabolites like H2O2, superoxide anions (Pied et 
al., 1991), and nitrogen oxides (Nussler et al., 1991b) have been shown to act as 
effectors in reducing the number of pre-erythrocytic forms in vitro after incubation 
with 11-6 or TNF-a. Interestingly, blocking of NO synthesis in naive hepatocytes 
enhances the number of pre-erythrocytic stages, suggesting that nitrogen oxides are 
part of the physiological defence mechanism of the hepatocyte (Vreden et al., 1992).
In aP  T cell deficient mice, an immune response to sporozoite challenge is 
induced that is inhibited by an in vivo depletion of y5 T cells. Moreover, y5-T cell 
clones upon adoptive transfer can protect normal mice against the development of 
liver stage P. yoelii parasites (Tsuji et al., 1994).
(c) Immunity to asexual erythrocytic stages
Much information is available on various aspects of the host’s immune response 
to erythrocytic stages of the parasite. However, the roles that each plays in the 
resolution of, and subsequent protection from, reinfection are still open to debate. 
Only some immune responses may be protective, whilst others may help the parasite 
to evade a protective immune response (Anders, 1986), or may give rise to 
immunopathological reactions, harmful to the host (Grau et al., 1987). Due to the 
complexity of the host immune response, the relative importance of various immune 
effector mechanisms very probably varies widely between different host-parasite 
models, and at different times during infection.
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(i) The role of the humoral response
The blood stages of Plasmodium can stimulate a strong Ab response. Malarial 
infection produces markedly increased levels of serum Ig (Cohen et al., 1961), and 
although the production of specific Abs appears to contribute to the clearance of at 
least some species from their hosts (eg. Freeman et al., 1980), most of the Ig 
synthesised (up to 95%) has no apparent reactivity with plasmodial Ags (Targett & 
Voller, 1965; Abele et al., 1965; Cohen & Butcher, 1969). The Ags recognised by 
this non-specific Ig may include Ags of lymphocytes and RBCs, complement, 
rheumatoid factor, and nuclear components (Deans & Cohen, 1983). The frequent 
presence of autoantibodies is related to the immunopathology of malaria infection 
(see later). In general, the correlation between total anti-malarial Abs and protective 
immunity and/or clinical status is poor, indicating that many of the Abs do not play a 
major role in controlling the asexual erythrocytic development of plasmodia (Cohen, 
1979). Specific anti-malarial Ab titres rise with repeated P. falciparum blood stage 
infection and correlate to some degree with the clinical immune status of the host 
(McGregor & Williams, 1978).
More specific evidence to correlate Ab levels with protection comes from 
passive transfer experiments. The passive transfer of protection with immune sera has 
been demonstrated. In 1937, Coggleshall & Kumm transferred protection with sera 
from rhesus monkeys with chronic P. knowlesi malaria to naive monkeys. Cohen et 
al. (1961) and Cohen & McGregor (1963) demonstrated protective activity in serum 
of humans infected with P. falciparum, the effective component consisting of the IgG 
fraction. More recently, others have shown that this protective effect may be 
mediated by cytophilic antibodies in co-operation with monocytes (Druilhe & 
Khusmith, 1987; Bouharoun-Tayoun & Druilhe, 1992). A variety of passive Ab 
studies using rodents has also demonstrated immune IgG mediated protection (Diggs 
& Osier, 1969; Stechschulte et al., 1969; Diggs et al., 1972; Phillips & Jones, 1972; 
Green & Kreier, 1978; Reese & Motyl, 1979). Treatment of serum with anti-IgG 
removes the protective activity of rat hyperimmune serum in the P. berghei system 
(Diggs & Osier, 1969). The passive transfer of serum collected from hosts recovering 
from infection has shown that the protective activity of serum is highest at the time of 
parasite elimination (Phillips & Jones, 1972; Murphy, 1979) and that protective 
activity diminishes rapidly after parasite clearance (Hamburger & Kreier, 1976; 
Murphy, 1979).
A role for B cells has been shown in some host-parasite relationships. Mice 
congenitally deficient in B cells have higher and more prolonged infections than 
normal controls (Jayawardena et al., 1979) and in some cases infections became lethal 
(Hunter et al., 1979a). Mice made B cell deficient by treatment with anti-|i-chain Ig,
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died from a normally self-limiting infection with P. yoelii (Weinbaum et al., 1976; 
Roberts et al., 1977). After drug cure and rechallenge, B cell deficient mice suffered 
a long lasting low grade parasitaemia (Roberts & Weidanz, 1979). B-cell enriched 
populations of immune spleen cells are effective in adoptively transferring protection 
to malaria. This has been observed in mouse-/5, chabaudi (McDonald & Phillips,
1978), mouse-/5, berghei (Ferranoni & Speer, 1982) and rat-P. berghei (Gravely & 
Kreier, 1976) systems. Recent reconstitution experiments using SCID and nude mice 
have shown that both B and T cells are necessary for the transfer of protective 
immunity to P. c. chabaudi (Meding & Langhome, 1991). However, there is little or 
no apparent B-cell involvement in the resolution of P. c. adami infection (data of Van 
der Hyde, cited in Greiner et al., 1992).
Antibodies could be effective against the parasite in a number of ways. 
Prevention of merozoite invasion or retardation of intraerythrocytic development are 
possibilities (Phillips et al., 1972; Miller et al., 1975a; Mitchell et al., 1976; Cohen et 
al., 1977; Epstein et al., 1981; Revin et al., 1981; Deans et al., 1982; Miller et al., 
1984; Saule? a/., 1984; 1985; Banjal & Inselburg, 1985; Schmidt-Ulrich et al., 1986; 
Udomsangpetch et al., 1986). In vitro agglutination of P. knowlesi merozoites has 
been shown to correlate well with specific sterilising immunity induced by merozoite 
vaccination (Butcher et al., 1978) but not always with functional immunity (Miller et 
al., 1977). That anti-merozoite Abs can control blood stage malaria has been 
confirmed by passive transfer studies using mAbs raised against P. yoelii (Freeman et 
al., 1980). Apart from the agglutinating activity of inhibitory Ab, other serum Abs 
offer protection against asexual parasites. Opsonising Abs, which promote 
phagocytosis of pRBCs, have also been detected in vitro (Zuckerman, 1945; 
Khusmith et al., 1982). Opsonins against/5, knowlesi have been shown to be variant 
specific (Brown et al., 1970a). While opsonisation may be important in vivo in the 
early stages of infection, phagocytosis may be inhibited later in infection by serum 
factors (Shear et al., 1979; Brown & Kreier, 1982).
(ii) The role of complement
In both experimental and naturally occurring human malarias depressed 
complement levels are observed (Dulaney et al., 1948; Neva et al., 1974; Greenwood 
& Brueton, 1974; Srichaikul et al., 1975). This decrease was correlated directly with 
the degree of parasitaemia and the presence of complement fixing Ab, with the lowest 
detectable complement titres observed within a few hours of schizont rupture and 
during peak fever (Neva et al., 1974). Infection of mice congenitally deficient in 
complement factors appears to have no effect on the course of P. berghei infection. It 
appears that complement has a negligible role in the immune response to malaria
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infection and may not contribute to any extent to parasite clearance. The depletion of 
complement components after schizont rupture is thought to be due to complement 
fixation by Ab-Ag complexes (Greenwood & Brueton, 1974) and may contribute 
immunopathologically to the vascular damage observed in P. falciparum infections 
(Greenwood & Brueton, 1974; Srichaikul eta l., 1975).
(iii) The role of the cell-mediated response
The presence of a functional thymus plays a major part in the development of 
immunity to malaria. Congenitally athymic nude (nu/nu) mice were unable to clear 
an infection with a strain of P. yoelii from which intact normal mice recover (Clark & 
Allison, 1974; Weinbaum etal., 1976b; Roberts etal., 1977). Consistent aggravation 
of non-lethal malaria infection by deprivation of T cells was also demonstrated with 
P. chabaudi, where nude mice on a CBA background developed lethal infections 
(Eugui & Allison, 1980; Cavacini etal., 1986).
In most studies, malaria infections of thymectomised hosts have resulted in 
higher, more persistent parasitaemias, with increased host mortality and anaemia in 
comparison to sham thymectomised controls. This has been observed in P. berghei 
infections in thymectomised rats (Brown et al., 1968; Stechschulte, 1969), mice 
(Cottrell et al., 1978) and hamsters (Chapman & Hanson, 1971); P. yoelii infections 
of thymectomised lethally irradiated and B cell reconstituted mice (Jayawardena et 
al., 1977); and P. c. chabaudi and P. c. adami infections in thymectomised mice 
(McDonald & Phillips, 1978; Cavacini et al., 1986). Resolution of acute infection in 
recipient adult-thymectomised mice following adoptive transfer of immune spleen 
cells was dose-dependent (Cavacini et al., 1986). A conflicting finding was reported 
by Wright (1968) who reported that thymectomy of golden hamsters increased their 
survival time on infection with P. berghei. This model system is unusual, however, in 
that normal golden hamsters die from P. berghei infection when the parasitaemia is 
very low. Post mortem reveals cerebral haemorrhages. Thymectomised animals die 
when the parasitaemia is much higher and show no cerebral complications at post 
mortem. Thus, this early observation implicated T cells in the occurrence of cerebral 
malaria, which has since been attributed to the toxicity of a key mediator of 
inflammation, TNF (Clark, 1987).
Potential animal hosts have also been made T-cell deficient by treatment with 
anti-thymocyte serum (ATS). ATS treatment of rats prior to infection suppressed 
both natural and age resistance to P. berghei, while ATS treatment after the infection 
had cleared failed to enhance rat susceptibility to reinfection (Spira et al., 1970). In 
contrast, Brown & Phillips (1971) found that rats with chronic P. berghei had a 
marked recrudescence following ATS treatment. Eling (1979) showed that ATS
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treatment had maximal effect when administered 6 hours after challenge of P. berghei 
infected, drug cured mice, implicating a role for T cells early in challenge infections.
The role of T cells in the immune response to malaria infections has been 
examined by looking at differences in the T-cell response to non lethal and lethal 
malaria infections. Massive T cell mitosis has been observed in the spleens of mice 
infected with a non lethal strain of P. yoelii, but not in lethal P. berghei infections 
(Jayawardena et al., 1975). Early in lethal P. yoelii strain infections there was a 
reduced splenic T cell response to malaria antigen in vitro.
Adoptive transfer experiments using rodent models of infection have indicated 
that animals receiving T cell enriched spleen cell preparations are protected against 
subsequent challenge (eg. McDonald & Phillips, 1978). Although some immunity to 
the blood stages of malaria can be transferred to irradiated recipient mice by immune 
T cells alone, better protection has been obtained when both T and B cells are 
transferred (Brown et al., 1976a; Gravely & Kreier, 1976; McDonald & Phillips, 
1978; Jayawardena et al., 1979; 1982; Brinkmann et al., 1985; Fahey & Spitalny,
1986), which is thought to be due to a synergistic effect (Jayawardena et al., 1982). 
Such experiments have established the helper role for T cells in the synthesis of anti- 
malarial Ab (Brown & Phillips, 1971; Brown et al., 1976a,b). This was confirmed by 
Jayawardena et al. (1977), who found that intact mice produce high levels of specific 
anti-malarial Abs while T cell deficient mice have considerably reduced levels of 
IgGi, IgG2 and IgM. The normal pattern of functional immunity was restored by 
reconstitution with syngeneic thymus cells. Adoptive transfer experiments will be 
discussed further in Chapter 4.
Additional support for the role of T cell mediated immune mechanisms in 
malaria has come from adoptive transfer studies in athymic nude mice. Immune T 
cell recipients resolve their infections more rapidly and demonstrate lower peak 
parasitaemias than recipients of non-immune T cells. Protection was best achieved 
with the T cell subsets expressing the CD4+ phenotype (McDonald & Phillips, 1980; 
Cavacini et al., 1986; Vinetz et al., 1990) or with in W/ro-propagated 11-2 dependent 
and P. c. adami-specific T cell lines or clones of the CD4+ phenotypes (Brake et al., 
1986; 1988). Taylor-Robinson & Phillips (1992; 1993; 1994a) have also 
demonstrated the protective activity of CD4+ T cell lines and clones of both ThI and 
Th2 phenotypes, reactive to P. c. chabaudi. Moreover, studies have also shown that 
the depletion of the CD4+ T cell subset in vivo by treatment with mAbs renders mice 
incapable of clearing an infection (Siiss et al., 1988; Kumar et al., 1989; Langhome et 
al., 1990; Podoba & Stevenson, 1991 - see also Chapter 3).
Chickens rendered agammaglobulinaemic by combined immunological and 
chemical bursectomy (Rank & Weidanz, 1976; Roberts & Weidanz, 1979; Grun &
20
Weidanz, 1981) displayed an Ab-independent immunity which was also T cell 
dependent. Similarly, studies of the murine malaria P. c. adami demonstrated that B 
cell deficient mice resolved acute primary infection with the same kinetics as normal 
mice and were immune to subsequent challenge with homologous parasites (Grun & 
Weidanz, 1981; 1983). Cavacini et al. (1990) furthered these studies by 
demonstrating that acute infections of P. c. chabaudi, P. vinckei petteri and Babesia 
microti are controlled by Ab-independent, T cell-mediated immune mechanisms.
It is therefore evident that T cells are important in the development of immunity 
against blood stage parasites (Jayawardena, 1981) but it must also be noted that the 
mechanisms by which T cells mediate clearance and provide protection are not 
identical in different rodent models. In general, however, CD4+ cells appear to be the 
more dominant T cell subset in conferring protection against asexual parasites 
(Jayawardena et al., 1982; Brinkmann et al., 1985; Brake etal., 1986; 1988; Cavacini 
et al., 1986) and thus may provide help for Ab production (Weinbaum et al., 1976; 
Jayawardena et al., 1977; Roberts et al., 1977; McDonald & Phillips, 1978; Playfair,
1982). CD4+ cells that act as helper cells for Ab production belong exclusively to the 
Th2 subset (Langhome et al., 1989b). However, it has recently been shown that ThI 
as well as Th2 cells are important during infection (Langhome, 1989; Langhome et 
al., 1989a,b; Langhome et al., 1990; Taylor-Robinson & Phillips, 1992; 1993; 
1994a). It appears that soon after challenge with P. c. chabaudi, T h I cells 
predominate, producing an inflammatory type response with the major mechanism for 
parasite destruction being via toxic mediators secreted by activated macrophages. 
Later during infection, the proportion of Th2 cells increases and Ab-mediated 
immunity begins to operate, so facilitating resolution of patent infection (Langhome,
1989). In this model of infection, therefore, first ThI cells activate various non­
specific immune mechanisms such as nitric oxide production (Taylor-Robinson et al., 
1993) or may in fact produce nitric oxide themselves (Taylor-Robinson et al., 1994), 
to control a rapidly escalating acute parasitaemia. This paves the way for the T h 2- 
promoted specific immunoglobulin response to effectively clear the blood infection.
An increase in the number and proportion of peripheral blood y5 T cells has 
been observed during acute P. falciparum infections of human patients (Ho et al.,
1990). It has been suggested that these y5 cells might exhibit anti-parasitic effects via 
secretion of cytokines or as non-MHC-restricted cytotoxic cells (Ho et al., 1990). In 
non-immune individuals, a vast majority of T cells vigorously proliferating in 
response to freeze-thawed extracts of P. falciparum blood stage parasites in vitro have 
been shown to be y5 T cells (Goerlich et al., 1991; Behr & Dubois, 1992; Goodier et 
al., 1992), and are the source of a significant fraction of TNF-a and IFN-y that were 
produced in these cultures (Langhome et al., 1992). Perera et al. (1994) have shown
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that in P. vivax infections, the proportion and absolute numbers of y5 cells increase, 
and that this increase is associated with the time of schizont rupture and the event of 
paroxysm. These findings support the view that y8 T cells may also be involved in 
the pathogenesis of malaria (Langhome et al., 1992) via the secretion of TNF. y5 T 
cell deficient mice, however, clear the blood stages of non-lethal P. yoelii infection, 
while a p  T-cell-deficient mice failed to control the parasitaemia (Tsuji et al., 1994). 
Similar results have been observed for P. c. chabaudi AS (A.W. Taylor-Robinson, 
personal communication).
(iv) The role of the reticulo-endothelial system
Macrophages may contribute to the control of malaria infections by 
phagocytosis and/or release of extracellular mediators. For a long time it was 
believed that phagocytosis of infected cells or free parasites was the principle 
mechanism by which immunity was effected (Taliaferro, 1929). Increased phagocytic 
activity has been observed during malaria infection. An increased carbon clearance 
rate has been observed during P. vinckei and P. chabaudi infections of mice (Lucia & 
Nussenzweig, 1969) and at the beginning of P. berghei infection in rats (Cantrell & 
Elko, 1966; Cantrell etal., 1970; Kitchen & Di Luzio, 1971). Hyperphagocytosis of 
several other added particles has been observed during malaria infections; these 
include 51Cr-labelled sheep RBCs in mouse-P. berghei infections (Loose & DiLuzio, 
1976) and l25I-labelled microaggregated human serum albumin in human malaria 
infections (Sheagren et al., 1970).
Peritoneal macrophages of mice with P. berghei infections showed enhanced 
phagocytic activity towards pRBCs and nRBCs in culture (Shear et al., 1979) and in 
millipore chambers implanted in the peritoneal cavity (Criswell et al., 1971). The 
former study revealed that splenic macrophages from P. berghei infected mice ingest 
pRBCs more efficiently than do those from normal mice in vitro, the ingestion 
apparently being mediated by disease-associated Igs which bind to the surface of 
pRBCs (Lustig et al., 1977).
Activated macrophages may also mediate pRBC destruction by the release of 
factors which can kill the intracellular parasite (Clark et al., 1981; Allison & Eugui,
1982). The mechanisms by which macrophage secretion products destroy blood stage 
parasites will be discussed elsewhere. The recruitment of macrophages and 
monocytes and their activation are mediated by cytokines such as IFN-y, macrophage 
chemotactic factor, IL-2 and 11-6 (F.E.G. Cox, personal communication) secreted by T 
cells, which are themselves activated by plasmodial mitogens as well as specific 
malarial antigens (Wyler & Gallin, 1977; Allison & Eugui, 1983; Ockenhouse & 
Shear, 1983).
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Both pRBCs and nRBCs have been observed within splenic macrophages in 
vivo in human malaria infections (Pongponratn et al., 1987). Splenic filtration is 
increased by splenomegaly. Both enhanced phagocytosis and splenomegaly in 
malaria infections have been found to be thymus-dependent responses (Roberts & 
Weidanz, 1978). This is unsurprising in light of the role of soluble factors secreted by 
T cells in macrophage activation.
The part played by immune phagocytosis in the clearance of P. falciparum  is 
controversial. In animals, however, increased clearance of pRBCs cannot be 
demonstrated in normal animals given hyperimmune serum (Quinn & Wyler, 
1979a,b) although in vitro immune serum has been shown to facilitate the 
phagocytosis of merozoites (Khusmith & Druilhe, 1983). In Thai patients with 
falciparum malaria the activity of monocytes from cases of uncomplicated malaria 
was significantly increased compared to healthy controls (Ward et al., 1984). In 
contrast, the activity of monocytes from cerebral malaria sufferers was within normal 
limits. In another study, the in vivo clearance of IgG-coated RBCs was accelerated in 
some but not all patients (Ho & Webster, 1990) with a significant positive correlation 
between the half-time for clearance of sensitised RBCs from the circulation and the 
level of parasitaemia. Together, the in vivo and in vitro evidence indicates that 
immune clearance through phagocytosis is important in reducing parasitaemia to 
subpatency, thereby controlling the acute phase of infection. The failure of immune 
clearance in some instances may be related to the development of severe clinical 
illness, including cerebral manifestations.
(v) The role of cytokines
The importance of CD4+ T lymphocytes in the resolution of a primary infection 
with blood stage malaria parasites has been described above. It is thought that soluble 
macromolecules (cytokines) such as interleukins derived from lymphocytes and other 
cells are instrumental both in the T cell-dependent regulation of the immune reponse 
and its effector phase. Most of these processes probably reflect the function of 
cytokines secreted by activated T cells responding to malarial Ags.
The first direct support for cytokine production in response to malarial Ags was 
provided by Wyler & Gallin (1977) who identified a mononuclear cell chemotactic 
factor in spleen cell extracts from malarious mice and monkeys. Infected nude mice 
lacked significant activity, therefore, it was concluded that the chemotactic activity 
was secreted by, or was dependent upon, T cells and their precursors. Lelchuk et al. 
(1984) showed that the ability of spleen cells from P. yoelii or P. berghei infected 
mice to produce 11-2 upon Con A stimulation varied according to the time following 
infection. An increase in the capacity to release 11-2 was seen early in both infections,
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a finding also shown for P. c. chabaudi infection (Langhome etal., 1989a,b).
Interferons are increasingly being considered important in acquired immunity to 
malaria blood stage parasites. Administration of exogenous IFN-y inducers or IFN-y 
containing serum was found to delay the progress of P. berghei infection in mice 
(Jahiel et al., 1968b, 1970). Treatment with anti-mouse IFN globulin accelerated P. 
berghei infections in mice (Sauvager & Fauconnier, 1978). Eugui & Allison (1982) 
and Rhodes-Feuillette et al. (1985) have reported the presence of IFN-y in the sera of 
infected humans as well as mice. T cells from malarious patients and immune 
individuals from endemic areas can secrete IFN-y and 11-2 upon stimulation with 
homologous Ag (Troye-Blomberg et a l,  1985; 1987). This has been confirmed by 
other workers (Sinaglia & Pink, 1985; Riley et al., 1988a). In contrast to its toxicity 
to the pre-erythrocytic stages, IFN-y by itself has no effect on the erythrocytic stages 
of plasmodia (Ferreiera et al., 1986). However, IFN-y is capable of activating 
macrophages. IFN-y (and 11-2) secretion is a unique property amongst T cells of the 
CD4+ T hI subset (Mosmann & Coffman, 1987). This has been confirmed for 
malaria by Langhome et al. (1989b) and Taylor-Robinson & Phillips (1992) using P. 
c. chabaudi AS. Intraerythrocytic P. yoelii parasites can be killed by normal 
macrophages after incubation with IFN-y containing S/N (Ockenhouse & Shear, 
1984). This killing is blocked with the addition of anti-IFN-y Ab (Ockenhouse et a l, 
1984). The same investigators showed that rIFN-y activated macrophages to induce 
the appearance of crisis forms of P. falciparum in cultures of human pRBCs.
Inflammatory mediators such as TNF can be induced in macrophages activated 
by IFN-y (Mosmann & Coffman, 1987) in response to malaria parasite stimulation 
(Bate et a l, 1988). TNF may contribute to protective immune mechanisms but it is 
also linked to the pathology of cerebral malaria (Grau et a l, 1987). In vivo, treatment 
of mice with exogenous IFN-y has been reported to have a protective effect during the 
blood stages of various rodent malarias (Clark et a l, 1987a; Bienzle, 1988; Shear et 
a l,  1989) and also enhanced antimalarial chemotherapy of P. vinckei malaria when 
given prophylactically or in the early phase of blood-stage malaria (Kremsner et a l,
1991). In P. c. chabaudi AS-infected mice, endogenous IFN-y has been detected in 
serum just before peak parasitaemia, and correlated directly with a relatively high 
frequency of IFN-y secreting T cells in the spleen (Slade & Langhome, 1989; 
Stevenson et a l,  1990a). In vivo depletion of IFN-y by mAb treatment exacerbates 
infection (Slade & Langhorne, 1989; Stevenson et a l ,  1990c). However, 
administration of IFN-y in combination with chloroquine in the late phase of P. 
vinckei malaria induced lethality despite effective parasite clearance by chloroquine 
(Kremsner et a l, 1992).
Stevenson & Tam (1993) have shown that both susceptible and resistant strains
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of mice are capable of producing IFN-y in response to both Con A and malarial 
antigen. However, the response is greater in resistant mice. Moreover, susceptible 
mice produce higher levels of 11-5, a marker of Th2 cells, earlier in infection, 
indicating that early activation of Tjj2 cells may be associated with severe and lethal 
malaria, as occurs in A/J mice infected with P. c. chabaudi AS. In addition, it seems 
that cerebral malaria in certain host-parasite combinations is associated with IFN-y- 
induced TNF production (Grau et al., 1987) suggesting that there may be a fine 
balance between the levels of serum IFN-y and TNF, and protective immunity or 
pathological consequences. Thus, the levels of IFN-y and TNF, which can vary from 
one mouse strain to another, may determine susceptibility or resistance to infection.
Based on serum cytokine profiles in patients with P. falciparum  and in vitro 
stimulation of peripheral blood lymphocytes from various populations with malaria, 
T h I and Th2 cells are activated during infection (Troye-Blomberg & Perlmann, 
1988; Troye-Blomberg et al., 1990; Mshana et al., 1991). Removal of CD8+ cells 
from the peripheral blood enhances T cell proliferation and the IFN-y response in 
normally low-responding immune individuals (Riley et al., 1989a). Although the in 
vivo significance of these findings is not clear, it confirms the importance of CD4+ T 
cells, but also supports strongly the concept that Ag-specific CD8+ T cells are 
involved in the suppressive regulation of CMI to malaria (Troye-Blomberg et al.,
1983).
Kumaratilake & Ferrante (1992) have shown that IFN-y and lymphotoxin (LT) 
enhance neutrophil-mediated killing of P. falciparum (Kumaratilake et al., 1991;
1992). These findings support a role for both T hI and Th2 cells in immunity to 
malaria, since IFN-y and LT are products of T hI cells and parasite killing by 
neutrophils is antibody-dependent (Kumaratilake etal., 1991; 1992).
11-4 can depress the macrophage mediated killing of P. falciparum  
(Kumaratilake & Ferrante, 1992). Recent results from other parasite systems 
demonstrate the ability of 11-4 to inhibit the microbicidal functions of IFN-y activated 
macrophages in vitro (Liew et al., 1991; Oswald et al., 1992). The role of 11-4, 
however, in host protection against malaria is far from clear. As yet unpublished 
results by Von der Weid et al. have shown that a P. c. chabaudi infection in mice in 
which the 11-4 gene has been inactivated by gene targetting (Kopf et al., 1993) is 
resolved with the same kinetics as wild-type littermate controls (Von der Weid & 
Langhome, 1993a).
Identifying the roles that a variety of cytokines play in the immunity to 
Plasmodium parasites will contribute to strategies for developing effective vaccines 
against malaria.
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(vi) The role of reactive oxygen intermediates
As discussed above, the release of IFN-y and other cytokines from CD4+ T cells 
is an important part of Ab-independent immunity. These stimulate cells of the 
mononuclear phagocytic cell system to exert anti-parasite effects either directly by 
phagocytosis or more often through the release of free oxygen radicals, which may in 
turn give rise to more stable parasiticidal components (Allison & Eugui, 1983; Clark 
et al., 1987a).
Injection of agents known to generate free oxygen radicals, including alloxan 
(Clark & Hunt, 1983) and t-butylhydroperoxide (Wood & Clark, 1982; Clark et al.,
1983) suppressed parasitaemia in mice. These chemical generators of reactive 
oxygen species including H2O2, superoxide anions (O2-) and hydroxyl radicals (OH*) 
may mimic a mechanism of CMI towards blood stage malaria. Indeed, not only have 
ROI been shown to be toxic to asexual stages of a variety of different Plasmodium 
species, both in vitro and in vivo (Dockrell & Playfair, 1983), free radical scavengers 
have accentuated P. c. adami infections (Clark etal., 1987a). Macrophage-oxidative 
capacity was also found to be deficient in susceptible mice compared to resistant mice 
(Stevenson etal., 1992).
Since oxygen radicals are extremely short-lived molecules, they may exert their 
activity locally in the liver and spleen, through lipid peroxidation leading to the 
generation of toxic aldehydes (Allison & Eugui, 1983; Clark et al., 1987a; Rockett et 
al., 1988). The chemicals may then circulate in the blood and effect parasite (and 
tissue) injury at distant sites.
(vii) The role of toxic nitrogen oxides
Despite the evidence for the involvement of oxidative mechanisms in the control 
of malaria infections, additional factors appear to be involved. Rockett et al. (1988) 
observed that a non-lipid factor was also involved in the parasiticidal component of 
tumour necrosis serum (TNS). In addition, in cases of chronic granulomatous disease, 
in which oxidative metabolism is impaired, macrophages (Ockenhouse et al., 1984) 
and PMN cells (Kharazmi et al., 1984) were able to inhibit the growth of 
intraerythrocytic parasites. Cavacini et al. (1989) have also reported proficiency of 
killing in hosts possessing cells deficient in the respiratory burst. These findings 
suggest the existence of an oxygen-independent parasite killling mechanism. This has 
recently been elucidated, and involves the cytokine-induced synthesis of toxic nitric 
oxide (NO) from L-arginine by macrophages, hepatocytes and endothelial cells. NO 
inhibits iron-sulphur-dependent enzymes involved in cellular respiration and energy 
production and may react with an oxygen free radical to yield a highly reactive 
hydroxyl radical and a more stable nitric oxide free radical (James & Hibbs, 1990;
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Liew & Cox, 1991).
The role of NO can be demonstrated in P. c. chabaudi AS infection (Taylor- 
Robinson et al., 1993). A sharp peak of NO production, measured as serum nitrate, 
consistently parallels peak parasitaemia. Treatment with L-NMMA, an inhibitor of 
NO synthase, completely abolishes NO production and mice suffer an extended 
primary parasitaemia; thymectomised, ThI cell reconstituted mice suffer a chronic 
patent parasitaemia. Treatment with L-NMMA during recrudescence does not effect 
the parasitaemia during this stage of infection. NO also inhibits the development of 
pre-erythrocytic stages of P. berghei (Mellouk et al., 1991) and P. yoelii (Nussler et 
al., 1991b) in vitro, and NO derivatives kill asexual erthyrocytic stages of P. 
falciparum (Rockett et al., 1991) in vitro. The results of Taylor-Robinson et al. 
(1993) show that NO involvement may be mediated by ThI secretion of IFN-y which 
activates macrophages to produce large amounts of NO (Marietta et al., 1988; Stuehr 
& Nathan, 1989) to kill the parasites directly. Alternatively, NO may have an indirect 
effect by causing blood vessel vasodilation (Knowles & Moncada, 1992). This effect 
would lead to less efficient parasite sequestration in deep tissue capillaries, allowing 
removal of the parasites by macrophages (Taylor-Robinson et al., 1993). However, 
an overproduction of NO, causing brain vessel dilation, could be responsible in turn 
for the increased intracranial pressure seen in cerebral malaria patients (Clark et al., 
1991; Newton et al., 1991) or it may be involved in another process at the neuron 
level (Clark et al., 1992) causing a disruption of the regulation of glutamate-induced 
neural NO. However, Senaldi et al. (1992), Asensio et al. (1993) and Kremsner et al. 
(1993) have reported that there is no influence of NO inhibitors on the development 
of cerebral malaria in the mouse model, P. berghei ANKA, even upon intracranial 
administration.
(viii) The role of the spleen
Resolution of malaria infection is dependent upon the presence of an intact 
spleen for the majority of host parasite combinations. Following splenectomy, non- 
lethal challenges may become lethal and latent infections may relapse (Taliaferro, 
1929; reviewed by Wyler et al., 1979). However, in some studies splenectomy does 
not effect the outcome of infection (Dockrell et al., 1980). This paradoxical situation 
may be reconciled by the finding of Wyler et al. (1979) that the spleen plays a 
beneficial role for the host early in infection, but it may later have a deleterious effect 
by promoting chronicity in some infections. The effect of splenectomy on the course 
of a subsequent malaria infection is dependent on the species of the host (Zuckerman 
& Yoeli, 1954; Langhome et al., 1979) and in the case of P. berghei, the age of the rat 
(Zuckerman & Yoeli, 1954). Although splenectomy removes a large population of
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effector cells (Brown et al., 1976a), this quantitative loss is probably not as important 
as losing access to the normal splenic architecture and filtering ability. In support of 
this, Phillips (1970) and Oster et al. (1988) showed that mice reconstituted with 
spleen cell suspensions after splenectomy experienced similar infections to the 
splenectomised controls, using several rodent malarias.
It was proposed by Barker & Powers (1971 a,b) that the generally deleterious 
effect of splenectomy on rodent malaria is attributable to a reduction of Ab response. 
However, the passive transfer of immune serum confers less protection to 
splenectomised rats than to intact rats, when infected with P. berghei (Brown & 
Phillips, 1974), suggesting the spleen is important for the phagocytosis of malaria 
parasites. This correlates with the pioneering work of Taliaferro & Cannon (1936) 
who observed an increased number of differentiated macrophages phagocytosing 
parasites in spleen sections taken from P. brasilianum-infected Panamanian monkeys. 
It was also reported for the first time that during a primary infection, the spleen 
becomes massively enlarged, splenomegaly, a hallmark of malaria. More recently, it 
has been shown that the total number of splenic macrophages increases dramatically 
during P. berghei (Wyler & Gallin, 1977) and P. yoelii (Lelchuk et al., 1979) 
infections of mice.
Why the spleen is so vital in malaria infection has only recently become clear 
with several claims for a physical role in trapping pRBCs, enabling localised parasite 
elimination (Conrad & Dennis, 1968; Schnitzer et al., 1972; Wyler et al., 1981). 
Observations suggest that the spleen efficiently filters out pRBCs as soon as they can 
be recognised as foreign. Rat P. berghei pRBCs are more rapidly removed from the 
circulation into the spleen than are nRBCs (Quinn & Wyler, 1976b; Wyler et al., 
1981). A unique structural feature of the spleen not found in other lymphoid organs, 
the red pulp, is considered to be the site where filtration occurs (Weiss, 1979). Within 
the red pulp, the intermediate circulation is such that arterioles open into cords that 
are connected with sinuses. The macrophage is the dominant leucocyte in the cords, 
monocytes entering the cords across arteriolar terminations appear to be selectively 
held in the interstices, or filtration beds, of the reticular mesh work (Weiss 1983 a,b). 
The migration of monocytes from the peripheral circulation to the spleen in vivo may 
be linked to the elaboration of a mononuclear chemotactic factor in vitro (Wyler & 
Gallin, 1977). Thus, immigrant mononuclear cells with high capacity for a 
respiratory burst are concentrated in the post-arteriolar region, and pRBCs entering 
through arterioles must pass through this site in close apposition to these effector 
cells, and can then be eliminated by direct phagocytosis by macrophages or by the 
cytotoxic effects of monokines and other macrophage-derived factors. Phagocytosis 
of P. knowlesi-infected RBCs by cordal macrophages has been observed in rhesus
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monkeys (Schnitzer etal., 1972).
There also exists a second filter system of the red pulp; blood leaving the cord 
enters the lumen of the vascular sinus by passing between endothelial cells (Weiss,
1979). This constitutes a slit-like space, and RBCs passing through it must be pliant. 
If RBC deformability is reduced, as is the case for pRBCs (Miller et al., 1971b), their 
passage is delayed and a pool of pRBCs forms within an environment rich in effector 
cells. This regional concentration of pRBCs was first reported by Taliaferro & 
Cannon (1936).
During malaria infection, the changes in the spleen depend on its singular 
capacities to trap circulating blood cells differentially in its filtration beds, where, for 
monocytes, they are stored for variable periods and proliferate (Weiss, 1983a,b) or, 
for pRBCs, are modified or destroyed (Weiss, 1978). Perhaps the most striking 
instance of splenic control of malaria is the phenomenon of crisis, the spontaneous 
and rapid disappearance of pRBCs from the blood (Taliaferro & Cannon, 1936; 
Taliaferro & Mulligan, 1937; Taliaferro & Taliaferro, 1944; Quinn & Wyler, 1979b; 
1980; Wyler etal., 1979a, 1981; Wyler, 1983a). Crisis fails to occur in the absence of 
the spleen. The disappearance of circulating pRBCs in crisis is due to their 
sequestration on the filtration beds of red pulp and their destruction by macrophages 
held there (Taliaferro & Cannon, 1936; Taliaferro & Mulligan, 1937).
As has been inferred above, the capacity of the spleen to clear the blood varies 
considerably during the course of blood stage malaria. It has been shown that, after a 
brief initial phase of active normal clearance, splenic clearance capacity falls to 
subnormal levels until crisis, when active clearance is restored (Quinn & Wyler, 
1979b; Wyler et al., 1981). Furthermore, during P. berghei malaria there is a change 
in blood flow through the spleen, with a switch from open arrangements (by which 
blood flows through the locules of filtration beds) during the time of normal or 
heightened clearance, to closed arrangements (by which blood is shunted from the 
locules) during depressed clearance (Quinn & Wyler, 1979b; Wyler et al., 1981).
In studies of lethal and non-lethal P. yoelii infections, an activation of reticular 
cells is at such a rate as to provide a competent blood-spleen barrier (Weiss et al., 
1986, Weiss, 1989; 1990). This barrier appears to exclude pRBCs from filtration 
beds, thereby protecting the proliferating and differentiating populations of 
erythroblasts (and lymphocytes, plasma cells and monocyte-macrophages) held there 
against infection. The position of this barrier, separating the powerful filtering 
capacities of the spleen from parasites carried in the blood, permits the development 
of a rising parasitaemia and anaemia (McGhee, 1960; Zuckerman, I960}. Crisis is 
associated with the relaxation of this barrier and with two important, complementary 
consequences: allowing pRBCs into the filtration beds of the spleen where they are
29
destroyed; and releasing the reticulocyte stores produced in the spleen by 
erythropoiesis into the circulation (Weiss et al., 1986). Blood flow characteristics, 
filtration capacities of the spleen and control of malaria appear intrinsically related, 
and depend upon the formation of the reticular cell blood-spleen barrier. Into such 
close apposition does this barrier bring host effector cells and parasite, it has been 
speculated that the very structure of the spleen may have been driven evolutionarily 
by malaria (Weiss, 1990).
(ix) The role of the liver
The liver is an important organ in the phagocytosis of malaria parasites. In 
splenectomised animals the liver takes over most of the extra burden of phagocytosis 
(Taliaferro & Cannon, 1936). In P. berghei infections of mice, the liver has a greater 
macrophage activity than the spleen (Singer, 1954). Partial hepatectomy of rats 
resulted in a striking enhancement of parasitaemia early in P. berghei infections 
(Cantrell & Moss, 1963).
Hepatomegaly occurs during malaria blood stage infections (Singer, 1954; 
Russell et al., 1963), the liver becoming extremely friable and dark. During P. 
berghei infection of rats hypertrophy of Kupffer cells occurs. There is also a 
progressive infiltration of the interlobular areas of the liver, initially with leucocytes 
and hypertrophying lymphocytes, but later increasingly with erythropoietic cells 
(Singer, 1954; reviewed by Aikawa et al., 1980).
(d) The immune reponse to gametocytes and gametes
Since the gametocyte is the stage of the malaria life cycle which transfers the 
parasite from the vertebrate host to the mosquito vector, stage-specific immunity 
against this form, or against gametes, would tend to reduce the infectivity of the 
parasite to the mosquito. This would thus suppress transmission and therefore, 
indirectly, protect the secondary host, notably humans, against malaria. For this 
reason, such immunity has commonly been referred to as transmission blocking 
immunity (reviewed by Carter etal., 1988; Targett, 1988).
After uptake by the mosquito in a blood meal, temperature (Sinden & Smalley, 
1976) and pH (Carter & Nijhout, 1977) changes trigger both male and female 
gametocytes to leave their erythrocytes. The gametes formed are then open to attack 
from any elements of the vertebrate's host immune response also present in the blood 
meal (Sinden & Smalley, 1976).
Vaccination studies have revealed that while gametocytes are poor immunogens 
(Carter et al., 1979a), vaccination with crude gamete mixtures of P. gallinaceum 
(Carter & Chen, 1976), P. knowlesi (Gwadz & Green, 1978) and P. yoelii (Mendis &
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Targett, 1979) limits or totally blocks mosquito transmission of challenge infections.
Serum from vaccinated animals does not affect the ability of gametocytes to 
initiate exflaggelation in vitro (Gwadz & Green, 1978; Mendis & Targett, 1979; 
Carter et al., 1979b). The male gametes, however, are subsequently immobilised 
(Carter et al., 1979b; Mendis & Targett, 1981), agglutinated (Carter et al., 1979b; 
Mendis & Targett, 1982) or fixed to the surface of the slide coverslip on which they 
are observed (Carter et al., 1979b). Induction of Abs can also be achieved by 
immunisation with ookinetes, a sexual stage, exclusive to the mosquito. These Abs 
prevent the development of the fertilised zygote in the mosquito (Grotendorst et al.,
1984) but the mechanism is unknown.
Harte et al. (1985a,b,c) have reported a form of transmission blocking immunity 
for P. yoelii nigeriensis. Adoptive transfer of immune T cells to naive recipients 
resulted in a near total reduction in transmission to mosquitoes following subsequent 
infection of grafted mice. The effect was best achieved with CD4+ cells and was 
manifested as a marked decrease in gametocyte numbers without affecting the course 
of asexual stage parasitaemia. While serum taken from immune donors was 
minimally effective alone, transfer of both serum and T cells gave the most 
protection, suggesting a synergistic effect between the cell-mediated and humoral 
immune compartments in suppressing gametocyte infectivity to mosquitoes. A 
human T cell response to gametes of P. falciparum has also been demonstrated in 
vitro (Good et al., 1987a). With both T cells taken from naive donors and those 
previously infected with malaria, Ag-specific proliferation and IFN-y secretion were 
readily stimulated by gametes, but not asexual stage P. falciparum parasites.
Ab-mediated anti-gamete immunity is quite easily induced in man during 
malaria infection. Studies in Sri Lanka and Papua New Guinea have shown 
detectable levels of Abs to gamete surface Ags for both P. falciparum and P. vivax 
(Mendis et al., 1987; Graves et al., 1988) and these Abs appear to be potent in 
reducing infectivity of the parasites to the mosquitoes. However, frequent re­
exposure to infection is required to maintain Ab levels (Mendis et al., 1987) since 
long term anamnestic responses are poor (Ranawaka et al., 1988).
1.9 Immunopathology
1.9.1 Non-specific cell activation
Polyclonal B lymphocyte activation occurs in malaria leading to a 
hyperproduction of IgG (McGregor et al., 1956; Cohen & Butcher, 1969). Non­
specific IgG has been shown to comprise a wide range of auto-Abs detected in sera 
from individuals with acute P. falciparum malaria, although autoimmunity is rare. 
Ags recognised include those of heart, thyroid and gastric parietal cells (Shaper et al.,
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1968), lymphocytes (Wells et al., 1980), and RBCs (Rosenberg et al., 1973; Ronai et 
al., 1981; Zouali et al., 1982; Wahlgren et al., 1983). High titres of Abs to 
rheumatoid factors (Shaper et al., 1968; Greenwood et al., 1971a), nuclear 
components (Greenwood et al., 1970; Adu et al., 1982), single strand DNA (Ribeiro 
et al., 1984), mitochondria (Boonpucknavig & Ekapanyakul, 1984), intermediate 
filaments (Mortazavi-Milani et al., 1984) and smooth muscle (Phanuphak et al., 1983) 
have also been found to be associated with malaria infections.
Hypergammaglobulinaemia was initially thought to be due to a direct mitogenic 
effect of malarial Ags on B cells (Greenwood, 1974) but has since been shown to be a 
T cell-mediated event (Weidanz, 1982), probably through the production of B cell- 
activating cytokines (Ballet et al., 1987; Kabilan et al., 1987).
1.9.2 Immunosuppression
Ag-specific unresponsiveness is quite often observed at the time of disease 
manifestation in residents where falciparum malaria is endemic (Ho et al., 1986; 
Riley et al., 1988b). In addition, malarious children have been shown to be deficient 
in their ability to mount primary immune reponses to certain, but not all non- 
plasmodial Ags. Vaccination with tetanus toxoid (McGregor & Barr, 1962); the O Ag 
of Salmonella typhi (Greenwood et al., 1972; Greenwood, 1984) and Group C 
meningococcal vaccine (Williamson & Greenwood, 1978) resulted in lower Ab levels 
and lower percentages of seroconversions than in uninfected controls.
Malaria-induced immunosuppression is also instrumental in the association 
between malaria, Epstein Barr Virus (EBV) and Burkitt's lymphoma (Burkitt, 1969). 
This hypothesis is supported by in vitro findings of Whittle et al. (1984), who 
reported that T-cell control by EBV-infected B cells was lost during P. falciparum  
malaria.
1.9.3 Cerebral Malaria (CM)
CM is the worst manifestation of infection with P. falciparum. The pathology 
of this disease is not directly parasite-related but instead may be due to induction of a 
detrimental host immune response to the malaria parasite. Vascular congestion and 
plugging of blood vessels with heavily parasitised RBCs (Polder et al., 1983), brain 
oedema (Oo et al., 1987), and damage of endothelial cells with altered capillary 
permeability (Areekul et al., 1984; Depierreux et al., 1987) are all recognised features 
of CM. The pathogenesis of these changes remains unknown although various 
hypotheses have been proposed. These include endothelial lesions (Wash, 1979) with 
attachment of monocytes to the endothelium (Rest, 1982); sequestration of pRBCs in 
capillaries (Yoeli & Hargreaves, 1974; MacPherson et al., 1985), possibly related to
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the particular adhesiveness of pRBCs to endothelial cells (reviewed by Howard & 
Gilladoga, 1989); T cell-mediated cellular immune reactions (Wright et al., 1971; 
Finley et al., 1982); and T cell-dependent humoral reactions involving circulating 
immune complexes (Contreras etal., 1980; Adam etal., 1981; Rest, 1982).
Rodent malaria infections have been used to study CM, although none can be 
labelled as falciparum-like by parasitological, morphological or molecular criteria. 
However, they have highlighted the importance of the immune system in modulation 
of cerebral pathology (Mackey et al., 1980; Rest, 1983; Franz et al., 1987; Cox et al., 
1987; Grau et al., 1987; Curfs et al., 1989). In addition they have implicated T cells 
in the development of experimental CM, since neurological complications are less 
severe in thymectomised or athymic animals (Wright et al., 1971; Finley et al., 1982). 
CD4+ T cells render thymectomised mice fully susceptible to neurological 
complications, while CD8+ cells did not induce pathological changes, although mice 
died of an overwhelming parasitaemia (Grau etal., 1986).
Multiple factors must determine why some acute P. falciparum  infections 
exhibit cerebral symptoms while others do not. Differences in P. falciparum parasites 
in genetically and phenotypically heterogeneous wild populations (Thaithong et al.,
1984), as well as variations in innate or acquired immune properties of the host are all 
important. Cytoadherence, however, appears to be consistent with all cases of acute 
CM in man. This is the attachment of pRBCs to endothelial cells lining brain 
capillaries, and consequent reduction of blood flow (MacPherson et al., 1985).
The most obvious cell-cell attachment involved in human CM is that of pRBCs 
with the endothelial cell lining of blood vessels (Trager et al., 1966; Luse & Miller, 
1971; MacPherson et al., 1985). Cellular adhesion between pRBCs and other host 
cells, including nRBCs (Handunnetti et al., 1987; 1989) may also be important in 
sequestration and pathology of acute P. falciparum malaria.
Three molecules have been discovered to be involved in the adhesion of pRBCs 
to the endothelial cell surface. These are: the integral membrane glycoprotein CD36 
(Oqendo et al., 1989); thrombospondin (Roberts et al., 1985); and the intercellular 
adhesion molecule ICAM-1 (Berendt et al., 1989). Howard & Gilladoga (1989) have 
suggested that P. falciparum pRBCs adhere to one or more of the receptors but not all 
of them. Induction of ICAM-1 expression is regulated by cytokines (Staunton et al., 
1988); indeed, TNF-a, II-1, 11-2 and IFN-y can all upregulate ICAM-1 levels on 
diverse cell types (Dustin et al., 1986; Rothlein et al., 1988; Asamow et al., 1989). 
Berendt et al. (1989) have suggested that severe malaria may occur when those 
individuals expressing high levels of ICAM-1 are also infected with a strain of 
malaria parasite that has a high affinity for ICAM-1.
In the P. berghei/CBAJCa mouse model, it has been demonstrated that excessive
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release of TNF plays a critical role in the pathogenesis of experimental CM (Grau et 
al., 1987). Elevated serum TNF levels were seen only at the time of neurological 
syndrome; in vivo depletion of CD4+ T cells, which blocks neurological 
complications, prevented the dramatic rise in serum titres of TNF (Grau et al., 1986). 
Moreover, treatment with a single injection of anti-TNF Ab exerted a protective effect 
on the P. berghei-induced neurological syndrome (Grau et al., 1987) and prevented 
all forms of lesions. Administration of recombinant murine TNF to a strain of mouse 
resistant to CM induced a lethal neurological complication with all the clinical and 
histopathological features of CM (Grau et al., 1989b). These observations show that 
TNF has both beneficial and deleterious effects depending on the degree of activation, 
timing and location, and thus may confer protective immunity, or, alternatively cause 
immunopathology during malaria infection.
TNF is known to induce NO. This may contribute to malaria associated 
pathology, particularly the coma accompanying CM (Clark et al., 1992). NO 
produced by vascular and endothelial cells stimulated by TNF-a might diffuse into 
the brain and disrupt the normal regulation of glutamate-induced neural NO, resulting 
in alterations in neurotransmission and possibly coma. However, evidence against 
this accumulates and has been reported earlier.
In man altered levels of TNF have been reported in the serum of malaria patients 
(Scuderi et al., 1986; Van der Meed et al., 1988; Grau et al., 1989c) and the levels 
shown to correlate with disease severity. TNF may, therefore, also be of pathogenic 
significance in human CM.
1.10 Immune evasion
Malaria infections are characteristically of long duration. In the case of P. vivax 
infections, latent liver stages intermittently complete their development and infect the 
blood. In the other malarias, however, such as P. falciparum , there are no latent 
forms and the persistent fluctuating blood infection must reflect, therefore, either an 
incomplete immune response, and/or evasion by the parasite of the full effects of the 
host's acquired resistance.
1.10.1 Sequestration
RBCs containing mature parasites of some malaria species undergo deep 
vascular tissue schizogony during which schizonts tend to withdraw from the 
peripheral circulation (Garnham, 1966). This is referred to as sequestration. 
Regardless of the state of immunity, only very immature sexual forms, rings, or 
mature gametocytes are usually found circulating in the blood of humans infected 
with P. falciparum. The more mature asexual stages localise to the post-capillary
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venular endothelium of the brain, placenta or gut. In the brain, sequestration may 
cause CM. Gametocyte development takes place initially in the deep vascular bed 
(Smalley et al., 1980); however, mature gametocytes are released into the peripheral 
blood, as they need to be accessible to mosquitoes.
In man, schizont withdrawal of P. falciparum, is almost complete. In other non­
human primates schizont withdrawal of this species does not occur to the same extent 
and the main sites are different (Miller, 1969; David et al., 1983). Therefore, host 
factors clearly influence sequestration. Sequestration occurs to some degree in P. 
vivax infections (Gamham, 1966) but not in P. malariae infections (Howard, 1988).
Relative schizont disappearance has been shown for several primate and rodent 
species. These include P. coatneyi, P. fragile (Desowitz et al., 1969; Fremount & 
Miller, 1975), P. knowlesi (Miller et al., 1971a) and P. berghei (Alger, 1963; Weiss, 
1983b; Mackey et al., 1980; Rest, 1982; Warrell, 1987). P. c. chabaudi, used in this 
study, also exhibits peripheral withdrawal (McDonald & Phillips, 1978; Gilks et al.,
1990) and schizonts have been noted to accumulate markedly in the liver (Cox et al.,
1987).
Marked stage-specific peripheral withdrawal of pRBCs is clearly a parasite- 
induced process. It is often suggested that the reason sequestration occurs is to avoid 
splenic filtration, or because of the parasite preference for the relatively anoxic 
environment of the deep vasculature (Howard, 1^88). The extent, however, to which 
sequestration represents a characteristic feature of many malaria species, or a specific 
feature of only a few host parasite combinations is thus unclear.
Cytoadherence of pRBCs to endothelial cells during falciparum malaria 
represents the acquisition of a specific, functional cell surface property on the infected 
cell. Immature pRBCs, rings and early trophozoites, and nRBCs do not adhere to 
endothelial cells (Udeinya et al., 1981). Thus, a specific receptor is expressed on the 
infected cell surface, capable of recognising a ligand(s) on the endothelial cells. The 
receptor is surface-exposed on pRBCs, must retain structural and functional 
homogeneity regardless of other phenotypic variations and therefore, it could 
represent an antigenically conserved target for an anti-malaria vaccine (Howard,
1988).
1.10.2 Antigenic variation
Extensive serological and immunochemical data point to the ability of blood 
stage plasmodia to undergo antigenic variation. Evidence for this phenomenon was 
presented by Cox (1962) for P. berghei and Brown & Brown (1965) in studies on the 
SICA antigen of P. knowlesi in rhesus monkeys. They found that antisera collected 
from monkeys reacted only with the population of parasites collected prior to the
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antisera. Parasites collected from later relapse populations in the same host did not 
react significantly with the earlier antisera. Howard et al. (1983) have confirmed 
these findings with cloned parasite lines of P. knowlesi. Antigenic variation of a 
cloned line of P. falciparum  has also been demonstrated in Saimiri monkeys 
(Hommel et al., 1983) and in vitro (Biggs et al., 1991; Roberts et al., 1992). Whilst 
the mechanism responsible remains unclear, major changes at the genomic level do 
not appear to be necessary (Hommel et al., 1991).
Using cloned lines of P. c. chabaudi AS in NIH mice, antigenic variation has 
been demonstrated in recrudescent populations by passive transfer of immune serum 
collected from mice following resolution of the acute infection but before any 
recrudescences had occurred (McLean et al., 1982b). This characteristic was stable 
through syringe passage and cryopreservation. Reversion to serum-sensitivity was, 
however, observed after the recrudescent population was passaged through 
mosquitoes (McLean et al., 1987). Using a live IFAT on schizont-infected RBCs 
Brannan et al. (1993) have also shown that mosquito transmission results in a change 
of antigenicity of cloned recrudescent parasites. Variant parasites have been detected 
during the ascending patent parasitaemia with a high rate of switching observed 
(Brannan et al., 1994), and have also been detected during the period of declining 
parasitaemia (McLean etal., 1990).
Overall, much work exists to suggest that antigenic variation occurs as a feature 
of recrudescing or relapsing chronic infection in malaria. Surface located parasite 
derived neo-antigens, expressed at late trophozoite and schizont stages have been 
shown to be one group of Ags that is variable. It is possible that the variant Ag has a 
specific function which needs a surface location. The obvious function is 
sequestration, and similarities between these two processes of immune evasion have 
been noted (Hommel, 1985; Howard, 1988). Many similarities are apparent between 
parasites showing the sequestering phenotype and undergoing antigenic variation. 
Both phenomena are parasite-induced changes on the surface of the pRBC that 
become apparent as schizogony commences, and both phenotypes are modulated by 
the spleen.
It has been suggested that the phenotypes may be the same Ags (Hommel, 1985; 
Howard, 1988). Until recently, ho system in which both phenotypes have been linked 
had been described; Gilks et al. (1990), however, have reported the use of P. c. 
chabaudi AS in CBA/Ca mice as such a model. Both clonal antigenic variation and 
deep vascular schizogony in the liver have been reported, and both these features 
were modulated by the spleen. Surface Ag expression was crucially involved in the 
sequestering phenotype.
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1.10.3 Antigenic diversity
Antigenic diversity is the expression of antigenically different forms of an Ag 
by different malaria isolates. Plasmodia exhibiting antigenic diversity may be derived 
from different geographical locations, different individuals at the same location, or 
different bouts of malaria within the one individual. In addition, diversity may also 
be recognisable in pRBCs taken at various times from a non-cloned parasite isolate 
cultivated in vitro. Ags that exhibit diversity may, but do not necessarily, confer a 
selective advantage to the parasite, and thus Ab-dependent selection of different 
phenotypes is not implied (Howard, 1984).
Significant antigenic diversity has been demonstrated in P. falciparum  in 
humans (eg. Jeffrey, 1966) by challenge with a heterologous strain of parasite from 
the infecting strain. Major geographical variation has now been shown by such 
techniques as enzyme electrophoresis, Ag characterisation, two dimensional protein 
electrophoresis, drug sensitivity and variation in Ag sequences. Nevertheless, P. 
falciparum is still considered a single species worldwide in which gene exchange can 
freely occur (Walliker, 1983).
It has been shown that numerous malarial Ags exhibit antigenic diversity in 
different P. falciparum isolates; eg. the major glycoprotein on the surface of mature 
asexual stage pRBCs (reviewed by McBride et al., 1982) and the S Ag released into 
plasma during rupture of schizont-infected RBCs (Wilson, 1980).
The great phenotypic diversity achieved by malaria parasites is thought to be of 
advantage to the parasite as many host immune responses are relatively specific, at 
least initially. Within the limited information available, it has always been assumed 
that the antigenic diversity of various pRBCs Ags reflects the expression of different 
allelic forms of a single gene. The diverse forms are generated either by 
accumulation of mutations or by genetic rearrangements during meiosis. That 
heterogeneity is maintained by genetic recombination in addition to mutation has been 
shown in P. c. chabaudi (Walliker et al., 1975) and with human malaria (Walliker et 
a l, 1987).
1.11 Development of a malaria vaccine
Due to the inability of insecticides and chemotherapy/chemoprophylaxis to 
eliminate the vectors or disease caused by Plasmodium, vaccines against the parasite 
are urgently needed.
Each of the different stages of the malaria life cycle presents target cells for 
immunisation, and experimental vaccines are being developed against all of them 
(Miller et al., 1986). Thus, Ags for vaccine development are being identified from 
sporozoites, pre-erythrocytic forms, asexual and sexual forms. These will be
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described later. However, as immunity appears to be stage specific, this presents a 
problem in that a parasite which escapes immunity at one stage of the life cycle may 
be unaffected by this immunity during its development in the next stage. Therefore, 
an effective vaccine may need to be multicomponent, providing protective immunity 
to all stages of the life cycle.
The features of a malaria vaccine may vary according to its role. In order to be 
successful in a public health capacity, a cheap, single inoculation preparation is 
required, which must be effective in conferring considerable and long lasting 
protection in infants who may have been exposed to both infection and to maternal 
Ab. In contrast, a vaccine for the non-immune visitor to endemic areas may be 
required to preclude the development of parasitaemia completely, because of the 
considerable danger of early death in an adult experiencing a first parasitaemia of P. 
falciparum , and in order to minimise the chances of spread of disease upon return 
home.
Regarding the potential usefulness of vaccines for disease control, permanent 
residents in endemic areas contribute by far the largest populations that would benefit 
from successful vaccination and they are the major target group for eventual vaccine 
use. Effective natural immunity to malaria is achieved only after repeated infection, 
usually over a period of years. At such a time, blood infections may not be 
suppressed completely and asymptomatic parasitaemias persist. It is possible that an 
asexual blood stage vaccine would have an effect similar to that produced by natural 
exposure, merely limiting disease severity whilst not completely preventing 
parasitaemia. In such a situation, subsequent infections may boost vaccine-induced 
immunity.
Attenuated (Clyde et al., 1973; Weinbaum et al., 1976b; Rieckmann et al, 1979; 
Waki et al., 1986) and killed (Desowitz & Miller, 1980) malaria parasites have been 
shown to be efficacious as vaccines for humans and animals. Such vaccine 
preparations are not currently used for disease prevention because of the difficulties 
of large scale in vitro cultivation of plasmodia (Trager & Jenson, 1976) and the 
associated risks of preparing pRBCs from cultures containing human serum, which is 
an essential requirement of in vitro cultivation. If such problems were overcome, an 
attenuated live P. falciparum vaccine could be developed, one which, through gene 
deletion, had lost its capacity to adhere to endothelial cells (Pologe & Ravetch, 1986). 
These pRBCs would not cause organ pathology, notably CM, and would circulate 
through the spleen, whereby they would be both cleared from the circulation and 
stimulate an immune response which would protect against a virulent parasite 
challenge.
At present, the goal is to stimulate protective immunity to the whole parasite
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from only one or a few parasite proteins, or derived peptides, prepared by 
recombinant or synthetic peptide technology, i.e. a subunit vaccine. It is necessary 
that these vaccines contain multiple T cell epitopes, to overcome genetic restriction, 
for natural boosting of the antibody response. Moreover, these vaccines must 
preferentially induce immune effector mechanisms rather than responses with no 
protective activity or worse still causing immunopathology.
1.11.1 Sporozoite/pre-erythrocytic stage vaccine
A fully effective sporozoite vaccine is expected to induce immunity which 
prevents infection by either stopping invasion of liver cells, or if invasion occurs 
preventing the parasite completing its pre-erythrocytic cycle. Incomplete immunity, 
through a single sporozoite escaping the response, would not prevent infection of the 
blood and in the non-immune in particular may not prevent disease. However, a 
reduction in the number of sporozoites invading or completing the liver cycle may 
delay the numbers of blood stage parasites increasing to levels which normally might 
cause pathology.
Attenuated sporozoites, eg. through X-irradiation, in rodents, monkeys 
(reviewed by Nussenzweig & Nussenzweig, 1986) and in man (Clyde et al., 1975) 
can induce a sterilising immunity. A mAb to the sporozoite coat protein 
(circumsporozoite/CS protein) was protective in mice to a sporozoite challenge 
(Yoshida et al., 1980). The gene coding for the CS protein was subsequently cloned 
and sequenced for human, simian and murine malarias (Ellis et al., 1983; Dame et al., 
1984; Enea et al., 1984; Amot et al., 1985; Eichinger et al., 1986; Lai et al., 1987). 
The CS protein is the major sporozoite protein and in each species it has the same 
general makeup. The central third consists of multiple repeating immunogenic 
sequences which are unique for each species.
In P. falciparum  the major repeating sequence (-40 times) is asparagine- 
alanine-asparagine-proline (NANP). The central repetitive region is the 
immunodominant B cell epitope and antibodies to the repetitive region block 
sporozoites in culture (Zavala et al., 1985). It is also conserved in different isolates of 
P. falciparum (Weber & Hockmeyer, 1985). For these reasons the repeat region was 
an attractive vaccine candidate and two human trials were carried out (Ballou et al., 
1987; Herrington et al., 1987). In one trial the immunogen was a synthetic peptide, 
(NANP)3, conjugated to tetanus toxoid, and in the other a 30 repeat unit of NANP, 2 
repeat units of the minor repeat of asparagine-valine-aspartate-proline (NVDP) and a 
32 amino acid tail of the tetracycline resistance gene (R32tet32) encoded by the 
vector : both used aluminium hydroxide as adjuvant. Protection in both studies 
correlated with antibody levels; most of the vaccinees, however, had poor antibody
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responses. From these studies the necessity to include T cell epitopes, preferably 
from the CS protein itself, was highlighted.
1.11.2 Asexual blood-stage vaccines
Protective immune responses to the asexual blood stages of malaria parasites 
include both antibody and non-antibody mechanisms and have been described 
elsewhere.
A large number of Ags of asexual blood-stages of P. falciparum have now been 
described and the genes or gene fragments encoding many of them have been cloned. 
As yet none of the antigens appears to be especially important in inducing protection 
alone and it is therefore likely, that an effective vaccine will require a combination of 
several antigens.
Antigens currently being considered as candidates for inclusion in an anti-P. 
falciparum asexual blood stage vaccine are briefly described below. The major 
surface proteins of the merozoite of P. falciparum  are a complex of processed 
products of a 185-220 kDa precursor glycoprotein and have variously been termed 
PMMSA, p i90, p i85, PSA, MSPP, MSA1, MSP1. The protein is synthesised during 
schizogony and is proteolytically processed around the time of schizont rupture. A 
number of mAbs to MSP1 inhibit merozoite invasion in vitro and homologous 
proteins in animal models are involved in protective immunity (Holder & Freeman, 
1984; Holder, 1988). Immunisation of monkeys with MSP1 purified from P. 
falciparum parasites (Siddiqui et al., 1987) or with an N terminal synthetic peptide 
gave some protection (Cheung et al., 1986; Holder et al., 1988). Antigenic diversity 
in this molecule between isolates has been reported The relative importance of 
conserved and variable regions in inducing specific immune responses is being 
investigated, and the molecule is being mapped for T and B cell epitopes.
The ring-infected erythrocyte surface antigen (RESA or Pfl55) was first 
detected by a modified immunofluorescence assay on ring-infected P. falciparum  
infected red blood cells (Holder et al., 1988; Foley et al., 1993). This molecule, MW 
155 kDa, may facilitate invasion by interfering with membrane or cytoskeleton 
organisation. The gene coding for the molecule has been cloned and sequenced 
(Cowman et al., 1984; Favaloro et al., 1986). Immunodominant epitopes are found in 
two blocks of repetitive sequences. Antibodies against the native molecule or to 
various repeat sequences block invasion in vitro. Vaccine experiments in monkeys 
with fragments of the molecule gave limited protection (Collins et al., 1986).
The gene for another merozoite surface antigen, MSA2 or MSP2, has been 
cloned and sequenced from several strains, and contains relatively conserved flanking 
regions around strain variable regions containing repetitive sequences (Smythe et al.,
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1988; Smythe et al., 1990). By SDS electrophoresis it has a molecular weight of 
approximately 45 kDa. Monoclonal antibodies to MSA2 have been found to inhibit 
merozoite invasion in vitro, which has encouraged further work on this molecule.
Rhoptry antigens at the apical end of the merozoite are implicated in the 
invasion process. Highly membranous material is discharged from rhoptries into a 
membrane lined vacuole which surrounds the merozoite as it enters the RBC 
(Bannister et al., 1986; Crewther et al., 1990). Two target antigens have been 
extensively studied. Rhoptry associated protein-1 (RAP-1) (Ridley et al., 1990) is a 
non polymorphic Ag which protects Saimiri monkeys against a lethal challenge of P. 
falciparum. AMA-1 (apical membrane antigen-1) described by Crewther et al. (1990) 
shows minimal strain variation. For this reason there is considerable interest in this 
molecule, as well as its probable functional importance and conserved nature 
(Phillips, 1992).
Antigens on the surface of infected erythrocytes containing mature asexual 
forms of P. falciparum have been detected by several methods (Hommel & Semoff,
1988). No RBC surface antigen has yet been used in a vaccine trial. Several Ags, 
however, are of particular interest. PfEMP-1 may mediate the the cytoadherence of 
the schizont infected cells to vascular endothelium (sequestration). Antigenically it is 
very diverse and varies in size from 240-350 kDa (Leech et al., 1984; Marsh & 
Howard, 1986; Anders & Smythe, 1989; van Schravendijk et al., 1991). As yet 
uncloned and despite considerable polymorphism, PfEMP-1 is an attractive vaccine 
candidate because induction of immunity would prevent cytoadherence and hence 
CM. PfEMP-2 (MESA) (Anders & Smythe, 1989); two histine rich proteins PfHRP-1 
and PfHRP-2 (Howard et al., 1986; Rock et al., 1987); rosettin (Helmby et al., 1993) 
and Ag332 (Mattei & Scherf, 1992; Mattei et al., 1992) are other membrane surface 
Ags with vaccine potential.
Patarroyo and colleagues have recently carried out extensive testing of purified 
protein preparations from merozoites for protective activity in Aotus monkeys 
(reviewed by Moreno & Patarroyo, 1989). On the basis of these experiments and 
information from published work they prepared two hybrid polymers, SPf66 and 
SPfl05. The former contained two merozoite specific proteins of unknown location, 
a fragment of MSP-1 and CS repeats. SPfl05 was made up of a MSP-1 fragment, a 
repeat of Pf 155/RES A, CS repeats and a T cell epitope from the CS protein 
(Patarroyo et al., 1987). In current vaccine trials the polymers are combined with 
alum. Initial studies (Patarroyo et al., 1988; Valero et al., 1993) and the recent 
reports by Sempertegui et al. (1994) and Teuscher et al. (1994) in vaccine trials of 
SPf66 show protection against severe clinical disease in a proportion of vaccinees.
pRBC rupture allows merozoite release and invasion of new RBCs. Since
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pRBC development in vivo is synchronous, large amounts of pRBC-derived lipids, 
glycolipids and (glyco)proteins, as well as particulate materials, are released into the 
plasma within a relatively short time. These materials undoubtedly elicit host 
responses that lead to the periodic symptoms of acute malaria. It has been proposed 
that vaccine-induced Abs specific for these components could lead to immune- 
mediated removal of these Ags without elicitation of the cascade of undesired host 
responses (Playfair eta l., 1990; Playfair, 1990; Kwiatkowski, 1991; 1992).
1.11.3 Sexual stage vaccine/Transmission blocking vaccine
A vaccine against the sexual stages of the parasite would not protect the 
vaccinee but would interrupt transmission by abolishing or reducing the ability of 
gametocytes from that individual to infect a biting mosquito. Such vaccines would 
only interrupt malaria transmission at the level of the mosquito, but would not afford 
any protection in the vaccinated human. The inhibitory immune response would be 
directed against gametocytes, gametes or zygotes/ookinetes. Animal studies 
(reviewed by Carter et al., 1988; Targett, 1990; Kaslow et al., 1992) have 
demonstrated the feasibility of artificially inducing transmission blocking immunity 
and there is also evidence that transmission blocking immunity develops in human 
populations to P. vivax (Peiris et al., 1988) and to P. falciparum (Carter et al., 1988). 
Abs appear to be the major effector mechanism but T cell mediated Ab-independent 
mechanisms have a role (Harte et al., 1985).
A number of vaccine candidate Ags have been identified. Three target Ags (230 
kDa, 48/45 kDa and 25 kDa) expressed on the surface of the extracellular forms of the 
sexual stage parasite have received the most attention. Abs to Pfs230 and Pfs48/45 
(which are also present in the intracellular gametocyte) disrupt development of the 
parasite if they are present before fertilisation occurs (Rener et al., 1983; Quakyi et 
al., 1987) and can be detected in immune sera in some humans resident in malarious 
areas (Graves etal., 1988; C a rte r^ a l, 1989; Quakyi etal., 1989).
The Pfs25 gene has been cloned (Kaslow et al., 1991) and Abs to this Ag can 
completely block transmission to mosquitoes (Kaslow et al., 1988). Polymorphism in 
Pfs25 is minimal, the gene has been inserted into both vaccinia virus and yeast 
(Kaslow et al., 1992), and expression of the recombinant protein found to be correct 
in both systems. These results suggest that human trials will soon be justified with a 
yeast secreted analogue of Pfs25, however, immunity to Pfs25 would not be boosted 
by natural infection.
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1.12 History of Plasmodium chabaudi chabaudi
Plasmodium chabaudi chabaudi, the parasite used in this study, was isolated 
from the blood of thicket rats, Thamnomys rutilans, caught in the Central African 
Republic by Landau in 1965. The parasite infects mainly mature RBCs (Landau, 
1965) although under conditions of anaemia, for example following peak 
parasitaemia, it can invade reticulocytes (Carter & Walliker, 1975; Jarra & Brown,
1989). Multiple infection of RBCs with P. c. chabaudi occurs (Carter & Walliker, 
1975).
P. c. chabaudi is an invaluable model in which to carry out many aspects of 
malaria research. It has become a recognised animal model for P. falciparum  
infection in humans, showing a number of important similarities (Long, 1988; Mons 
& Sinden, 1990; Gilks et al., 1990). Asexual stage parasites of both species have a 
synchronous cycle in the peripheral circulation, although for P. c. chabaudi the 
asexual erythrocytic cycle is completed in only 24 hrs. Peripheral withdrawal of 
schizonts to deep tissue capillaries occurs in both species as schizont maturation takes 
place (Shungu & Arnold, 1972; McDonald, 1977; McDonald & Phillips, 1978; Gilks 
et al., 1990).
The CB strain of P. c. chabaudi was selected for this project because it is a more 
virulent strain of parasite than the commonly used AS strain. Cloned, well 
characterised lines of the CB strain have been established by Carter & Walliker 
(1975) in laboratory mice from wild-caught infected Thamnomys isolates without any 
need for adaptation. These clones have been cyclically passaged in Anopheles 
stephensi and are free from contamination with other rodent malaria species or 
pathogens such as Eperythrozoon coccoides and Haemobartonella muris (Cox, 1978). 
Isoenzyme patterns have been established for these CB strain clones, which have, 
unlike many laboratory strains of rodent malaria, remained close to the original isolate 
(Beale et al., 1978; D. Walliker, personal communication)
While P. c. chabaudi CB is virulent, infected mice usually eliminate infection 
with this strain. In NIH mice, which show a genetic resistance to P. c. chabaudi 
(Stevenson et al., 1982), it displays a course of infection consisting of a high peak 
parasitaemia followed by a subpatent period of unpredictable duration, and one or two 
short lasting recrudescences of low parasitaemia (Figure 1.12.1a). It is sometimes 
necessary, however, to assist mice through the peak parasitaemia with subcurative 
chloroquine treatment. Such treatment results in rapid parasite remission but a higher 
recrudescence than that seen in naturally recovering mice follows (Figure 1.12.1b). In 
addition, the course of infection is much more predictable following chloroquine 
intervention.
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FIGURE 1.12.1 The course of Plasmodium chabaudi chabaudi CB strain infection 
usually observed in naive NIH mice (a) naturally recovering from infection, or (b) 
treated with chloroquine 10 days post infection.
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1.13 Experimental Rationale
Within Professor Phillips' laboratory much work has been carried out on the role 
T cells play during infection with the AS strain of P. c. chabaudi. It is now clear that 
the major protective immune mechanisms to the erythrocytic stages of this strain of 
parasite require the presence of CD4+ T cells. Indeed, cloned T cell lines of either the 
ThI or Th2 phenotype (Taylor-Robinson & Phillips, 1992; 1993; 1994a) can protect 
immunocompromised mice upon adoptive transfer. This model of infection, however, 
differs from another subspecies of P. chabaudi, P. c. adami, where immunity is 
mediated solely by Ab-independent mechanisms (Grun & Weidanz, 1981). Only a 
limited number of studies have been carried out using the more virulent strain, P. c. 
chabaudi CB. One report suggests that this strain is also resolved in a totally Ab- 
independent manner (Cavacini et al., 1990), thereby differing from the AS strain 
(Langhome et al., 1989; Taylor-Robinson & Phillips, 1992; 1993; 1994a). The 
experiments described in this thesis were performed to define further the role of 
cellular immunity to rodent malaria infection, using the P. c. chabaudi CB/NIH 
mouse model. In this host parasite combination there is an unpredictable course of 
infection, and in order that mice survive the acute peak parasitaemia subcurative 
chloroquine treatment is often required at this time. Such treatment, therefore, also 
allowed the effect of chemotherapy on the development of an immune response to be 
investigated.
At the outset of this study, the effect of depletion of specific T cell subsets on 
the course of P. c. chabaudi CB infection by mAb treatment was investigated. This 
established that T cells of the CD4+ phenotype were critical for resolution of this 
strain. Adoptive transfer experiments were performed with lymphocyte populations 
taken from naturally recovered or chloroquine treated donor mice at various times 
during infection. This was of interest, for all previous reconstitution studies had 
employed lymphoid populations taken after parasite clearance from recovered 
animals. Initial findings showed that immunity could be transferred with 
lymphocytes prepared from all stages of infection investigated. Interestingly, T cells 
from donor mice 21 days post infection could transfer an immunity that appeared to 
transcend antigenic variation. To analyse this further, a passive transfer system was 
employed to dissect the degree of immunity which could be transferred with serum 
and to look at the ability of the CB strain of P. c. chabaudi to undergo antigenic 
variation, a phenomenon well documented for the AS strain (McLean et al., 1982b; 
1986a; Gilks et al., 1990). In addition, the effect of chloroquine treatment on 
antigenic variation was also considered. The role of nitric oxide during the course of 
infection of P. c. chabaudi CB was also studied and the effect of different chloroquine 
treatment regimes on the production of NO determined. Finally, to examine further
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the role of the CD4+ T lymphocyte subset in the mediation of protection to P. c. 
chabaudi CB infection, an attempt was made to establish spleen cells in vitro as 
homogeneous CD4+ T cell lines. The ability of one successful line to moderate a 
challenge infection and to respond in vitro to P. c. chabaudi CB Ags is described.
The results of the experiments outlined above are described and the dynamics of 
T cell subsets during the evolution of an effective immune response to malaria 
infection are discussed with regard to the development of effective asexual blood 
stage malaria vaccines. The implications of subcurative chloroquine treatment on the 
development of immunity are also considered.
CHAPTER TWO 
MATERIALS AND METHODS
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2.1 Mice
For most experimental procedures female inbred NIH mice were used. These 
were bred in the WLEP animal house breeding facility, inbred to between 26 - 35 
generations from an original mating pair purchased from Hacking and Churchill Ltd 
in 1980. All mice bom in the breeding facility were weaned at three weeks of age, 
and were used for experimental procedures between 6 and 12 weeks old when they 
weighed approximately 25 g. The mice were kept in the animal house at 22°C ± 2°C 
and 50-60% relative humidity and maintained in 12 hrs artificial light from 0800 to 
2000 hr. They were maintained on pelleted CRM breeder diet (Labsure Ltd) and 
given both food and water ad libitum.
2.2 Parasites
The CB strain of Plasmodium chabaudi chabaudi was originally isolated from a 
thicket rat (Thamnomys rutilans) caught in the Central African Republic in 1970 and 
transported to Edinburgh (Beale et al., 1978). The parasite line was established in 
laboratory mice and then cloned by limiting dilution (Walliker et al., 1971) in 1979 
and the parasites frozen. The parasites were supplied to WLEP by Professor Walliker 
from the World Health Organisation Registry of Standard Strains of Malaria Parasites 
in 1989. Since then, CB parasites have been maintained by cryopreservation and 
subpassage through mice (see 2.3 & 2.4). Figure 2.2.1 shows a history of P. c. 
chabaudi CB since isolation.
FIGURE 2.2.1
History of Plasmodium chabaudi chabaudi CB strain populations
Derived from Thamnomys rutilans caught in the Central African Republic in
September 1970
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2.3 Maintenance of Parasites
Suspensions of pRBCs taken at a specific time from a known source were 
designated stabilates as proposed by Lumsden & Hardy (1965). For longterm 
preservation, parasite stabilates were kept in liquid N2 (-196°C) (BOC). When 
required for experimental use, infected blood was recovered from stabilate following 
the method of Mutetwa & James (1984a,b). Each stabilate was defrosted by 
immersion of the vial in a 37°C waterbath, then diluted with an equal volume of 15% 
w/v glucose in PBS (pH 7.2) (Appendix) before immediate i.v. or i.p. injection into 
one or two recipient naive mice.
Parasites were maintained by blood passage in mice every 2-4 days. Mice were 
bled by cardiac puncture, under terminal ether anaesthesia, into a syringe containing 
sodium heparin (1000 i.u./ml, Evans Medical Ltd.) in PBS as an anticoagulant, at 10 
i.u. heparin per ml of blood. The infected blood was subinoculated into recipient 
mice either by i.v. or i.p. injection. Experimental mice were infected with blood one 
passage from stabilate.
2.4 Cryopreservation of infected blood
Parasites were cryopreserved as stabilates using the method of Phillips & 
Wilson (1978). Blood with a parasitaemia of 5-10%, containing ring stage parasites 
(rings survive the freezing and subsequent thawing the best), was collected into 
heparinised PBS (10 i.u./ml) and diluted 1:1 with a solution of sorbitol-glycerol 
(Appendix), added slowly dropwise with frequent mixing (Gray & Phillips, 1981).
0.2 ml aliquots were dispensed into 1.2 ml cryopreservation vials, each labelled with 
the WEP code and a number. These were immediately snap frozen by immersing in 
liquid N2, and stored in cannisters (Union Carbide or Taylor-Wharton).
2.5 Challenge Infections
Infected blood for challenge infections was obtained by cardiac puncture (as 
above) and collected into 10 i.u./ml heparinised PBS. The parasitaemia of the donor 
mouse was determined by examination of a Giemsa's stained thin blood smear (see 
below). The blood was diluted to the required concentration of pRBCs/ml in 
complete RPMI 1640 medium (Gibco) (Moore et al., 1967) (Appendix). For all 
infections, naive mice were challenged with 5 x 104 pRBCs administered as a 0.2 ml
1.v. inoculum, using a 1 ml syringe fitted with a 26 G needle (both Becton Dickinson).
2.6 Inoculation
Prior to injection mice were warmed gently under a heat lamp to cause 
vasodilation. I.v. infection was then performed via one of the lateral tail veins.
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2.7 Chloroquine treatment
Where necessary experimental mice were treated with subcurative doses of 
chloroquine. Each mouse received approximately 50 mg/kg chloroquine diphosphate 
(Sigma) in PBS (Appendix) administered i.p. as a 0.25 ml inoculum on one or 
sometimes two occasions.
2.8 Determination of parasitaemias
Infections with P. c. chabaudi CB were monitored by determining parasitaemias 
from thin blood smears made directly from infected mouse tail blood. The smears 
were taken between 0900 - 1100 hr each day.
Blood smears were made on microscope slides with ground glass edges (BDH 
Ltd) from drops of tail blood drawn by piercing the mouse tail with a lancet 
(Monoject Scientific). The lancet was routinely sterilised in alcohol between each 
mouse and group of mice in order to minimise the possibility of transfer of pRBCs 
between animals. The smears were air dried at RT, fixed in 100% methanol (Analar, 
BDH Ltd) for 1-2 min and then stained in Giemsa's stain (Gurr, BDH Ltd) diluted 
1:10 in Giemsa's phosphate buffer (pH 7.4) (Appendix) for 30 min. The blood smears 
were rinsed in tap water, air dried and examined under oil immersion using X I00 
objective and X10 eyepiece lenses on a Leitz S.M. Lux binocular microscope.
Parasitaemias were obtained by calculating the number of pRBCs from a total 
number of RBCs. If the parasitaemia was >2-3% (determined by observing more than 
3-4 parasites per field of view), direct counts of the number of parasites per 500 RBCs 
were made. Lower parasitaemias were enumerated by counting the number of 
parasites observed in a total of 30 fields. At this magnification, each field represented 
about 250-300 RBCs. Infections were considered subpatent when no parasites were 
seen in 50 fields.
For experimental procedures, the day of infection was termed d 0 and smears 
were taken from d 4, when most mice began to carry a patent infection, to d 60, when 
all mice had cleared infection.
2.9 Presentation of parasitaemic data
The course of infection of a group of mice was represented graphically by 
plotting the geometric mean of the parasitaemia (mean logio of the number of 
pRBCs/105 RBC) against time (expressed in days). Vertical bars showing one S.D. 
are included where necessary. However, for clarity, S.D.s are only put in if 
differences in the courses of parasitaemia are not self-evident. From the data 
collected and their graphical presentation, four main criteria were used to evaluate the 
effects of protective immune responses on challenge parasitaemias. These were (i) 
the time taken for mice to show a 2% parasitaemia (the pre-2% latent period)
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(Warhurst, 1966); (ii) the day and level of the peak parasitaemia; (iii) any extension of 
the time taken for the primary parasitaemia to be resolved relative to controls 
(assessed by recording the total time for the parasitaemia to rise from the 2% level to 
peak and then to fall to subpatency) (a modification of the data evaluation of Jarra et 
al. (1986)); (iv) any extension of the pre-recrudescent subpatent period relative to 
controls.
The minimum number of mice in each experimental group was 5-6 for all in
vivo studies. For such a group size, the reproducibility of individual parasitaemia
determinations, which includes the variable of smear preparation as well as the
parasite counting, is close to the predicted theoretical minimal level calculated using
the binomial distribution (Gilks, 1988). Groups of 5-6 mice were used so that the
random scatter of parasitaemias would be expressed to cancel each other out. Thus,
parasitaemia curves are relatively smooth. Despite these precautions, some variability
was encountered in the counts, especially after crisis and resolution of the primary
parasitaemia. The data were transformed using Cricketgraph version 1.3.2 (Cricket
Software) on an Apple Macintosh Classic microcomputer (Scotsys Computer
Systems). Nonparametric statistical analysis was performed on parasitaemia data
using the Mann-Whitney or Kruskal-Wallis tests! . Test results and degrees of freedom 
have been inappropriately omitted from the text; only p values are presented.
2.10 Production of mAbs for T cell subset depletion
Rat IgG2b mAbs to murine T lymphocyte subsets were prepared by propagation 
of Ab-secreting hybridoma cells as ascites tumours in (LOU x DA) Fi rats. The 
hybridomas were obtained from the European Collection of Animal Cell Cultures, 
PHLS Centre for Applied Microbiology and Research, Porton Down, Salisbury, 
Wiltshire (originally deposited by Prof H Waldmann and Dr S P Cobbold, Dept of 
Pathology, University of Cambridge). The two mAbs used recognise in all strains of 
mice tested the two monomorphic cell surface glycoproteins CD4 and CD8 the 
differential expression of which separates all T cells into two subsets. YTS 169.4 
binds to mouse suppressor/cytotoxic T cells (CD8+) and their precursors in vitro, but 
not to helper T cells. Conversely, YTS 191.1 is specific for CD4-bearing mouse 
helper/inducer and delayed hypersensitivity T cells, but not for cytotoxic T cells or 
their precursors in vitro (Aqel et al., 1984).
mAb production in high concentration was conveniently achieved by growing 
the Ab-secreting hybridoma cells in vivo as ascites tumours in (LOU x DA) Fi rats 
primed with mineral oil (Potter et al., 1972). The ascitic fluids were partially purified 
by precipitation with 40-45% ammonium sulphate. The precipitates were redissolved 
in PBS, concentrated by dialysis and sterilised by filtration. Before use in vivo, the 
specificity and cytotoxic potential of the mAbs were ascertained by complement 
mediated cytolysis (Bruce et al., 1981) and immunofluorescence (Cobbold et al.,
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1986) respectively.
2.10.1 In vitro culture of hybridoma cells
The hybridomas were received as two frozen ampoules packed in dry ice. The 
contents of each cryopreservation tube were thawed rapidly in a 37 °C water bath, and 
the cells washed in excess RPMI 1640 medium containing 10% FCS (complete 
medium) (250 g for 5 min). They were then cultured at 37°C in an atmosphere of 5% 
CO2 at 2 x 105 cells/ml. When the cells had reached confluency they were 
subcultured every 2-3 days in 20ml volumes at 2 x 105 cells /ml. Stocks of the two 
cell lines were cryopreserved in liquid N2 for longterm storage as outlined later (2.29- 
Cryopreservation of T cell lines).
2.10.2 Ascites production
Adult female LOU and male DA rats were purchased from Harlan Olac Ltd and 
were mated in the WLEP animal house. At 12 weeks old ten male (LOU x DA) Fi 
hybrids were used. Rats were primed with an i.p. injection of 0.5 ml of pristane, 
2,6,10,14-tetramethylpentadecane, a component of mineral oil (Hoogenraad et al., 
1983; Brodeur et al., 1984) (Aldrich Chemical Co.), 7 d prior to inoculation with 5 x 
106 cells of each hybridoma in 0.4 ml incomplete RPMI 1640 medium. Animals were 
monitored daily for abdominal swelling. Ascitic fluid was collected by inserting a 21 
G needle into the peritoneal cavity and allowing the ascites to drain into 20 ml sterile 
Universals. Animals were tapped subjectively based on the degree of swelling from 
12-19 d after hybridoma implantation. On each day, the ascites collected were 
centrifuged at 500 g for 10 min, the S/N harvested and stored at -20°C.
2.10.3 Purification of ascitic fluid
The IgG fraction of the collected ascitic fluid was isolated by salting out with a 
40-45% w/v saturated solution of ammonium sulphate. Aliquots of 20 ml of ascitic 
fluid were thawed in a 25°C waterbath and 5.4 g ammonium sulphate (BDH Ltd) 
added to each to make a 45% w/v solution. Each ascites sample was then incubated 
for 30 min at 25°C after thorough stirring. The large precipitate was pelleted by 
centrifugation at 1000 g for 30 min at 25°C. The S/N was discarded and the protein 
precipitate redissolved in distilled water up to 10 ml. The IgG was reprecipitated by 
addition of 1.35 g ammonium sulphate to make an overall 40% w/v solution. Once 
dissolved, each solution was incubated for 30 min at 25°C. The white precipitate was 
collected by centrifugation (1000 g for 30 min at 25°C), pooled and redissolved in 
distilled water up to 80 ml.
The redissolved precipitate was dialysed overnight against PBS (pH 7.2) to 
remove any traces of ammonium sulphate and to concentrate the IgG present in
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solution. 35 cm lengths of cellulose acetate dialysis tubing (nominal MW cut-off 
12000, flat width 35 mm) (Sigma) were presoaked in PBS and then sealed at one end 
with a Pierce dialysis clip. 20 ml of either mAb solution was then pipetted into the 
tubing. After sealing the top end, each tube was placed in a 5 1 glass beaker filled 
with PBS and agitated gently with a magnetic bar and stirrer motor. The dialysis 
tubes were left overnight at 4°C to reach equilibrium. When dialysis was complete 
the volume in each tube had approximately doubled due to the high osmolarity of the 
salted out S/N. The partially purified IgG anti-Ly-2 and anti-Ly-4 mAb samples were 
pooled, filter sterilised (0.22 fim, Millipore), and the IgG concentration determined by 
a modification of the Bradford dye-binding assay. For each of the mAbs the protein 
concentration was approximately 16 mg/ml. The mAb preparations were stored as 
either 10 ml or 1 ml aliquots at -20°C and repeated freeze-thawing avoided.
2.11 Determination of total protein concentration
A quantitative estimation of protein concentration in the prepared rat mAbs (and 
pRBC and nRBC lysates - see later) was determined by spectrophotometric 
measurement at 595 nm. The procedure used was the BCA standard assay (Smith et 
al., 1985) using the Coomassie Blue G-250 Pierce protein assay reagent (Pierce 
Chemical Co.) and BSA as a protein standard. This method was adapted from the 
original technique of Bradford (1976), and is based on the absorbance shift from 465 
to 595 nm which occurs when Coomassie Blue binds to proteins in an acidic solution. 
The standard assay procedure can be used to determine protein concentrations in the 
range of 150 fig/ml to 1500 (ig/ml, where the colour response is relatively linear, 
allowing quick, accurate determinations.
A known protein concentration series was prepared by diluting a 2 mg/ml stock 
BSA standard (Pierce Chemical Co.) in deionised water. Convenient standard data 
points were used to cover the range 150-1500 (ig/ml. 5 ml protein assay reagent was 
added to 100 |il of each of the diluted standards or unknown protein samples in 16 x 
100 mm clear, clean test tubes. The samples were mixed well. Absorbance was read 
versus deionised water at 595 nm on a u.v. spectrophotometer (Pye Unicam PU 
8600). The net absorbance of each standard or unknown protein sample was obtained 
by subtracting the absorbance of the deionised water from each sample. A standard 
curve was constructed from which the protein concentration for each unknown sample 
was determined.
2.12 In vivo depletion of T cell subsets
The mAbs raised as outlined above were used to deplete substantially in vivo 
either or both of the two subsets of T cells recognised. The methodology followed 
was essentially similar to that described by Suss et al. (1988). Mice were injected i.v.
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with purified mAbs diluted to the appropriate concentration in PBS (pH 7.2) and 
delivered as a 0.25 ml inoculum. Animals received a total of three pretreatments 
before infection , 500 |ig of purified Ab 5 d prior to challenge, followed by 250 |ig Ab 
4 d and 1 d before infection. At 14 DPI experimental mice were given a further dose 
of 250 pg Ab. A control group of mice that received normal rat serum in place of the 
specific mAb was set up in parallel.
At various time points throughout the course of an infection, individual mice 
were sacrificed and splenic T cells were examined to monitor the efficiency of 
depletion of the relevant T cell subset(s), as determined by immunofluorescence (see 
later).
2.13 Complement-mediated cytotoxicity assay
The specificity and cytotoxic potential of the anti-Ly-2 and anti-Ly-4 mAbs was 
ascertained by use of the technique of complement-mediated cytolysis (Bruce et al., 
1981). The mAbs were used to kill enriched splenic T cells carrying these Ags, with 
the aid of complement, and cell death was assayed by exclusion of the vital dye 
trypan blue (see later).
T cells prepared from the spleens of naive mice by incubation on nylon wool 
columns (see later) were washed twice (300 g for 5min) in 10% FCS RPMI 1640 
medium and the proportion of viable cells assayed by the trypan blue dye exclusion. 
The concentration of cells was adjusted to 1 x 107 cells/ml.
Six serial dilutions of each of the mAbs were made in 1ml volumes in PBS (pH
7.2) to cover the titration range 1:10-1:5000 initial concentration. A 200 pi aliquot of 
every mAb dilution was added to 0.5 ml volumes of the T cell sample in a 
microcentrifuge tube and incubated at RT for 30 min. After incubation, each tube 
was spun (300 g for 5 min) in a microcentrifuge and the cell pellet resuspended in a 
minimal volume. 0.5 ml of a 1:40 dilution in PBS of unabsorbed guinea-pig 
complement (Wellcome) was overlayed, then mixed and the suspension incubated at 
37°C for 45 min. After incubation the microcentifuge tubes were placed on ice to 
prevent any further complement fixation and cell lysis. The cells were washed again 
and resuspended to their original volume (0.5 ml) in PBS (pH 7.2) prior to cell 
counting. 0.1 ml of each cell suspension was mixed with an equal volume of 0.2% 
w/v trypan blue in PBS and incubated for 2-3 min at RT.
The number of viable lymphocytes (phase bright, unstained) was counted using 
a phase contrast microscope. Assuming approximately equal proportions of both 
major T cell subsets in a suspension of naive spleen T cells, the efficacy of the mAbs 
was determined.
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2.14 Determination of cell viability
The viability of cell preparations was measured by the trypan blue dye 
exclusion test (Naysmith & James, 1968; recommended by Jeme et al., 1974). An 
appropriate dilution of cells in PBS (pH 7.2) were further diluted 1:1 in a solution of 
0.2% w/v trypan blue (Gurr, BDH Ltd) in PBS (pH 7.2) and mixed thoroughly. The 
suspension was incubated for 2-3 min at RT and then examined by phase contrast 
under oiHmmersion (XlGO-objeetive, X10 eyepieces)-on stlight microscope. Dead 
cells were unable to exclude the vital dye and stained blue, whereas viable cells 
remained clear. The proportion of live to dead cells was expressed as a percentage 
viability, and adjustments to total cell numbers made accordingly.
At least 100 cells were counted.
2.15 Live Immunofluorescent Antibody Test (live IF AT)
As a confirmatory test to determine the specificity of the rat mAbs raised 
against the CD4 andCD8 cell surface glycoproteins, splenic T cells were assessed for 
the presence of these two markers using live IF AT.
Serial 1:2 dilutions of the primary mAbs and normal rat serum (as a negative 
control) starting at an initial dilution of 1:10 were prepared in PBS (pH 7.2). 50 |il of 
each mAb dilution was mixed with 50 jil of test suspension (1 x 108 cells/ml) and 
incubated for 1 hr in a 37°C waterbath. The cells were then washed twice in PBS 
(300 g for 3 min in an MSE microcentaur microcentrifuge), resuspended in 100 pi of 
a 1:200 dilution of FITC-conjugated goat anti-rat IgG (Sigma) and incubated for 30 
min at 37°C. Cells were washed twice as before to remove any unbound conjugate, 
resuspended in 100 pi of cold PBS and kept on ice until ready to view.
The % of positive cells was determined by fluorescencemicroscopy with the use 
of a Leitz incident light u.v. microscope equipped with a mercury lamp with an 
appropriate excitation filter for fluorescein. Positively stained cells were visible as 
green rings, since the FITC-conjugated antiserum is unable to cross the intact cell 
membrane of viable lymphocytes, while dead cells showed a bright homogeneous 
intracytoplasmic fluorescence. The % of live fluorescing lymphocytes was 
determined for each specimen tested [from a minimum of 200 cells counted.
2.16 Irradiation of mice
Mice were irradiated with 400 rads (4 Gy) whole body gamma irradiation from 
a 60Co source chamber (Nuclear Engineering) in the Department of Veterinary 
Physiology, University of Glasgow. To receive doses of 4 Gy mice were exposed for 
appropriate lengths of time depending on the dose output of the source. During the 
course of the study, the source emitted between 3.35 and 2.49 Gy/min. Mice were 
lowered in pairs, in a restraining container, into the source chamber and irradiated in 
an upright position. Preceding treatment mice were starved for 24 hours. Irradiation
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of recipient mice took place either 24 hours prior to transfer or on the day of transfer. 
Subsequently, mice received terramycin (3g/1)(Pfizer) in their drinking water for one 
week to prevent superinfection-associated deaths (McDonald & Phillips, 1978).
2.17 Preparation of splenic lymphocytes for adoptive transfer i .v.
Suspensions of splenic lymphocytes suitable for adoptive transfer were prepared 
as follows. Donor mice were killed by ether (Rhone-Poulenc Ltd.) overdose, the 
spleens dissected out aseptically and placed in a 9 cm Petri dish (Sterilin) containing 
incomplete RPMI 1640 medium. The spleens were dissociated by pushing through a 
stainless steel sieve (mesh size 0.025 cm2) using the inside plunger of a syringe to 
push the cells through, and collected into the medium. Using a sterile Pasteur Pipette 
the cells were disaggregated by aspiration, and the supernatant collected after 
connective tissue debris and clumps of cells had sedimented. The spleen cells were 
washed twice in fresh medium (250 g for 5 min), then resuspended in 1 ml of 10% 
FCS RPMI 1640 medium. Contaminating red blood cells were removed by 
haemolysis. 1 ml of spleen cells was incubated in 9 ml cold 0.83% Tris-ammonium 
chloride (pH 7.4) (Appendix) for 5 min at RT (Boyle, 1968) Most macrophages and 
other adherent cell populations were removed by filtration through glass wool (Julius 
et al., 1973; Trizio & Cudkowicz, 1974). Glass wool columns were prepared by 
packing 10 ml plastic syringe barrels to the 8 ml mark with glass wool (Travenol 
Laboratories). Before the removal of phagocytic cells, the column was clamped in a 
vertical position and 30 ml incomplete RPMI 1640 medium followed by 10 ml 10% 
FCS complete medium washed through. The spleen cell suspension was loaded onto 
the soaked glass wool column under gravity, incubated for 15 min at RT and washed 
out dropwise with 10% FCS complete medium.
2.17.1 Enrichment of spleen T and B cell populations by nylon wool separation
Spleen cell suspensions were fractionated on the basis of their differential 
adherence to nylon fibres. Enriched T cell populations were collected by passage 
through nylon wool columns, based on the modification by Handwerger & Schwartz 
(1974) of the technique of Julius et al. (1973). Recovery of the enriched B cell 
fraction was achieved by following the method of Trizio & Cudkowicz (1974).
Sterile nylon wool columns were prepared by packing tightly, to the 7 ml mark, 
the barrels of 10 ml plastic syringes with scrubbed nylon wool (Leuko-pak, Fenwal 
Laboratories) followed by autoclaving. These were stored wrapped in aluminium foil. 
Before use, the columns were rinsed with 30 ml 10% FCS RPMI 1640 medium, 
followed by 20 ml 20% FCS RPMI 1640 medium (used in all subsequent procedures) 
and any air bubbles dislodged by gentle tapping. The wet columns, sealed at the top 
with nescofilm (Bando Chemical Ind. Ltd) and at the bottom with a 25 G needle stuck
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in a rubber bung, were kept in a humidified incubator at 37 °C for at least 90 min prior 
to use. They were then washed through with 10 ml of warm, fresh medium before 2-3 
x 108 cells in 2 ml volumes were added dropwise to each column. The cells were 
washed into the columns with 1 ml of medium, the columns resealed and incubated at 
37°C for 45-60 min. After incubation, the non-adherent cells - considered as the 
enriched T cell population - were run out dropwise from the syringe and washed out 
with 20 ml of prewarmed medium. Nylon wool adherent cells were eluted from the 
columns by physically disrupting the nylon wool with flamed forceps and by forcing 
fresh medium through the column using a 10 ml syringe plunger. The released 
adherent cells were collected in 10 ml and thereafter referred to as the enriched B cell 
subpopulation. Both cell populations were washed and resuspended in 10% FCS 
RPMI 1640 medium and kept on ice until either injected into recipient mice or 
manipulated in vitro. Spleen cell numbers were counted in a haemacytometer 
(Improved Neubauer, Weber) and counts adjusted after cell viability was determined 
by the trypan blue exclusion method (2.14).
The proportions of cells in each enriched subpopulation was determined by 
immunofluorescence (for methodology see 2.15), using a rat IgG2b mAb against Thy-
1.2 (Sera-Lab) as a T cell marker, and a rat IgGi, IgM cocktail mAb against mouse 
IgG heavy chain (Serotec) as a B cell marker. The enriched T cell populations 
typically contained >85% T cells with <1-2% contaminating B cells, while the B cell 
enriched populations contained >55% B cells with <7% contaminating T cells.
2.18 Collection of serum
Large volumes of sera were collected by exsanguination by cardiac puncture 
under ether anaesthesia. Where appropriate the blood was pooled and allowed to clot. 
The clot was loosened from the edges of the container and left to contract for 1 hr at 
37°C. The overlying serum was collected by pipetting and any contaminating RBCs 
removed by centrifugation (300 g for 5 min). The serum was then aliquoted and 
stored frozen at -20°C until required. Subsequent freeze-thawing was kept to a 
minimum. Large volumes of hyperimmune and normal mouse sera were collected 
using this methodology. A stock of hyperimmune serum for use as a positive control 
in the anti-P. chabaudi slide IFAT was raised from donors which were challenged on 
three occasions successively with 5 x 104, 1 x 107 and 1 x 108 pRBCs at two monthly 
intervals. The mice were bled one week after the last challenge. Normal serum was 
obtained from uninfected animals.
Smaller volumes of serum (up to 100 jul) were collected from tail blood by the 
method of Gray (1979) using hard glass capillary tubes (BDH Ltd). Mice were 
prewarmed under a heat lamp, then the tip of the tail snipped off using a pair of clean, 
sharp scissors. Later in the study, blood was obtained from mice by venepuncture
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alone, using a lancet (Monoject Scientific). Blood was collected into the capillary 
tubes and was allowed to clot for 30 min at 37°C and then placed in a 4°C refrigerator 
for a further 30 min to contract the clot. The serum was removed from the 
sedimented RBCs and transferred to a microcentrifuge tube and spun (300 g, 5 min) 
(MSE Microcentaur, Fisons) to pellet any remaining RBCs. The samples were then 
stored at -20°C.
For the collection of immune serum from infected mice to show the levels of 
specific anti-malarial antibodies or levels of nitric oxide during the course of 
infection, serum was collected from individual mice in different experimental groups 
at 2-3 day intervals from d 0-60. Within each group, every mouse was bled on an 
equal number of occasions to ensure that anaemia did not result from the repeated 
bleeding of an individual mouse, and also that the circulating leukocyte count was 
maintained in a steady state (Sluiter et al., 1985).
2.19 Determination of anti-malarial antibody titres
Total anti-parasite antibody determinations were carried out on serum taken 
from infected mice (described above) using the slide IF AT procedure of Van 
Meirvenne et al. (1975) modified by McLean et al. (1982a), based on the indirect 
fluorescent antibody method for malaria parasites as described by Voller (1964) and 
O'Neill & Johnson (1970).
2.19.1 Preparation of malarial antigen slides
Trophozoite/schizont stage parasites were collected from infected mice and used 
as the source of antigen. Donor mice with an ascending parasitaemia of 5-15% were 
bled into 10 i.u./ml heparinised PBS. pRBCs were washed three times in 20 ml PBS 
(pH 7.2) by centrifugation (250 g for 5 min) and resuspension. After the last wash the 
cells were resuspended to less than the original blood volume and used to make thin 
blood smears covering the microscope slide. The slides were dehydrated overnight in 
a desiccator, wrapped in batches of five in tissue, packed with silica gel and stored at 
-20°C until required (Manawadu & Voller, 1978).
2.19.2 Assay
Slides were brought up to RT in a desiccator for 1-2 hr before use in the IF AT 
to avoid condensation. The slides were fixed in absolute acetone (Rhone-Poulenc 
Ltd) for 5 min and air dried. Reaction zones were marked on the antigen slides using 
an H series texpen (Deacon Laboratories). The slides were washed in two successive 
Coplin jars of PBS, drained and rehydrated in a third jar of PBS for 15 min. From 
this point onwards it was important that the slides remained hydrated, preventing non­
specific fluorescence (A.W. Taylor-Robinson, S.A. McLean, personal
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communication). The area around each reaction zone was dried and serial 1:2 
dilutions of test and control sera applied to the reaction zones in 20 |il volumes. For 
each slide, the first reaction zone contained PBS in place of serum, to act as a control 
for non-specific fluorescence. The slides were incubated for 15 min at RT in a 
humidified chamber, then washed and rehydrated (as above). The slides were 
recovered from PBS and the edges dried. 1 ml of FITC-conjugated sheep anti-mouse 
IgG (SAPU) diluted 1:200 in PBS containing Evans Blue (1:10,000 w/v) (Merck) was 
applied to each of the slides which were then incubated for a further 15 min. The 
Evans Blue was required as a counterstain for the RBC in the antigen slide 
preparations (El Nahel & Bray, 1963). The slides were washed again to remove any 
unbound conjugate, and rehydrated in fresh PBS before mounting under a long 
coverslip in a 1:1 solution of non-fluorescent PBS:glycerol (Merck).
2.19.3 Examination of slides
Fluorescence was observed using a Leitz Ortholux microscope linked to an 
Epson PX4 computer through a Leitz MPV Compact 2 microscope photometer. The 
overhead u.v. source was a Wotan HBO-50 mercury lamp with 2 x kP490 exciting 
filters and a TK 510 dichroic beam-splitting mirror and a k515 suppression filter.
The slides were examined using a X50 water immersion objective and a X12 
binocular eyepiece. The titre (endpoint) of the serum was considered to be the last 
dilution of serum at which specific parasite fluorescence was observed. The control 
zones of hyperimmune or normal serum, as well as that of PBS alone, were examined 
for comparison for each slide.
2.20 Passive transfer of serum
Sera collected for passive transfer was stored at -20°C. After thawing, the sera 
was dialysed overnight against PBS to remove any residual chloroquine that may 
have been present in the serum. Benzoylated dialysis tubing (for separating 
compounds with a MW of 1200 or less, flat width 32 mm) (Sigma) was cut into 20 
cm lengths and presoaked in PBS. Each serum sample was poured into the tubing, 
sealed with a Pierce dialysis clip and placed in a 5 1 beaker filled with PBS which was 
agitated gently with a magnetic bar and stirrer motor. The dialysis bags were left 
overnight at 4°C to reach equilibrium.
Mice challenged with 5 x 104 pRBCs were injected with 0.65 ml serum i.v. 
within 1 hr of infection. Their subsequent course of infection was followed by 
examination of Giemsa's stained thin blood smears (see earlier). Results of passive 
serum transfers were usually presented as histograms showing the average day of 2% 
parasitaemia. The day on which each mouse reached 2% was estimated by drawing a 
graph of log no.pRBC/105 RBCs against time expressed in days, and estimating the
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time at which the line passed the 3.303 level (2%). The arimethic mean and standard 
deviation were calculated for each group and displayed on histograms. Significance 
of differences between control (receiving NMS) and experimental (receiving immune 
serum) groups was obtained using the Student's t test (Minitab Release 8.2, Minitab 
Inc.). Groups were considered to be significantly different if p<0.05.
2.21 Live IF AT on schizont-infected RBCs
In order to detect variant recrudescent populations in mice receiving subcurative 
chloroquine treatment or mice naturally recovering from infection, IFATs were 
carried out on viable, P. c. chabaudi schizont-infected erythrocytes as described by 
McLean et al. ( 1986b).
Since peripheral withdrawal of schizonts of some strains of P. c. chabaudi has 
been shown to occur in vivo (Shungu & Arnold, 1972), short-term in vitro culture was 
used to obtain considerable numbers of schizont stage pRBCs.
Infected mice were kept under reversed light conditions (12 hr light between 
2000-0800 hr) for a minimum of 10 d acclimatisation before infection. Using this 
system, schizogony is usually synchronous and occurs between 1100-1300 hr 
(compared to maintenance on a normal daylight cycle, when peak schizogony occurs 
at 2300-0100 hr, an unreasonable time to perform an experiment!) (Jarra & Brown, 
1985).
Cardiac blood was collected from donor mice with a parasitaemia >20%, by 
bleeding from the heart into heparinised PBS (10 i.u./ml). Bleeding took place 
between 0800-0900 hr, when most parasites were at the late ring-stage (i.e. prior to 
deep vascular tissue sequestra tion). After washing twice in 5% FCS RPMI 1640 
medium, RBCs were resuspended to a 10% haematocrit in the same medium and 
cultured using the candle jar method of Trager & Jensen (1976). 1.5 ml of the 10% 
w/v suspension of the infected blood in medium were dispensed in 35 mm Petri 
dishes (Cel-Cult, Sterilin), which were placed together with a candle, in a humidified 
glass dessicator. The candle was lit and the lid put on with the stopcock open. When 
the candle flame extinguished, the stopcock was closed. This procedure provided a 
gas phase of 3% CO2 and 15-17% O2, ie. an atmosphere low in O2 and high in CO2 
(Trager, 1987). The candle jar was placed in a 37°C incubator until the parasites had 
reached the schizont stage; parasite maturation was monitored every 30-45 min by 
examination of Giemsa's stained thin blood smears. After harvesting, cultured 
parasites were washed with 25 ml filtered (0.22 J i m  pore size, Millipore) PBS (pH
7.2), before use in the immunofluorescence test.
For the live IF AT all washes and dilutions were made with filtered PBS, 
supplemented with 5% v/v FCS (PBS/FCS). Between each incubation with serum or
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reagent, the cells were washed twice in 1 ml PBS/FCS and centrifuged for 1 min at 
low speed in a MSE microfuge. Incubations were for 30 min in a 37°C waterbath: 2 x 
107 pRBCs were incubated with, successively, 100 jul of the appropriate dilution of 
immune serum; 100 pi (12.5 pg/ml) biotinylated anti-mouse IgG (Sera-Lab); then 100 
pi of a 1:200 dilution of phycoerythrin-conjugated streptavidin (Sera-Lab). After a 
further two washes with 1 ml PBS/FCS the cells were resuspended in 20 pi PBS/FCS 
and fluorescence observed as for section 2.19.
The test was performed on the infecting parasite population and each of the 
collected recrudescent populations from chloroquine treated or naturally recovering 
mice, using subpatent sera from both models of infection. The test was scored 
qualitatively on a positive/negative basis. Samples were scored negative when no 
positive fluorescence was observed on >3000 pRBCs. Hyperimmune and normal 
serum (2.18) acted as positive and negative controls, respectively.
2.22 Measurement of serum nitrate
Nitrate levels in the sera of infected mice were used to reflect the serum NO 
(see text) (Moncada et al., 1991). This was assayed by chemiluminescence as 
described by Palmer et al. (1987) and Downes et al. (1976). Initial measurements 
were carried out by Dr Alison Severn (Department of Immunology, University of 
Glasgow) and then later with assistance from Dr Kate O'Donnell and Ms Jackie Doyle 
(Department of Immunology).
The nitrate in the serum was first converted to nitrite using the nitrate 
conversion assay. This was set up in 96 well v-bottomed microtitre plates (Sterilin). 
Standards of both NO2' and NO3' were prepared in the range of 0 - 300 pM by 
diluting a 10-2 mM stock of NaN02 and NaN03 respectively in distilled water. 30 pi 
of the standards in duplicate and the samples, diluted if necessary, were plated out and 
then 30 pi of conversion buffer (Appendix) containing the enzyme nitrate reductase 
and the cofactors NADPH and FAD added. The plate(s) were then incubated at 37 °C 
for 2 hours, after which time they were assayed for NO2" or frozen at -20°C.
A chemiluminescence method was used for the determination of NO2'. Briefly, 
20 pi of serum sample or standard was injected, using a Hamilton syringe, into a 
reaction vessel containing 75 ml 1.0% sodium iodide in glacial acetic acid under 
reflux. NO was removed from the refluxing mixture under reduced pressure in a 
stream of N2, mixed with ozone and the chemiluminescent product measured with a 
photomultiplier (Model 2107 Chemiluminescent Nitric Oxide analyser (Dasibi 
Environmental Corporation)) and quantified by reference to lm in infusions of 
authentic NO into the reflux vessel.
Nitrate levels given represent the mean ± 1S.D. of individual values (nM/ml) 
from two or three mice within each group of mice in an experiment, and these were
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compared by the Student's t test, significance achieved if p<0.05.
2.23 Measurement of nitrite in culture supernatant
J774 macrophages were stimulated to produce NO with 10 ng/ml LPS (Sigma) 
and 75 U/ml recombinant IFN-y (Sigma). Cells were maintained in culture in 20% 
FCS RPMI 1640 medium and plated out in 1 ml volumes at 1 x 10^ cells/ml in 24- 
well tissue culture plates (Greiner) and the cells allowed to adhere. The medium was 
replaced with fresh medium or medium containing LPS and IFN-y. After 48 hours 
incubation, the supernatants were collected and stored at -20°C until tested for NO2'.
The Greiss reaction for nitrite analysis was carried out in 96-well flat bottomed 
plates. 50 pi of samples and standards (10 pg/ml NaN02 (217 nmol/ml) diluted in 
medium in two-fold dilutions) in duplicate were plated out and 50 pi of the Greiss 
reagent (Appendix) added to each well. After 10 mins at RT the plate was read in an 
ELISA reader (Dynatech, MR5000) at 540 nm. Nitrite levels were compared by the 
Student's t test, significance achieved if p<0.05.
2.24 IFN-y ELISA
To quantify IFN-y in spleen cell supernatants stimulated with Con A, a capture 
ELISA was performed.
Spleen cell suspensions were prepared as described in section 2.17. 
Erythrocytes were lysed with cold NH4CI, the cells washed twice in fresh medium 
and the viability of the resulting suspension determined by trypan blue exclusion. 
The cells were adjusted to a final concentration of 3 x 106 cells/ml in RPMI 1640 
10% FCS complete medium. Aliquots of 1 ml in triplicate were incubated in 24 well 
flat-bottomed tissue culture plates (Greiner) with Con A (5 pg/ml; Sigma). Control 
cultures were unstimulated. Forty-eight hours later, supernatants were collected, 
centrifuged at 350 g for 10 min and stored at -70°C until they were assayed for IFN-y.
For the ELISA flat-bottomed 96-well plates (Corning Easy-Wash, Coming) 
were coated with 50 pl/well of the capture antibody (Pharmingen) in PBS, and the 
plates incubated overnight at 4°C. The wells were blocked with 150 pi of 10% FCS 
in PBS and incubated for 45 mins at 37°C. The plates were then washed three times 
with PBS/0.05%Tween 20 and this was then repeated twice for 3 mins . The samples 
and recombinant IFN-y standards prepared in 10% FCS RPMI, 50 pl/well, were 
added to the plates and incubated at RT for 2 hrs. The plates were then washed as 
above and 50 pi biotinylated antibody in 1% BSA/PBS-Tween 20 added and 
incubated for a further hr at RT. After washing the plates, 75 pi of streptavidin 
peroxidase (Serotec), 1:1000 in 1% BSA/PBS-Tween 20, was added to each well, 
incubated for 1 hr at RT and washed three times. 100 pi of the substrate, TMB 
peroxidase (KPL) was added per well and after 15 mins the plates were read in an
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ELISA reader (Dynatech, MR5000) at a wavelength of 630 nm. Units of IFN-y were 
calculated from a standard curve constructed for the recombinant cytokine standard.
Differences between experimental groups were analysed by the Student's t test, 
a probability of less than 0.05% was considered significant.
2.25 Preparation of pRBC lysate
For use in the stimulation of T-cell lines, soluble P . c. chabaudi CB strain 
antigens were prepared from whole blood cells enriched for mature 
trophozoite/schizont-infected RBCs using a modification of the method described by 
McDonald & Sherman (1980).
Mice to be used as the source of Ag were kept under reversed light conditions, 
and were bled when most parasites were at the late ring stage. The parasites were 
cultured to trophozoite/schizont stages as described in section 2.21. After harvesting, 
the cultured parasites were washed in 5% FCS RPMI 1640 medium (200 g for 10 
min) and resuspended to their original volume in sterile PBS. The blood solution was 
filtered through sterile Whatman CF11 powdered cellulose paper columns to remove 
leucocytes (Beutler et al., 1976) and the filtrate subsequently washed. The pellet 
containing the malaria parasites was restored to its previous volume in PBS and then 
freeze-thawed five times. Each cycle of freeze-thawing entailed snap-freezing the 
preparation by plunging into liquid N2, then immediately defrosting the solution by 
placing it in a 37°C waterbath. The rapid temperature transition brought about by this 
process acted to fracture the RBC, so releasing parasitised material from those lysed 
infected RBCs present. The disrupted pRBC suspension was centrifuged at 1500 g 
for 10 min and the S/N fluid collected. This was termed the pRBC lysate and was 
stored in 50 |il aliquots at -20°C until required. Erythrocytes from normal uninfected 
mice (nRBC lysate) treated in the same way were used as a control for testing Ag 
specificity (Dodge et al., 1963).
Since all procedures used were carried out in sterile conditions, the lysate 
samples were suitable for direct in vitro use without prior filtration. The total protein 
concentration of the lysates was determined by the standard BCA assay (2.11).
The optimal concentration of pRBC lysate for cell stimulation was determined 
by the ability of the lysate to cause immune spleen cell proliferation, as measured by 
incorporation of tritiated thymidine (see 2.31, Helper T cell proliferation assay).
2.26 Antigen presenting cells
Irradiated syngeneic spleen cells were used as the most convenient source of 
large numbers of APCs for routine maintenance of T cell lines (Schwartz et al., 1978). 
A spleen cell suspension was prepared from the spleens of syngeneic naive NIH mice
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(haplotype, H-24), in 10% FCS RPMI 1640 medium and placed on ice. The cells 
were then irradiated to 30 Gy (3000 rads) by exposure to a 60Co y-emitting source 
(thereby inhibiting accessory lymphocyte proliferation in vitro). The cells were then 
washed (300 g for 5 min) once and resuspended in complete medium. After taking a 
total cell count, the suspension of APCs was added to the cultured T cells at an 
appropriate final concentration.
2.27 In vivo priming of Th cells to P. c. chabaudi
Prior to generating a helper T cell line by culturing spleen cell suspensions with 
pRBCs or the pRBC lysate as sources of plasmodial antigens, and irradiated splenic 
APCs, the donor mice were primed in vivo to the relevant antigenic stimulation, ie., 
CB strain parasites of P. c. chabaudi.
Mice were primed in vivo to varying degrees to the full range of plasmodial 
asexual erythrocytic stages. At different times following infection or reinfection 
donor mice were killed and the spleens dissected out aseptically. Both naturally 
recovering and chloroquine treated mice were used as spleen cell donors.
2.28 Initiation and maintenance of Ag-specific helper T cell lines.
The protocol followed for generation of Th cell lines in vitro was that first 
described by Kimoto & Fathman (1980) and Fathman & Kimoto (1981), as modified 
by Taylor et al. (1987). Conditions were optimised from Taylor-Robinson (1991) and 
in consultation with Dr A.W. Taylor-Robinson (W.L.E.P).
Spleen cell suspensions were prepared and an enriched T cell population 
obtained by nylon wool incubation. Cultures were established at 4 x 106 cells/ml in 
10% FCS RPMI 1640 medium containing either 250 pg/ml pRBC lysate (previously 
determined optimal concentration of lysate shown to induce T cell proliferation) or 5 
x 105 pRBCs, and freshly prepared APCs at a final concentration that ranged between 
5 x 105 and 2 x 106/ml. 40 ml aliquots were dispensed into 75 ml tissue culture flasks 
and these incubated in a humidified 5% CO2 atmosphere for 4 d. The cells were then 
recultured every 4 d, the number of responder cells reduced at each subculture to 2.5 x 
104 cells/ml, whence the concentration of proliferating cells was maintained at this 
level. From an initially low starting concentration, successfully primed responder 
cells, once established, were capable of proliferating sufficiently to outgrow the fixed 
APCs (1 x lOfyml) in culture.
2.29 Cryopreservation of Th cell lines
Th cell lines were stored for an indefinite period in a frozen state under liquid 
N2. A cryoprotective solution was prepared by mixing 10% v/v DMSO (Sigma) and 
90% v/v FCS (Gibco), usually as a 10 ml final volume. This solution was kept on ice
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till use. Viable, actively growing cells were harvested from healthy cultures, pelleted 
by centrifugation at 350 g for 10 min and resuspended in freezing medium. Cells 
were dispensed in 1 ml aliquots to 1.2 ml cryopreservation tubes (Nunc, Gibco) 
(labelled with the WEP code and a number) and frozen by controlled cooling 
(Theander et al., 1986a). A cooling rate of l°C/min was obtained by placing the 
ampoules in a freezing tray (Taylor-Wharton), this fitted on top of a liquid N2 
cannister, and incubating in the vapour phase above liquid N2, either for 6-8 hr or 
overnight. Once frozen, the tubes were transferred to -196°C for permanent storage.
Cells were recovered from liquid N2 storage by thawing rapidly by incubating at 
37 °C; a warming rate of 12000°C/min could be achieved by removing the 
cryopreservation tubes from frozen storage and dropping them directly into a 
waterbath at 37°C (Mutetwa & James, 1984b). The contents of an ampoule was 
transferred to a plastic Universal tube and the cell suspension diluted by adding 2 ml 
warm 10% FCS RPMI 1640 medium dropwise with shaking, and another 7 ml of 
warm complete medium slowly. Cells were washed twice (250 g for 5 min at RT) 
using the minimum of centrifugation and pipetting, resuspended in a minimal volume 
and a viable cell count performed. The suspension was adjusted to a suitable cell 
concentration immediately prior to culturing in vitro.
2.30 Surface phenotyping of T cell lines
In vz7ro-propagated T cell lines were evaluated for the presence of cell 
membrane Ags by indirect immunofluorescence, necessary to characterise at the 
cellular level the T cell subset of the T cells derived by in vitro culturing.
Cultures of T cell lines were washed twice (300 g for 5 min) in chilled 10% 
FCS RPMI 1640 medium, cleansed of dead cells on Metrizamide (see 2.30.1) and 
washed again. Cells were resuspended in 1 ml of complete medium, and their 
concentration adjusted to 2 x 107/ml. Naive spleen cells were used as a control for 
surface phenotyping; these were prepared as single cell suspensions as described 
previously.
As the IFAT can be adapted for use with live cells or fixed material, at this stage 
the cells requiring phenotyping were either kept on ice for immediate testing (see 2.15 
for method) or coated onto glass slides for slide IFAT (modified from McLean et al., 
1982a). For the latter, thin smears of each lymphocyte suspension were aliquoted 
onto individual zones of teflon-coated 12 well multitest slides (Flow) and air-dried. 
These Ag slides could then be stored dessicated at -20°C for testing at a later date.
2.30.1 Removing dead cells from culture
Dead responder cells and APCs were removed from suspension prior to surface 
phenotyping. The methodology used was first described by Kumick et al. (1979a, b)
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using the centrifugation gradient medium Metrizamide (Nycomed (UK) Ltd).
A stock solution of 35.3% w/v centifugation grade Metrizamide was prepared in 
distilled water, filter-sterilised and kept at 4°C. For use, the colloid was diluted to 
18% (v/v) by making up 1.02 ml of stock, 0.94 ml PBS and 0.04 ml FCS.
1 ml of this solution was dispensed into a 12 x 75 mm plastic centrifugation 
tube (Nunc), carefully overlayed with 1 x 107 cells (washed and resuspended to 1 ml 
with 10% FCS RPMI 1640 medium) and the gradient centrifuged at 450 g for 15 min. 
Viable cells were recoverable from the interface and washed twice (300 g for 5 min) 
with 1 ml complete medium.
2.30.2 IFAT on fixed T cells
The methodology used for the slide IFAT was essentially similar to that detailed 
for anti-malarial Ab titre determinations, except for using FITC-labelled goat anti-rat 
IgG (Sigma) as the second step reagent (without the addition of Evans Blue 
counterstain for RBCs).
Each sample to be analysed, using either the live or fixed method, was tested 
against a panel of primary mAbs of rat origin, specific for different surface Ags. 
Anti-mouse IgG2b mAbs specific for CD4 (Dialynas et al., 1983) and CD8 (Ledbetter 
& Herzenberg, 1979) surface Ags were purified from ascitic fluid as outlined in 
section 2.10. An IgG2b mAb to the lymphocyte marker Thy-1.2 (pan T cell) (Chayen 
& Parkhouse, 1982) (Sera-Lab) was also used throughout. Normal rat serum was 
used as a negative control in place of each primary reagent to confirm the lack of non­
specific fluorescence in the absence of specific mAbs. All reagents were diluted 1:10 
in PBS upon receipt and stored in working aliquots (20-50 |il) at -20°C ready for use.
As for the live IFAT the % of positive cells was determined by fluorescence 
microscopy (see 2.15).
2.31 Helper T cell proliferation assay
This assay measured the ability of cultured Th cells to respond to specific 
antigenic stimulation and was a necessary inclusion in all in vitro studies to 
demonstrate that the cell lines employed experimentally were primed to the asexual 
erythrocytic stages of P. c. chabaudi CB to which they were raised. In principal, the 
assay measured, at the microtitre level (ie. within a 96 well tissue culture plate), the 
same cellular proliferation after restimulation with Ag and APCs that accounted for 
cell growth after freshly feeding flask cultures.
Cell lines were deprived of Ag for 6-8 d before testing for cellular proliferation 
by incorporation of tritiated thymidine. This treatment avoided high background 
counts which would occur in the presence of residual stimulatory Ag.
For the assay, APCs were prepared at 4 x 106/ml in 10% FCS RPMI 1640
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medium. The Th cells to be tested were washed twice in complete medium (300 g for 
5 min) to remove residual Ag, resuspended in the APC suspension at 2 x 105/ml, and 
the complete preparation then plated out at 100 pl/well in 96 well flat-bottomed 
microtitre plates (Nunc).
A range of Ag dilutions in complete medium was prepared from standard stocks 
of pRBC and nRBC lysates as well as from infected pRBCs and nRBCs. For each 
concentration, 100 pi of diluted Ag was added to four successive test wells containing 
T cells and APCs.
The 96 well plates were cultured at 37°C in a humidified atmosphere containing 
5% CO2 for 72 hr, at which time 1 pCi (37 kBq) of [3H-methyl]-thymidine (20 
pCi/ml, specific activity 5 Ci/mmol; Amersham International) was added to each 
well. 18 hr later, the wells were harvested with a semi-automatic cell harvester 
(Titertek, Flow) onto glass fibre filter paper (FG/A, Whatman). When dry, each filter 
disc was transferred to a plastic beta vial (LKB) and 4 ml non-aqueous scintillationI
fluid (Optiscint 'safe', LKB) added using an automated dispenser (Jencons (Scientific)
| Ltd). All the insert tubes were lidded and placed inside outer plastic scintillation vials
j  ready for counting. The beta activity in each sample was detected using a liquid
| scintillation counter (LKB Wallac 1219 Rackbeta) and quantified on a programmed
computer (Olivetti DM282 100).
For individual wells, c.p.m. were measured, from which the arithmetic mean 
| c.p.m. for quadruplicate wells could be calculated. Dose-response curves were1
| constructed where necessary, from which optimum Ag concentrations could be
determined.
In all cases, control wells containing responder cells alone, T cells and APCs 
and T cells and Ag were set up to enable enumeration of background responses. Also, 
in certain instances, control cultures with APCs, Ag or medium alone were added to 
give even lower background responses. The inclusion of negative control wells was 
necessary for statistical analysis of the proliferation measured; cells were considered 
to have given a positive cellular response if the counts for their wells were »2 S.D. 
more than the c.p.m. values for appropriate negative controls.
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CHAPTER THREE 
SELECTIVE DEPLETION OF T CELL SUBSETS IN VIVO
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3.1 Introduction
For many years antibody-mediated effector mechanisms have been considered 
to be a major component of the protective immune response against the erythrocytic 
stages of malaria parasites in humans and in experimental animal models (Cohen et 
al., 1961; Diggs & Osier, 1969). It has become increasingly evident in recent years 
that cellular and antibody-independent effector pathways operate, at least in rodent 
malaria models. Early adoptive transfer experiments in a model of P. yoelii or P. 
chabaudi in the mouse and of P. berghei in the rat demonstrated that T cells alone 
could transfer immunity - see also Chapter 4 - (eg. Stechschulte, 1969; Phillips, 1970; 
Brown et al., 1976a, b; Gravely & Kreier, 1976; McDonald & Phillips, 1978; 
Jayawardena et al., 1982; Brinkmann et al., 1985). This can be explained by the fact 
that T helper cells are contained within the transferred population and these cells 
provide help for the production of antibody; however, partial protection can be 
achieved by transfer of CD8-bearing T cells (Mogil et al., 1987). Further evidence 
for T cell-dependent non-antibody mechanisms of immunity has been obtained from 
experiments utilizing B cell-deficient animals and a number of species of plasmodia 
(Roberts & Weidanz, 1979; Grun & Weidanz, 1983). In particular, Grun & Weidanz 
(1981) demonstrated that an acute infection with P. chabaudi adami can be cleared in 
the absence of B cells, highlighting a role for antibody-independent immune 
mechanisms. Since then, B cell-deficient mice have been shown to resolve acute 
infections with P. vinckei petteri, P. chabaudi chabaudi CB, and Babesia microti 
(Cavacini et al., 1990). In the same study, athymic nude mice died when infected 
with these parasites.
Protection against the sporozoite stage of P. berghei in the mouse is absolutely 
dependent on the presence of CD 8-bearing T cells, elucidated by T cell depletion in 
vivo and adoptive transfer experiments (Schofield et al., 1987; Weiss et al., 1988). 
Moreover, IFN-y appears to be a necessary component of such protection (Ferreira et 
al., 1986; Schofield etal., 1987). Although CD8+ T lymphocytes are clearly involved 
in protecting mice during the pre-erythrocytic stage of infection, their role during the 
erythrocytic stage of malaria is less clear. In the model of blood-stage P. c. adami 
infection, protection was transferred most efficiently to recipient nude mice by CD4+- 
enriched immune spleen cells; CD8+-enriched T cells were also found to transfer 
protection, albeit to a lesser extent (Cavacini et al., 1986). Mogil et al. (1987) 
demonstrated that adoptive transfer of CD8+ T cells from P. yoelii-immune animals 
into naive mice accelerated recovery, whereas Vinetz et al. (1990) were unable to 
demonstrate a protective effect of CD8+ T cells. Recent experiments by Suss et al. 
(1988), Podoba & Stevenson (1991) and Taylor-Robinson (1991) have demonstrated 
and confirmed the importance of CD4+ T cells in the development of immunity to 
blood stage P. c. chabaudi AS. Suss et al. (1988) and Taylor-Robinson (1991)
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suggested that CD 8+ T cells did not play a role while Podoba & Stevenson (1991) 
demonstrated a role for these cells in the resolution of infection.
In the experiments described in this chapter, the contribution of CD4- and CD8- 
bearing T lymphocytes to acquired immunity to blood stage P. c. chabaudi CB 
infection in NIH mice is examined. Mice treated with mAbs to deplete specific T cell 
subsets in vivo were observed for aberrations in the course of infection with P. c. 
chabaudi CB. The use of these mAbs in vivo allows manipulation of the immune 
response without the concomitant disturbance of the experimental system by whole- 
body irradiation (Cobbold et al., 1984; Leist et al., 1987). Through a course of 
repeated treatment, it is possible to reduce to minimal levels the host complement of 
CD4 and/or CD8 T cells during infection. In vivo depletion of one T cell subset 
enables the analysis of the role of the remaining subset in relative isolation. This 
method represents the negative corollary of adoptive transfer experiments mentioned 
above and those that will be described in Chapter 4.
3.2 The effect of anti-CD4 and anti-CD8 mAb treatment on host immunity to 
P. c. chabaudi CB
Five groups of 10 age-matched female NIH naive mice were used for this study. 
Individual mice were immunologically modified by a series of injections of a specific 
rat anti-mouse mAb prepared from ascitic fluid (2.10). The methodology was 
essentially that described by Suss et al. (1988). Experimental groups were as follows: 
mice treated with either anti-CD4 or anti-CD8 mAbs, both mAbs, NRS, or no 
treatment/mAb diluent only. Treatment with mAbs began four days prior to infection, 
with a total of three pretreatments before parasite challenge. One further treatment 
with mAbs was administered 14 DPI. Each mouse within a group was challenged 
with 5 x 104 pRBCs P. c. chabaudi CB on day 0. From each group of mice, 2 mice 
were sacrificed on days 0 and 23 post infection to determine the efficacy of depletion 
of the relevant T cell subset; assessed by immunofluorescence (2.15). The remaining 
mice were retained to determine the parasitaemia throughout infection. In a 
preliminary experiment, the resulting parasitaemias were very high in all groups of 
mice. To assist mice through the peak of infection in this experiment, therefore, all 
animals were treated with 50 mg/kg chloroquine 8 and 9 DPI.
The phenotypic characterisation of spleen cells taken from individual 
immunodepleted mice (0 and 23 DPI) is shown in Table 3.2.1. These data indicate 
that the regimen of mAb treatment was effective at in vivo immunodepletion of naive 
mice. The appropriate subset of T lymphocyte was depleted accordingly. For both 
mAb treatments, by 23 DPI a greater than 90% depletion was achieved. The level of 
depletion achieved at the time of parasite challenge was, however, somewhat less.
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The % depletion attained by 0 DPI was 50.1%, 44.1% and 74.3% for anti-CD4, anti- 
CD8 and both mAbs respectively. From this it is assumed that the mAb treatment 
took some time to take effect. Without any analysis between the two time points it is 
difficult to determine when the maximal depletion was achieved; although only one 
further injection of mAbs was administered after day 0 (14 DPI) and significant 
differences in the course of infection had been observed before then (see below). 
Depletion never reached 100% indicating that there were a few remaining cells of the 
respective subset present throughout the experiment. Immunofluorescent staining for 
phenotypic analysis was carried out using the same mAbs as those used to deplete the 
mice. Masking of the molecules by bound Abs in vivo may have affected the level of 
staining with the anti-CD4 and anti-CD8 mAbs. For all treatments, the appearance of 
CD4* and/or CD8" T cells was not tested for.
DEPLETION a STAIN DAY
0 23
CD4 anti-CD4 50.1 94.7
anti-CD8 2.6 3.3
anti-Thyl.2 35.7 63.0
CD8 anti-CD4 1.8 3.4
anti-CD8 44.1 97.1
anti-Thyl.2 18.5 31.1
CD4/CD8 anti-CD4 44.2 92.1
anti-CD8 34.4 93.6
anti-Thyl.2 74.3 89.9
a % depletion compared to control mice given NRS treatment (0% depletion).
TABLE 3.2.1 - Phenotypic analysis of T cell subset depletion in vivo by continuous 
mAb treatment on the day of infection and 23 DPI.
For individual T cell subset depletion, the proportion of the total T cells (Thy
1.2 bearing) lost differed. In those animals treated with anti-CD4 mAb, a 63% 
depletion of total T cells occurred. In contrast, although 97% of CD8 bearing T
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lymphocytes had been removed from the spleen with anti-CD8 therapy, the 
proportion of Thy 1.2 staining cells lost represented 31% (Table 3.2.1). This probably 
reflects the balance of CD4 and CD8 cells at this stage of infection (Goronzy et al., 
1986).
No functional assays, such as cytotoxic responses to alloantigens, helper T cell 
function, or proliferation studies, for confirmation of specific functional depletion, 
were carried out.
The effect of the different T cell subset depletions on the outcome of P. c. 
chabaudi CB infection is shown in Figure 3.2.1. There was a marked difference in 
the patterns of parasitaemia of mice receiving varying T cell subset depletion 
treatments following subsequent pRBC challenge. The courses of infection in the 
diluent only treated group and NRS treated group were essentially the same. Mice 
receiving anti-CD8 mAbs also demonstrated the same course of infection. Parasites 
were observed in the peripheral blood 4 days after infection, and the peak 
parasitaemia (52%, 52% and 47% respectively) occurred 8 or 9 DPI. This 
parasitaemia was reduced to subpatent levels 14 DPI with the aid of subcurative 
chloroquine treatment. A recrudescence occurred for each of these groups peaking at 
approximately 3% for each group. After clearance of this recrudescence by 23 DPI, 
no further parasites were detected in the peripheral circulation by blood smear 
examination. At no stage of infection were any significant differences observed 
between these groups of animals. In contrast, the courses of infection in mice treated 
with anti-CD4 or both mAbs differed from those described above. Although the peak 
parasitaemia of the anti-CD4 treated group of mice did not differ significantly from 
those of the other groups (49%), the peak parasitaemia in the double depleted animals 
was 60%, significantly different from the other groups (p<0.05). Following 
chloroquine treatment the parasitaemias were reduced to 2% and <1% by 13 DPI but 
this decrease in parasitaemia was not maintained and the infection peaked again with 
a mean parasitaemia of 51% for the anti-CD4 treated mice and 49% for double 
depleted mice; highly significant compared to control mice and anti-CD8 treated mice 
(p<0.001). This parasitaemia, for both groups, was subsequently reduced and 
remained at between 3 and 14% until the experiment was terminated 30 DPI.
These results suggest that lymphocytes of the CD8+ phenotype are only of 
marginal importance to host acquired resistance to infection, since in their absence the 
pattern of parasitaemia is very similar to undepleted control animals, with only a 
slightly higher parasitaemia noted in animals that had been depleted of both CD4 and 
CD8 lymphocytes compared to CD4 depletion alone. Elimination of CD4+ 
lymphocytes, however, in the presence or absence of CD8 cells, had a profound effect 
on the outcome of infection. Despite subcurative chloroquine treatment, animals with 
only CD8+ cells (CD4 depleted) or those essentially devoid of functional T cells were
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never able to reduce their parasitaemias below 3%. The experiment was terminated 
30 DPI. This was due to a high proportion of mice (~75%) that had been treated with 
anti-CD4 mAb alone, or in combination with anti-CD8 mAb, developing unusual 
complications of infection. Mice developed ascites and subcutaneous oedema, an 
apparently fatal condition in some mice, with post mortem pathology revealing many 
signs of a typical chronic malaria infection, including hepatosplenomegaly. Liver and 
kidney, haematoxylin and eosin stained, sections of a not seriously affected mouse 
revealed no obvious severe hepatic or renal pathology but demonstrated very nicely 
the presence of malaria pigment in kupffer cells and glomeruli respectively. The 
ascites did not show any specificity for P. c. chabaudi CB pRBCs by slide IFAT.
3.3 Discussion
The experiment described herein was designed to examine and evaluate the 
roles of the major T lymphocyte subsets in the immune response of an unprimed host 
to primary infection with P. c. chabaudi CB.
Selective depletion of the T cell subsets was effectively achieved with rat IgG2b 
anti-CD4 or anti-CD8 mAbs. A greater than 90% depletion (Table 3.2.1) was 
achieved with serotherapy with either Ab. This degree of elimination compares 
favourably with that recorded originally using mAbs prepared in an identical manner 
(Cobbold et al., 1984). Total elimination of each T cell subset did not occur in this 
study but this is in agreement with previous investigations (Cobbold et al., 1984; Leist 
et al., 1987; Schofield et al., 1987; Siiss et al., 1988; Weiss et al., 1988; Howard et 
al., 1989; Podoba & Stevenson, 1991; Taylor-Robinson, 1991). However, it has been 
shown in similar studies that functional depletion is achieved using the same regime 
as described here (Siiss et al., 1988; Podoba & Stevenson, 1991). Efficacy of 
depletion was examined by immunofluorescence of spleen cells. It was considered 
important to use splenic lymphocytes due to essential role of the spleen in malaria 
infections and the relative ease with which they can be prepared. IgG2b mAbs have 
been found to be very effective in eliminating the appropriate T cells in the blood, 
spleen, lymph nodes and bone marrow after in vivo administration (Cobbold et al., 
1984; 1985; Nash et al., 1987). In vivo administration of the mAbs resulted in 
approximately 25% of the double-depleted animals dying immediately after the last 
inoculation of Ab 14 DPI. Although it may have been a consequence of high 
parasitaemia, it is possible that the mice produced an Ab response to the injected 
mAbs. This is a feature of in vivo depletion of primates and calves (Howard et al.,
1989) but it has not been observed with murine recipients. It has previously been 
reported, however, that mice inoculated with rat IgG2b mAbs directed against either 
CD4 or CD8 surface determinants become tolerant to the injected Abs (Benjamin & 
Waldmann, 1986; Gutstein et al., 1986). The best regime that has been demonstrated
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to result in the most effective immunosuppression, leading to the induction of 
tolerance, is obtained with Abs that can both deplete T cells and exert functional 
inhibition (Cobbold et al., 1985). The same workers have shown that the best suited 
Ig isotype to perform this task is the IgG2b subclass, used in this study.
Although the importance of T cells in immunity to the CB strain of P. c. 
chabaudi has been demonstrated by use of B-cell deficient mice (Cavacini et al.,
1990) the relative contributions of CD4+ and CD8+ T cells has not previously been 
dissected for this strain of parasite. Herein, it has been shown that CD4+ T cells are 
critical for the development of an effective immune response to P. c. chabaudi CB; 
the depletion of these cells resulted in mice being unable to clear their infections. 
More than one wave of high parasitaemia occurred, despite subcurative chloroquine 
treatment, and until the experiment was terminated 30 DPI the parasitaemia was never 
reduced below 3%. These results are very similar to those of Siiss et al. (1988), 
Podoba & Stevenson (1991) and Taylor-Robinson (1991) working with P. c. 
chabaudi AS. In these studies the strain of mouse used was either C57B1/6 (H-2b) or 
NIH (H-2Q) (used in this study). For both of these strains of mice infection with the 
AS strain of parasite is usually non-lethal (Stevenson et al., 1982). The data 
described here show that CD4 cells are critical for the resolution of infection with the 
more virulent strain of parasite, even with chloroquine intervention.
One difference observed between the results of the studies cited above and those 
presented in this chapter is the % parasitaemia during the chronic phase of infection 
observed in CD4 depleted mice. The studies of Siiss et al. (1988), Podoba & 
Stevenson (1991) and Taylor-Robinson (1991) demonstrated that for the AS strain of 
P. c. chabaudi, following peak parasitaemia, the parasitaemia was reduced to 
approximately 20%, at which it remained with small variations until the termination 
of the experiment in each case. Here mice were treated with 50 mg/kg chloroquine at 
the peak of infection, a subcurative dose, and this treatment resulted in a rapid 
reduction of the parasitaemia in all the experimental groups. However, CD4 depleted 
and double-depleted mice experienced another wave of high parasitaemia, the peak of 
which was as high as that observed before chloroquine treatment. This was 
subsequently reduced to 3%, without further chloroquine intervention, with only 
minor fluctuations until 30 DPI when the experiment was terminated. It therefore 
appears that, even in mice depleted of both T cell subsets, their parasitaemias were 
controlled at around 3% for the duration of the experiment. These mice were 
demonstrated to be substantially depleted of T cells (Table 3.2.1). It is possible that 
the few remaining CD4- or CD8-bearing cells are responsible for this reduction, 
although 89.9% of Thyl.2+ cells were depleted; in other studies severe impairment of 
the immune responsiveness of these cells in all lymphoid organs studied was 
demonstrated using functional assays (Siiss et al., 1988). In addition, adult
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thymectomised and irradiated mice, infected with P. c. chabaudi AS, control their 
parasitaemias, maintaining a chronic parasitaemia, but not to the same extent as 
observed in this experiment. Some other mechanism, T cell independent, must be 
operative to partially control parasitaemia. Siiss et al. (1988) attributed partial 
limitation of parasitaemia to the presence of low titres of transient malaria-specific 
IgM Abs in the peripheral blood of CD4 depleted mice. To rule this out in the study 
described here, the experiment would have to be repeated with measurement of Ab 
levels and Ig subclasses and also in mice without circulating Igs. This would be of 
interest since it has been reported that B cell-deficient mice can completely resolve an 
infection with P. c. chabaudi CB (Cavacini et al., 1990).
Another mechanism for the partial control of parasitaemia demonstrated could 
be due to CD4'CD8' T cells having some immune function. Recent evidence 
indicates that the y8 T cell subset responds in both human and murine malaria. The 
splenic y5 T cell number significantly increases in the spleens of both mice and 
humans with malaria (Minoprio et al., 1989; Ho et al., 1990; Roussilhon et al., 1990; 
van der Heyde et al., 1993b) and specific proliferative responses have been 
demonstrated in vitro with human blood-stage parasites (Goerlich et al., 1991; Behr & 
Dubois, 1992; Goodier et al., 1992). Although the y 8 T cell subset is not 
developmentally regulated by a p  T cells (Philpott et al., 1992; Mombaerts et al.,
1992) van der Heyde et al. (1993b) have shown that CD4+ ap  T cells are required for 
the y5 T cell response to occur during murine P. c. adami malaria. It, therefore, 
seems unlikely, that in the context of this experiment, y8 T cells have contributed to 
the limitation of parasitaemia.
Siiss et al. (1988) and Podoba & Stevenson (1991) observed at the same time as 
the reduction in parasitaemia, a sudden influx of reticulocytes followed by a persistent 
reticulocytosis. This was also noted in this experiment, but is also a feature of P. c. 
chabaudi CB infection following peak parasitaemia. It has been suggested therefore, 
that the rapid reduction in the number of mature erythrocytes, the host cell preferred 
by P. c. chabaudi, as a result of lysis of infected cells and the influx of reticulocytes 
may account for the sharp drop in parasitaemia (Siiss et al., 1988; Podoba & 
Stevenson, 1991). A similar conclusion was reached by Ott (1968) on the basis of the 
observation that stimulation of reticulocytosis by injection of phenylhydrazine 
resulted in a diminished level of parasitaemia during infection with P. c. chabaudi. It 
appears that the chronicity of infection is maintained by a balance between 
reticulocytosis and parasite invasion of immature red cells. Podoba & Stevenson 
(1991) proposed that CD4 depleted mice may compensate for the lack of immune 
function by mounting a marked and sustained erythropoietic response, with the spleen 
becoming the major site of erythropoiesis. In the present study the spleens of CD4 
depleted mice on day 29 post infection were twice the size of those from animals that
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received either NRS or no mAb treatment (Dr H. Thompson, personal 
communication). However, Yap & Stevenson (1994) have recently shown that 
inhibition of in vitro erythropoiesis is not dependent on T cell derived cytokines.
The CD4+ T cell can be characterised functionally as a cell which can mediate 
delayed-type hypersensitivity and which can act as a helper cell for Ab production. 
Mosmann & Coffman (1987) indicated that these functions may be carried out by 
separate subsets of CD4 cells (ThI and Th2, respectively). This study, however, did 
not allow delineation of the functions of the CD4-bearing lymphocytes in vivo as the 
anti-CD4 mAb used could not discriminate between T hI and Th2 cells. Recent 
evidence, which will be discussed at greater length in Chapter 8, indicates that CD4 
cells of both phenotypes are activated during the course of P. c. chabaudi AS 
infection (Langhome et al., 1989a, b). Moreover, Taylor-Robinson (1991) and 
Taylor-Robinson & Phillips (1992; 1993; 1994a) have produced T cell clones of both 
phenotypes which are protective upon adoptive transfer to naive and 
immunocompromised mice. In addition, the protective mechanisms of T hI and Th2 
clones have been elucidated by Taylor-Robinson et al. (1993). ThI cells protect by a 
nitric oxide dependent mechanism, whereas Th2 cells protect by the enhancement and 
accelerated production of specific IgGi Ab.
Studies of P. yoelii in the mouse have suggested that CD8 cells can partially 
protect against challenge infection (Mogil et al., 1987). This ability was correlated 
with an increase of expression of class IMHC molecules on infected erythrocytes and 
led to the postulation that CD8+ cells may be directly cytotoxic for intraerythrocytic 
parasites (Jayawardena et al., 1982; Jayawardena et al., 1983). CD8+ T cells may 
also exert an antiplasmodial effect indirectly via the production of IFN-y. The results 
presented here, and those of Siiss etal. (1988) and Taylor-Robinson (1991) show little 
indication that CD8+ T cells have any significant role in an erythrocytic infection with 
P. c. chabaudi. In their absence, parasitaemias did not deviate from those of control 
animals, although in double-depleted mice the peak parasitaemia was significantly 
higher than in all other groups. Siiss et al. expressed the opinion that, under 
experimental conditions, a role for CD8 cells could not be discounted, since it is 
possible that in the absence of CD4 cells and their soluble mediators CD8 effector 
cells could not be activated appropriately. Although it is not known whether CD8+ T 
cells in vivo require an exogenous 11-2 source (supplied at least in vitro by CD4+ 
cells), in a second experiment, recombinant 11-2 was given to CD4-depleted mice. 
This did not affect parasitaemia significantly, challenged recipients still being 
incapable of clearing infection (Siiss et al., 1988). In contrast, however, Podoba & 
Stevenson demonstrated a role for CD8 cells in immunity to the blood stages of P. c. 
chabaudi AS. Depletion of CD8+ cells had no effect on the course and level of 
parasitaemia during the prepatent or peak parasitaemia. However, compared to
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control animals, CD8 depleted mice had two recrudescences. These workers, 
therefore, concluded that both T cell subsets play a role in acquired immunity to P. c. 
chabaudi AS. These data supported the adoptive transfer studies of Cavacini et a l 
(1986) and Mogil et al. (1987) in P. c. adami and P. yoelii infections, respectively. 
These conflicting reports led van der Heyde et a l  (1993a) to examine the courses of 
P. yoelii yoelii 17X, P. c. adami and P. c. chabaudi blood stage infection in P2- 
microglobulin-deficient (P2-1110/0) mice. These mice are completely devoid of 
functional CD8+ T cells, since the p2-m°/° mouse lacks surface expression of both 
MHC class I glycoproteins on nucleated cells, this being required for positive 
selection to occur in the thymus (Koller et a l , 1990; Zijlstra et a l , 1990). The 
resolution of each of the three subspecies of Plasmodium in p2-m°/° mice was similar 
to intact mice, supporting the lack of a requirement for CD8+ T cells in the 
suppression of malarial parasitaemia. This is in direct contrast to the crucial role 
played by CD8+ cells in the protective response against the pre-erythrocytic stages of 
P. berghei (Schofield et al., 1987; Weiss et al., 1988).
In conclusion, the results described in this chapter demonstrate that CD4+ but 
not CD8+ T cells are essential for a successful primary immune response to the 
erythrocytic stages P. c. chabaudi CB. These findings justified the generation of 
stable CD4+ T cell lines specific for this strain of parasite, as described in Chapter 7.
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CHAPTER FOUR
ADOPTIVE TRANSFER OF IMMUNITY WITH SPLENIC LYMPHOCYTES
79
4.1 Introduction
In order to study the contribution of lymphocytes to the immune response 
against malaria parasites, various investigators have performed experiments in which 
immune spleen cells or selected spleen cell populations were transferred to non- 
immune recipient animals. The basic model for cell transfer studies in rodent malaria 
was developed by Stechschulte (1969), who showed that immunity to P. berghei 
could be transferred from recovered rats to syngeneic susceptible rats by the injection 
of splenic lymphocytes. Since this study, a wealth of evidence has shown that 
protection can be conferred by adoptive transfer with immune spleen and lymph node 
cells (Roberts & Tracey-Patte, 1969; Phillips, 1970; Kasper & Alger, 1973; Brown et 
al., 1976a, b; Gravely & Kreier, 1976; Zuckerman & Jacobsen, 1976; McDonald & 
Phillips, 1978, 1980; Jayawardena etal., 1978; Fahey & Spitalny, 1986; Cavacini et 
al., 1986; Mogil et al., 1987; Favila-Castillo et al., 1990; Legorreta-Herrera et al., 
1993). In most of these studies unfractionated cells or enriched T and B cell 
populations were used from mice that had recovered from at least one previous 
infection. Only in two instances have spleen cells been taken from donor animals at a 
range of time points during the course of a primary infection; P. berghei in rats 
(Brown et al.y 1976a) and P. yoelii 17X in mice (Fahey & Spitalny, 1986).
Until the present study, no adoptive transfer experiments have been carried out 
for the P. c. chabaudi CB system, although transfer of immunity with splenic 
lymphocytes has been shown in NIH (McDonald & Phillips, 1978, 1980), CBA/Ca 
(Favila-Castillo et al., 1990) and (BALB/c x C57B1/6) Fi (Legorreta-Herrera et al.y
1993) mice infected with P. c. chabaudi AS. However, in these investigations, only 
spleen cells taken from recovered or post-infective mice were used. A study was 
therefore undertaken to determine whether lymphocytes from P. c. chabaudi CB 
strain infected mice at different stages of infection were capable of transferring 
immunity to sublethally irradiated recipient mice. In addition, similar experiments 
were carried out using spleen cells from mice that had received subcurative 
chloroquine treatment, to investigate if such treatment would affect the ability of 
splenic cells to confer protection.
In all the adoptive transfer experiments described in this thesis the lymphocytes 
transferred were of splenic origin, as the spleen represents a large pool of readily 
available T and B cells. In addition, all recipient mice were exposed to y-irradiation 
shortly before cell transfers and subsequent parasite challenge. It is widely accepted 
that lethal or sublethal irradiation of an animal results in a depression of the recipient's 
own immune response to an antigenic stimulus administered after such treatment 
(Taliaferro & Taliaferro, 1951). Immunologically suppressing the host immune 
response of recipient animals prior to challenge has been used for the P. c. chabaudi
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AS/NIH mouse system to study the adoptive transfer of splenic cells (McDonald & 
Phillips, 1978; 1980). The reason for using irradiation as a tool in these studies is that 
in immunologically competent recipients, it is often difficult to differentiate between 
the protective activity provided by the transferred cells alone and that resulting from 
the cooperation between the repopulating inoculum and the host's fully operational 
immune system. In sublethally irradiated recipients, the contribution of the recipient's 
own immune response is reduced considerably. Within the present study, this 
depression of background immunity allowed differences in the primary parasitaemias 
of mice given normal or primed lymphocytes to be amplified, and thus enabled a 
clearer examination of the effect of the transferred populations on the course of P. c. 
chabaudi CB infection.
4.2 Adoptive transfer of splenic lymphocytes from donor mice 75 DPI
A group of 10 NIH female mice was infected with 5 x 104 P. c. chabaudi CB 
pRBCs and the course of infection followed. At the same time, another group of mice 
was sham-infected. These mice were used as the donor animals for the transfer. 75 
DPI, when the infected animals had completely cleared their infections, the donor 
mice were killed, their spleens removed and the cell populations prepared.
Recipient NIH female mice were exposed to 4 Gy y-irradiation on the morning 
of the cell transfer. At the time of challenge with 5 x 104 pRBCs, each mouse was 
also inoculated with an aliquot of 2 x 107 lymphocytes. Recipients of day 75 
lymphocytes were separated into groups of 6 mice each, and received either immune 
or naive unfractionated splenic lymphocytes, or immune or naive enriched T cell 
populations. In addition, a further group of 6 mice received only an inoculation of 
medium and served to demonstrate the course of infection in irradiated hosts without 
any influence from a transferred cell population. The identity of the transferred cell 
populations is shown in Table 4.2.1. The degree of enrichment of the T cell 
populations was assessed by live IFAT. For the immune T cell fraction (75 DPI 
cells), prepared by nylon wool incubation, 86.7% of the cells were Thy-1.2 staining, 
with 2.3% contaminating B cells. In the case of the naive cell fractions a similar 
proportion of cells was achieved with 86.2% T cells and 1.7% contaminating B cells. 
The unfractionated cell suspensions contained roughly equal numbers of T and B 
cells. In all cases, no staining for other contaminating cells, such as macrophages was 
carried out.
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TRANSFERRED CELL 
POPULATION
PERCENTAGE OF CELLS STAINING FOR:
THY-1.2 (T cells) IgG (Heavy chain) (B cells)
Unfractionated 75DPI cells 46.3 39.9
Unfractionated naive cells 37.3 36.8
Enriched 75 DPI T cells 86.7 2.3
Enriched naive T cells 86.2 1.7
TABLE 4.2.1 Phenotypic analysis of the identity of the transferred cells (75 DPI) by 
live IFAT.
The courses of infection in recipient mice are shown in Figure 4.2.1. Mice 
receiving immune T cells taken from donor mice at 75 DPI expressed a depression 
and shortening of the primary parasitaemia with no recrudescences of infection 
(Figure 4.2.1a). In comparison, mice receiving the same number of naive T cells did 
not control the primary parasitaemia until 17 DPI, with a recrudescence occurring 2 
days later. Statistical comparison of the peak parasitaemia revealed that there was no 
significant difference between these two groups, but a significant difference (p<0.01, 
pcO.OOl and p<0.01) was detected during the remission, the values quoted being 
those for days 11, 12 and 13 respectively. The transfer of a population of 
unfractionated cells resulted in a similar pattern of protection (Figure 4.2.1b). The 
mean peak parasitaemia of mice receiving immune 75 DPI unfractionated cells was 
8.5% compared to 25.8% observed in mice receiving naive cells and this was a 
significant difference (p<0.05). Again there was rapid parasite clearance, with no 
parasites detected in the peripheral blood of the recipients from 12 DPI onwards. 
Recipients of naive unfractionated cells experienced two recrudescences. Figure 
4.2.1c shows the course of infection in mice that did not receive any cells. Although 
there were no significant differences between the peak parasitaemia of these animals 
and mice that received naive cell suspensions, the mice did experience an extended 
primary parasitaemia, and the recrudescence that followed was significantly higher 
(p<0.05) than that observed in any other of the groups. This demonstrates that a 
degree of protection was achieved by the transfer of naive cell populations.
Splenic T cells, prepared 75 DPI, were, therefore, very effective upon adoptive 
transfer to immunocompromised hosts. Although the pattern of protection was 
similar in recipients of unfractionated cells, these cells conferred a better level of 
protection than the T cells alone, indicated by the significant reduction in peak 
parasitaemia. The enhanced ability of these cells to reduce the peak of infection was 
probably due to a synergistic activity of the T and B cells and unidentified cells within 
this population.
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FIGURE 4.2.1 The course of infection in 4 Gy irradiated recipients of 2 x 10 7 spleen 
cells: a) enriched naive (♦ ♦) or 75 DPI (□— □) T cells, b) unfractionated naive
(•-----♦) or 75 DPI (o— «a) cells, or c) no cells. Mice were challenged with 5 x 10 4
pRBCs P. c. chabaudi CB.
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4.3 Adoptive transfer of splenic lymphocytes 21 DPI
In the experiment described here, spleen cell suspensions were prepared from 
donor mice on day 21 post infection. This stage of infection represented the point at 
which the parasitaemias of all mice were subpatent. This experiment was performed 
to determine the degree of immunity that could be transferred with cells prepared 
from subpatent mice, and to determine whether either or both T and B lymphocyte 
subsets were responsible for the protection conferred by immunologically primed 
lymphocytes.
Six groups of six NIH female mice were irradiated with 4 Gy on the day of 
transfer and parasite challenge. As soon as possible after parasite challenge with 5 x 
104 pRBCs of P. c. chabaudi CB mice received an inoculum of either 2 x 107 
enriched 'semi-immune' T or B cells (21 DPI), 2 x 107 enriched naive T or B cells, or 
2 x 107 semi-immune or naive unfractionated splenic cells. In addition, another group 
of irradiated mice received 2 x 107 unfractionated cells prepared from 21 DPI donor 
animals, with no parasite challenge, as a control of pRBC contamination in the 
prepared spleen cell suspensions. A further group of mice were given only the 
parasite challenge. To provide sufficient numbers of cells for the adoptive transfer of 
primed or naive splenic lymphocytes, 10 infected mice were sacrificed 21 DPI and 12 
naive animals were killed at the same time.
The degree of enrichment of the spleen cell populations was assessed by live 
IFAT and is shown in Table 4.3.1.
TRANSFERRED CELL 
POPULATION
PERCENTAGE OF CELLS STAINING FOR:
THY-1.2 (T cells) IgG (Heavy chain) (B cells)
Unfractionated 21 DPI cells 51.1 43.9
Unfractionated naive cells 45.8 44.2
Enriched 21 DPI T cells 85.1 1.8
Enriched naive T cells 83.9 2.2
Enriched 21 DPI B cells 5.5 62.1
Enriched naive B cells 6.1 57.5
TABLE 4.3.1. Phenotypic analysis of the transferred cell populations (21 DPI) by 
live IFAT.
For both the naive and 21 DPI enriched T cell preparations more than 80% of 
the cells were Thy-1.2 staining, with 2.2% and 1.8% contaminating B cells 
respectively. The enrichment of B cells was somewhat less. The 21 DPI suspension 
contained 62.1% B cells with 5.5% contaminating T cells; the naive B cell preparation 
contained 57.5% B cells with 6.1% contaminating T cells. As for the 75 DPI adoptive
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transfer, the unfractionated cell suspensions contained approximately equal numbers 
of T and B cells.
The effect of the transferred 21 DPI cell populations on the course of P. c. 
chabaudi CB infection is shown in Figure 4.3.1. The transfer of a population of semi- 
immune 21 DPI enriched T cells resulted in a reduction of the peak parasitaemia, 
rapid parasite clearance and no recrudescences of infection compared to recipients of 
the same number of naive T cells (Figure 4.3.1a). The peak parasitaemia of 21 DPI T 
cells was 25.8% compared to 33.7% in naive recipients (p<0.05). Mice receiving 
naive T cells experienced two recrudescences. The transfer of a population of B cells 
21 DPI resulted in a reduction in the peak parasitaemia, with a more rapid .parasite 
remission compared to naive B cell recipients (Figure 4.3.1b) Although a 
recrudescence did occur in these animals, it followed an extended subpatent period 
compared to recipients of naive B cells. The parasitaemia in the 21 DPI B cell 
recipients reached a peak of 23.8% 10 DPI which was significantly lower (p<0.05) 
than in naive B cell recipients (41.7%). Remission of the peak parasitaemia was 
complete by 15 DPI, significantly different from the parasitaemia of naive B cell 
recipients (p<0.01 on days 13 and 14 post infection, and p<0.001 on days 15-19 post 
infection). Naive B cell recipients did not control their primary parasitaemias to 
subpatent levels until 23 DPI. A recrudescence occurred in these mice 2 days later, 
while semi-immune B cell recipients did not,recrudesce until 27 DPI. There was no 
significant difference in the level of the recrudescence. Recipients of day 21 
unfractionated cells demonstrated a course of infection shown in Figure 4.3.1c. This 
shows that the transfer of an unfractionated population of spleen cells results in a 
similar pattern of protection as the transfer of enriched T cells from the same stage of 
infection. Compared to the transfer of a population of naive unfractionated cells, 
there was a reduction in the peak parasitaemia (28.2% compared to 47.4%, p<0.05) 
and a much faster parasite remission (p<0.01, days 12, 13, 14, 15 post infection; 
p<0.001 days 16-22). No recrudescences were observed in 21 DPI unfractionated cell 
recipients. Naive cell recipients either died at the peak of infection or were killed due 
to anaemia and the development of ascites. Parasitaemias did not develop in the 
unchallenged recipients of unfractionated 21 DPI cells. The course of infection is not 
shown in the mice that did not receive any cells. These mice either died or were 
killed at peak parasitaemia (37.8%).
There were no significant differences (p>0.05) between the peak parasitaemias 
of any of the recipients of the 21 DPI cell preparations or those of the recipients of 
naive cell populations. Similarly there were no significant differences during the 
remission phase between 21 DPI cell recipients.
Cell populations prepared from donor mice at 21 DPI transferred a considerable 
degree of protection. Enriched T cells and unfractionated cells, upon adoptive
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transfer, resulted in what appeared to be a sterilising immunity (see section 4.4). With 
no recrudescences of infection detected by monitoring of daily blood smears it
Vappeared that T cells could transfer an imipunity that transcended antigenic variation, 
since the donor mice at 21 DPI would still have experienced one or more 
recrudescences. A difference in the pattern of protection was observed between 
recipients of enriched day 21 T or B cells. B cells, upon transfer, controlled the 
primary peak parasitaemia in the same manner as T cells (no significant differences, 
p>0.05), the only difference between the two groups of recipients was the appearance 
of a recrudescence in the B cell recipients. 4
«
4.4 Titration of effective lymphocyte numbers, 21 DPI, for the transfer of 
protection against P. c. chabaudi CB challenge
As a result of the efficiency with which enriched T cells from donor mice during
i
subpatency (21 DPI) could transfer immtmity, a study was carried out to determine 
the number of T lymphocytes that had to be transferred to an immunocompromised 
mouse to confer the level of resistance observed in section 4.3.
Four groups of recipient female NIH mice were exposed to 4 Gy of y-irradiation 
24 hours prior to adoptive transfer and challenge with 5 x 104 pRBCs P. c. chabaudi 
CB. The groups of mice were as follows: recipients of 2 x 107 enriched T cells from 
donor mice 21 DPI (32 mice), recipients of 107 T cells (6 mice), recipients of 106 T 
cells (6 mice) and recipients of 2 x 107 naive T cells (25 mice). A further group of 3 
mice were not challenged but received 2 x 107 T cells as controls for pRBC 
contamination in the enriched spleen cell population.
The course of infection in recipient mice was followed by monitoring daily 
blood smears. In addition, to explore the function of the transferred T cells, serum 
was taken from recipient mice, either daily or every two to three days, for 
determination of Ab levels by IF AT, and nitrate levels as a measurement of NO 
production. On days 8, 9, 10, 11 and 13, four mice from the recipients of 2 x 107 
naive or day 21 T cells were sacrificed and spleen cells prepared from the individual 
mice. These were stimulated with Gon A and the supernatants analysed for IFN-y by 
ELISA.
The proportion of cells staining by live IF AT for T and B cell markers is 
shown in Table 4.4.1. The percentage of T cells in the naive and 21 DPI cell 
preparations was 83.8% and 84.9% respectively, with less than 1.5% contaminating B 
cells in each case. Thus, the degree of enrichment was very similar to that in the 
previous 21 DPI transfer (4.3).
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TRANSFERRED CELL PERCENTAGE OF CELLS STAINING FOR:
POPULATION THY-1.2 (T cells) IgG (Heavy chain) (B cells)
Enriched 21 DPI T cells 84.5 1.4
Enriched naive T cells 83.8 1.3
TABLE 4.4.1 Phenotypic analysis of 21 DPI T cell populations for titration of
lymphocyte numbers. t
*
The courses of infection in recipient mice are shown in Figure 4.4.1. The course 
of infection in mice receiving 2 x 107 day 21 T cells (Figure 4.4.1a) showed the same 
pattern of protection as that described earlier (4.3). There was a significant reduction 
in the peak parasitaemia compared to naive T cell recipients (11.2% compared to 
28.1%, p<0.01) and there was a very rapid parasite remission; parasites were not 
detected in the peripheral blood of recipient mice from 15 DPI onwards. 15, 18, 21, 
and 30 DPI one mouse was killed, exsanguinated and the blood sub-inoculated into a 
naive recipient mouse. The recipients were then monitored for the presence of 
parasites in the peripheral blood by examination of daily blood smears. After 14 days
none of the recipients showed signs of a patent parasitaemia, indicating that the
immunity transferred by 2 x 107 T cells prepared from donor mice 21 DPI was a 
sterilising one, demonstrable as early as 15 DPI. On day 56 post infection, the 
remaining mice in this group were challenged with 1 x 107 pRBCs P. c. chabaudi CB. 
No patent parasitaemia developed. In appropriate controls, however, a parasitaemia 
was detected two days later. '
%
Recipients of 107 day 21 enriched splenic T cells displayed a course of infection 
consisting of a reduction in peak parasitaemia, rapid parasite remission and extension 
of the subpatent period compared to naive T cell recipients (Figure 4.4.1b). The peak 
parasitaemia occurred 9 DPI, at 10.6% compared tp 28.1% in naive cell recipients' f
(p<0.02). During the remission phase, significant differences were detected in the 
parasitaemia from day 10 onwards compared to naive cell recipients (p<0.001). 
Although there were no differences between the peak parasitaemias of the recipients 
of 2 x 107 and recipients of 107 day 21 T cells (p>0.05), or between the parasitaemias 
during the remission of primary parasitaemia, the recipients of 107 cells showed a 
recrudescence 29 DPI, 5 out of 6 recipients recrudescing by 33 DPI. The peak of this 
recrudescence was lower than in naive recipients but was not statistically significant. 
Elimination of this recrudescence represented complete parasite clearance; sub­
inoculation of blood into naive mice 43 DPI did not result in the development of a 
patent parasitaemia.
The adoptive transfer of 10^ T cells from day 21 donors resulted in a course of 
infection shown in Figure 4.4.1c. Again there appeared to be a reduction in the peak
parasitaemia compared to naive cell recipients but this was not significant (14.3% 
compared to 28.1%, p>0.05). There was, however, no significant difference between 
the peak parasitaemia of this group of mice and the 2 x 107 and 107 T cell recipients. 
Parasite remission was more rapid in these recipients compared to naive cell 
recipients (p<0.05 11, 12 and 14 DPI) but a recrudescence occurred the day after the 
parasitaemia reached subpatent levels. There was no difference in the level or day of 
the peak of this recrudescence.
The pattern of protection, therefore, changed as the number of transferred T 
cells decreased. A sterilising immunity was the result of the transfer of 2 x 107 day 
21 T cells, complete parasite clearance having occurred by 15 DPI. The transfer of a 
smaller number of T cells conferred a level of immunity, but in each case a 
recrudescence did occur. The timing of this recrudescence was affected by the 
number of transferred cells, such that 107 cells delayed the onset of a recrudescence 
by 9 days whereas 106 transferred cells did not effect the timing or level of 
recrudescence compared to the naive cell transfer.
The antibody levels of the cell recipients, as measured by slide IF AT, are 
illustrated in Figure 4.4.2. The maximal Ab titres differed between the groups of cell 
recipients. In the recipients of 2 x 107 and 107 T cells, the peak Ab titre occurred just 
after the peak of parasitaemia while 106 T cell or naive T cell recipients showed 
maximal Ab titres following the recrudescence. The mean peak Ab titre of 2 x 107 T 
cell recipients was significantly higher (p<0.05) than in the other groups. It appears, 
therefore, that a more rapid antibody response occurs in mice receiving 2 x 107 T 
cells. The transfer of a smaller number of cells did not significantly affect the level or 
the pattern of antibody production.
Figure 4.4.3 shows the levels of nitrate in the serum of recipient mice. In every 
case a peak of NO production occurred on the day of peak parasitaemia, with no 
significant differences between any of the groups.
IFN-y production by spleen cells from 2 x 107 day 21 T cell or naive T cell 
recipients is shown in Figure 4.4.4. Uninfected mice were used as controls and in 
response to stimulation with Con A produced approximately 20 U/ml IFN-y within 
this experiment. On days 8 and 9 post infection, 21 DPI cell recipients produced 
significantly higher levels of IFN-y (p<0.01) compared to either naive cell recipients 
or uninfected mice. Naive cell recipients produced a high level of IFN-y 10 DPI, the 
day preceding peak parasitaemia, significantly higher (p<0.01) than on any other day 
when levels were measured. There was no significant difference (p>0.05) between 
the maximum levels in naive or day 21 cell recipients. These results indicate that in 
both naive and 21 DPI T cell recipients IFN-y is produced maximally before the peak 
parasitaemia, but that in the latter case this occurs earlier and is more prolonged.
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FIGURE 4.4.4 Interferon-gamma production by spleen cells from 4 Gy irradiated 
recipients of 2 x 107 21 DPI or naive T cells.
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4.5 Adoptive transfer of splenic lymphocytes from chloroquine treated donor 
mice 75 DPI
This experiment was carried out to determine if subcurative chloroquine 
treatment (50mg/kg) of donor mice 10 DPI would affect the level of immunity 
transferred with T cells 75 DPI compared to that observed with T cells from naturally 
recovered mice at the same stage of infection. In addition, fluorescenceAb levels, to 
fixed parasite material, were measured every 3 days in the serum of recipient mice. In 
the transfer carried out 75 DPI from naturally recovered mice, only T cells were 
transferred (see 4.2); in this experiment mice receiving enriched B cells were also 
included.
Eight groups of six mice were irradiated to 4 Gy 24 hours before the transfer. 
The groups of mice received 2 x 107 aliquots of: enriched T or B cells from 75 DPI 
donors, enriched naive T or B cells, unfractionated spleen cells from 75 DPI or naive 
mice, no cells (challenge inoculum only), or 75 DPI unfractionated cells and no 
challenge (as a control for pRBC contamination in the spleen cell preparation). Mice 
were challenged with 5 x 104 pRBCs P. c. chabaudi CB immediately prior to 
adoptive transfer.
The identity of the transferred spleen cell populations was analysed by IF AT 
following the transfer, and this is shown in Table 4.5.1.
TRANSFERRED CELL PERCENTAGE OF CELLS STAINING FOR:
POPULATION THY-1.2(T cells) IgG (H eavy chain) (B cells)
Unfractionated 75DPI cells 47.6 41.0
Unfractionated naive cells 31.1 34.9
Enriched 75 DPI T cells 86.4 0.4
Naive enriched T cells 86.0 0.7
Enriched 75 DPI B cells 5.3 60.9
Naive enriched B cells 5.0 51.5
TABLE 4.5.1 Phenotypic analysis of the transferred cell populations prepared from 
chloroquine treated (10 DPI) mice 75 DPI, measured by live IF AT.
The degree of enrichment achieved was good. In each of the enriched T cell 
populations, greater than 85% of the transferred population consisted of T cells, with 
less than 1% contaminating B cells. The enriched B cell populations consisted of 
more than 50% B cells, with less than 6% contaminating T cells.
The courses of infection in the recipient mice are shown in Figure 4.5.1. 
Recipients of 75 DPI unfractionated cells, without challenge, did not develop a patent 
parasitaemia. The course of infection in the mice that did not receive any cells is not
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shown but was similar to that shown in Figure 4.2.1c.
The transfer of a population of T cells from chloroquine treated donor mice 75 
DPI, resulted in a course of infection consisting of a reduced peak parasitaemia 
compared to the transfer of a naive T cell population (Figure 4.5.1a). There was a 
significant difference between the levels of the peak parasitaemia (10.4% compared to 
28.7%, p<0.05). A faster parasite remission occurred in the 75 DPI T cell recipients 
compared to naive T cell recipients (p<0.01, 10 and 11 DPI; p<0.001,12 and 13 DPI), 
no parasites were detected by blood smear from day 13 post infection through to 60 
DPI when the experiment was terminated. Naive T cell recipients did not all become 
subpatent until 34 DPI and a recrudescence followed 4 days later in 4 out of 6 mice. 
There were no recrudescences of infection in the 75 DPI T cell recipients.
Mice that received enriched 75 DPI B cells displayed a course of infection 
similar to T cell recipients (Figure 4.5.1b). There was, however, no significant 
difference between the peak parasitaemia in 75 DPI B cell recipients compared to 
naive B cell recipients (p>0.05) although the peak occurred a day earlier in the 
former. Protection was manifest as a more rapid parasite remission compared to 
naive B cell recipients, p<0.01 (10, 11 and 12 DPI) and p<0.001 (13 and 14 DPI). 
There were no recrudescences of infection; two occurred in naive B cell recipients.
The transfer of an unfractionated population of splenic cells from day 75 
chloroquine treated donors significantly reduced (p<0.01) the peak parasitaemia 
(5.6%) compared to naive unfractionated cell recipients (17.8%) (Figure 4.5.1c). 
There was rapid parasite remission and no recrudescences of infection. Naive 
unfractionated cell recipients experienced a prolonged primary parasitaemia, with a 
very short subpatent period before a recrudescence appeared. A further recrudescence 
occurred in 2 out of 6 mice 53 DPI.
Subcurative chloroquine treatment of donor mice 10 DPI did not affect the 
ability of selected lymphocyte populations to transfer immunity. Protection was 
manifest in the same manner as the adoptive transfer of splenic lymphocytes from 
naturally recovered mice 75 DPI (4.2). In this experiment, however, a population of 
B cells was also transferred. The course of infection in these recipients followed the 
same pattern as that of T cell recipients. The peak parasitaemia, however, was not 
significantly affected by the transfer of B cells. The transfer of a population of 
unfractionated cells resulted in a better degree of protection than the transfer of either 
T or B cell enriched populations alone. There was a significant reduction (p<0.05) in 
the peak parasitaemia (5.6%) of unfractionated cell recipients compared to that 
(10.4%) of T cell recipients. This indicates that a level of synergy between the T and 
B cell populations within an unfractionated cell population occurred.
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FIGURE 4.5.1 The course of infection in 4 Gy irradiated recipients of 2 x 107spleen cells: 
a) enriched naive (♦ ♦) or 75 DPI T cells, b) enriched naive (»■ ♦) or 75 DPI
(b— 43) b  cells, or c) unfractionated naive(» ♦) or 75 DPI (H B) cells. Day 75 cell 
populations were prepared from donor mice that had been treated with chloroquine 10 DPI. 
Mice were challenged with 5 x 104pRBCs P. c. chabaudi CB.
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The Ab levels in the recipient mice is illustrated in two different ways. Figure
4.5.2 illustrates the Ab levels, as measured by slide IF AT, associated with the course 
of infection of recipient mice. Figure 4.5.3 shows the Ab titres of the recipients of 
each lymphocyte population from 75 DPI compared to the recipients of the 
corresponding naive population.
In each group of recipient mice, the maximum Ab titre occurred after the peak 
parasitaemia (Figure 4.5.2). There then followed a decline in the Ab level, although 
in the recipients that experienced a recrudescence, the Ab titre increased following the 
recrudescence.
Recipients of cell populations from 75 DPI donors developed specific anti-P. c. 
chabaudi CB Abs before recipients of naive cell populations, these in turn making an 
Ab response before irradiated mice that did not receive any cells (Figure 4.5.3). In 
each case there was a significant difference (p<0.05) between the maximum Ab titres 
in 75 DPI recipients compared to those in naive recipients. There were no significant 
differences (p>0.05) at any stage throughout the course of infection in the Ab titres of 
any of the 75 DPI cell recipients.
The 75 DPI transferred cell populations, therefore, all caused an increase in the 
production of anti-malarial Abs compared to the transfer of naive cell populations. 
There was, however, no difference between the different cell populations in the 
kinetics of Ab production. The titres illustrated in Figures 4.5.2 and 4.5.3 are 
measured by slide IFAT and do not give a measure of protective activity or Ig isotype 
conferring immunity in each of the recipients.
4.6 Adoptive transfer of splenic lymphocytes from chloroquine treated mice 14 
DPI
In mice that are treated with 50 mg/kg of chloroquine at peak parasitaemia 
(usually 10 DPI) there is a rapid parasite remission to subpatent levels by 14 DPI. 
This is followed by a recrudescence which is higher than that observed in untreated 
mice. The time point of 14 DPI was chosen for this adoptive transfer because it 
represented the first point during the course of infection in chloroquine treated mice 
where the parasitaemia was subpatent. It, therefore, was used as a comparison of the 
21 DPI adoptive transfers from naturally recovering mice; subpatency in these mice.
Ten donor mice were infected with 5 x 104 pRBCs P. c. chabaudi CB and the 
course of infection monitored. 10 DPI, at the peak parasitaemia (35.4%), the mice 
were treated with 50 mg/kg chloroquine. Four days later (14 DPI) when the 
parasitaemias of these mice were subpatent, the mice were killed and spleen cell 
populations prepared. Ten naive, sham-infected and chloroquine treated mice were 
used as the naive cell donors.
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FIGURE 4.5.3 The serum antibody titres of 4 Gy irradiated recipients of a) T cells, 
b) B cells, and c) unfractionated cells prepared from chloroquine treated donor mice 
75 DPI (° d) or from naive mice (♦— —♦).
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Six groups of six mice were exposed to 4 Gy y-irradiation 24 hours before 
adoptive transfer and parasite challenge. The groups of mice receiving aliquots of 2 x 
107 spleen cells were as follows: recipients of enriched T or B cells from 14 DPI 
donors, recipients of naive enriched T or B cells and recipients of 14 DPI or naive 
unfractionated cells. In addition three mice received unfractionated cells without 
parasite challenge as a control for pRBC contamination. Mice were challenged with 5 
x 104 pRBCs prior to adoptive transfer.
The degree of enrichment of the prepared spleen cell populations was analysed 
by live IF AT and is shown in Table 4.6.1. The percentage of T cells in the enriched 
14 DPI and naive spleen cell populations was 83.8% and 81.0% respectively with less 
than 2% contaminating B cells in each case. The enriched B cell populations 
contained greater than 45% IgG (heavy chain) staining cells with less than 8% 
contaminating T cells. The unfractionated populations contained approximately equal 
numbers of T and B cells, but less than 40% of each in both prepared populations.
TRANSFERRED CELL 
POPULATION
PERCENTAGE OF CELLS STAINING FOR:
THY-1.2(T cells) IgG (Heavy chain) (B cells)
Unfractionated 14 DPI cells 39.0 31.2
Unfractionated naive cells 36.0 33.1
Enriched 14 DPI T cells 83.8 1.6
Naive enriched T cells 81.1 1.2
Enriched 14 DPI B cells 7.8 48.8
Naive enriched B cells 7.5 45.3
TABLE 4.6.1 Phenotypic analysis of transferred cell populations from chloroquine 
treated donor mice 14 DPI.
The courses of infection in recipient mice following adoptive transfer are shown 
in Figure 4.6.1. Recipients of 14 DPI enriched T cells demonstrated a course of 
infection consisting of a slight reduction in peak parasitaemia, although this was not 
significant compared to the peak parasitaemia in naive T cell recipients (p>0.05) 
(Figure 4.6.1a). Protection, however, was manifest as a more rapid parasite remission 
(p<0.01, 10 and 11 DPI; p<0.001,12-15 DPI). All mice had subpatent parasitaemias 
by 17 DPI although this was not long lasting. By 19 DPI 4 out of the 6 recipients had 
shown recrudescences and there were no further significant differences throughout the 
rest of the infection.
The course of infection in recipients of 14 DPI B cells is shown in Figure 4.6.1b. 
Compared to naive B cell recipients there was a reduction in the peak parasitaemia
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FIGURE 4.6.1 The course of infection in 4 Gy irradiated recipients of 2 x 10 spleen 
cells: a) enriched naive (♦ ♦) or 14 DPI (■——^ T cells, b) enriched naive (♦ ■— $
or 14 DPI d3 H) B cells, and d) unfractionated naive (♦——^ or 14 DPI (B-----
cells. 14 DPI cell populations were prepared from donor mice that had been treated 
with chloroquine 10 DPI. All mice were challenged with 5 x 104pRBCs 
P. c. chabaudi CB.
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(11.8% compared to 22.1%, p<0.05) and a faster parasite remission (p<0.001, 12-15 
DPI), subpatency reached 15 DPI. A recrudescence occurred a few days later, from 
which point no further significant differences were observed between these two 
groups of cell recipients.
The adoptive transfer of 14 DPI unfractionated spleen cells engendered the 
greatest level of protection. Compared to the transfer of a naive unfractionated cell 
population (Figure 4.6.1c) there was a significant depression of the peak parasitaemia 
(13.6% compared to 30.8%, p<0.02) and more rapid parasite remission (p<0.01, 10 
DPI; p<0.001, 11-15 DPI). Parasitaemias of all recipient mice were subpatent by 14 
DPI and remained so until 22 DPI when one of the recipients showed a patent 
parasitaemia. A defined recrudescence then followed significantly lower than that 
observed in naive cell recipients (p<0.05).
Cell populations from chloroquine treated mice 14 DPI were, therefore, clearly 
effective at transferring a degree of immunity. While recipients of naive/unstimulated 
cell populations ultimately cleared their infections they never achieved a period of 
subpatency. Primed T and B cells both conferred a degree of immunity, but a 
sterilising immunity was not achieved as was demonstrated with the other adoptive 
transfer experiments. Interestingly, an enhanced protection was conferred by B cells 
over the T cell population, seen as a more profound reduction of primary parasitaemia 
and day at which subpatency was reached. Unfractionated cells clearly gave the most 
protection, with significant reduction of peak parasitaemia and extension of the 
subpatent period.
Most in vitro investigations have shown that chloroquine suppresses the 
proliferation of lymphocytes in a dose-dependent manner. To examine whether the 
dose of 50 mg/kg of chloroquine used at peak parasitaemia may have affected the 
proliferative response of lymphocytes from donor animals 14 DPI in vivo, naive mice 
were treated with chloroquine prior to in vitro stimulation of splenic lymphocytes. 
Five groups of two mice were used for this experiment, receiving chloroquine 
treatment four days, three days, two days or one day prior to Con A stimulation in 
vitro of spleen cells. Another group of mice was untreated. Figure 4.6.2 shows the 
result. There was no difference in the proliferative response to Con A of naive spleen 
cells whether they were treated with chloroquine or not. It appears, that at least to a T 
cell mitogen, naive cells are not affected by the addition of chloroquine at doses used 
in vivo. The response of primed lymphocytes to either Con A or pRBCs was not 
tested for.
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FIGURE 4.6.2 The effect of in vivo chloroquine treatment (50 mg/kg) on the 
proliferation of naive spleen cells with 5 pg/ml Con A.
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4.7 Discussion
The spleen represented a readily available source of lymphocytes for the 
adoptive transfers throughout the course of P. c. chabaudi CB infection. Kumararatne 
et al. (1987), however, showed that by day 11 post P. c. chabaudi AS infection the 
spleen shows partial lymphocyte depletion, coinciding with a massive absolute 
lymphocytosis in the peripheral blood, due to a redistribution of lymphocytes. 
Shortly after peak parasitaemia, lymphocyte localisation in the spleen is reduced 
(Brissette et al., 1978); concomitantly, there is a rise in lymphocyte migration to the 
blood, and to the lungs and especially the liver (Playfair & DeSouza, 1982). 
Sequestration of malaria parasites occurs in the liver (Shungu & Arnold, 1972; Cox & 
Hommel, 1984) and this may be the reason for lymphocytes accumulating in this 
organ. This suggests that the liver is important in the development of protective 
immunity to malaria. A study, therefore, to investigate the ability of liver, lung and 
peripheral blood lymphocytes to transfer protection would also be of interest.
A consistent proportion of enriched splenic cell subpopulations was achieved by 
nylon-wool incubation. For each of the adoptive transfers the degree of enrichment 
was such that an enriched effluent T cell population always contained >80% T cells 
and less than 2% contaminating B cells. Eluted B cell populations contained more 
than 50% B cells and always less than 7% contaminating T cells. These are similar 
proportions as those obtained by Julius et al. (1973) who first used this method.
Subpopulations of lymphocytes derived from the spleens of infected donor mice 
were effective at transferring immunity from all the stages of infection from which 
cells were prepared. In general, both enriched T cells and enriched B cells upon 
adoptive transfer were able to confer a level of protection to immunocompromised 
mice, but unfractionated spleen cells conferred the greatest level of protection. These 
observations with the P. c. chabaudi CB/NIH mouse system were in accordance with 
those of Fahey & Spitalny (1986) using P. yoelii 17X infection of A/Tru mice. In this 
model, successful adoptive immunisation of naive recipients with unfractionated 
spleen cells, T cells or B cells was first demonstrable with lymphocytes harvested 7 
DPI, peaked at 14 DPI and was no longer detectable by 21 DPI, concomitant with the 
elimination of the primary infection in donor mice. This study and the results 
described in this chapter are, however, at variance with the report of Favila-Castillo et 
al. (1990). These investigators used the AS strain of P. c. chabaudi, but in CBA/Ca 
mice, and reported that it was only possible to transfer immunity to 4.5 Gy-irradiated 
mice with spleen cells taken from donors which had been infected seven times prior 
to cell transfer. In mice inoculated with unfractionated splenic lymphocytes taken 
after recovery from a single infection, there was a 100% mortality rate. This 
discrepancy is difficult to reconcile. A recent study by the same workers (Legorreta- 
Herrera et al., 1993) showed that spleen cells from recently recovered P. c. chabaudi
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AS infected (B ALB/c X C57B1/6) Fi mice could transfer protection into irradiated 
syngeneic recipients. In addition, Taylor-Robinson (1991) using the same strain of 
parasite demonstrated that protection could be achieved as early as 12 DPI with 
unfractionated peripheral blood lymphocytes. This points to the possibility of a 
genetic factor involved in host immunity to P. c. chabaudi, as suggested by Stevenson 
et al. (1982), although neither CBA/Ca or NIH mice were employed in this study. 
Other reasons for the lack of immunity transferred with lymphocytes other than those 
from superinfected donors, as described by Favila-Castillo (1990) are difficult to 
explain considering the ease with which immunity could be transferred in this study 
and those reported above.
In none of the experiments described in this thesis did the adoptive transfer of 
lymphocytes, regardless of source or state of immunological commitment, suppress 
the ascending acute blood infection. Instead, protection was indicated by the 
subsequent suppression of parasitaemia. This was in agreement with previous studies 
of adoptive immunity to rodent malarias (Brown et al., 1976a, b; Gravely & Kreier, 
1976; McDonald & Phillips, 1978; 1980; Brinkmann et al., 1985; Cavacini et al., 
1986) which showed that in various levels of immunosuppression, infected mice and 
rats inoculated with immune lymphocytes exhibited a protective response 
demonstrable by a reduction in the peak parasitaemia, quickened pRBC elimination 
and/or host survival.
Regarding the adoptive transfer experiments described in this chapter, in 
general, the protective effect of unfractionated splenic cells was greater than that of 
either enriched T or enriched B lymphocytes. This was manifest as a significantly 
reduced peak parasitaemia compared to all other cell recipients. In some cases, 
however, the immunity conferred by T cells and unfractionated cells could not be 
distinguished. The maximal protection of unfractionated cells was suggestive of a 
synergistic effect between the cells of mixed phenotypes within the population. 
McDonald & Phillips (1978), working with P. c. chabaudi AS in the NIH mouse, 
showed that for the most efficient protection of irradiated mice against infection with 
immune syngeneic cells (from donor mice infected at least twice), a population 
containing both T and B cells, such as unfractionated spleen cells,was required. They 
failed, however, to show unequivocally synergistic activity between primed 
lymphocyte subsets in irradiated mice. The same pattern of protection was conferred 
by T and B lymphocytes from donor mice 75 DPI, with or without chloroquine 
treament, indicating that both lymphocyte subsets are required for the elaboration of 
immunity to P. c. chabaudi CB. This is not in agreement with the findings of 
Cavacini et al. (1990) who showed that B-cell deficient mice could resolve infection 
with the CB strain of P. c. chabaudi with the same kinetics as normal mice. In each 
of the 75 DPI cell transfers, the greatest level of protection was achieved by the
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transfer of an unfractionated population of spleen cells. This was manifest as a 
significant reduction in the peak parasitaemia. To investigate the synergistic activity 
of the cells within the unfractionated cell population, the Ab levels of the day 75 cell 
recipient mice were measured by IF AT. Recipients of immune day 75 lymphocytes 
all showed higher antibody titres compared to the recipients of naive cells, but there 
was no difference in the titres of unfractionated spleen cell recipients compared to 
recipients of either T cells or B cells. Synergy, therefore, was not indicated by the 
IF AT Ab levels of the recipient mice.
McDonald & Phillips (1978) showed that most but not all of the protective 
activity on adoptive transfer of P. c. chabaudi AS immune spleen cells lay in the B 
cell-enriched fraction; Ferraroni & Speer (1982) showed a similar result with P. 
berghei-primed mouse splenic lymphocytes. Brown et al. (1976a) demonstrated 
protective activity of T-enriched populations from the spleen of P. berghei infected 
rats upon adoptive transfer of naive syngeneic recipients, but there was increased 
protection on the addition of B cells. In a similar study, Gravely & Kreier (1976) 
concluded that the bulk of the protection conferred to rats infected with P. berghei 
resided in the differentiated splenic B cell population. The enriched splenic T cell 
fraction was generally less protective than the B cells or the mixed T and B cells. 
They considered, therefore, that the primed T cells were acting as helper cells in the 
production of specific anti-P. berghei protective Ab as first proposed by Brown 
(1974).
The results of the 21 DPI cell transfers are in direct contrast to the above studies. 
The transfer of enriched T cells conferred a sterilising immunity, while the transfer of 
the same number of B cells, while conferring protection, did not prevent the 
development of a patent recrudescence. It appeared, therefore, that T cells from mice 
during the subpatent period of infection were capable of imparting an immunity that 
transcended antigenic variation. Brown (1974) suggested that T cells might be 
important as helpers in establishing variant-transcending immunity. He suggested 
that, during malarial infection T cells become primed to a determinant common to all 
plasmodial variants but characteristic of the strain producing the infection. The 
sensitisation of T cells with one variant type would produce an expanded T cell 
population capable of acting as helpers to all B cell clones responding to variants 
developed later in infection. This could be feasible as the transfer of B cells alone, 75 
DPI, could transfer immunity without the development of recrudescences while those 
from 21 DPI could not. 75 DPI B cells were presumably primed to all variant parasite 
Ags while those from 21 DPI donors had not seen the variants arising during the 
recrudescent parasitaemias that would have developed in donor mice. The transfer of 
B cells from 21 DPI donors (immunologically immature) to immunocompromised 
hosts would result in the recipients having only the immunity conferred by the
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differentiated B cells that they received. Because insufficient T cells were present in 
the transferred population these animals could not respond rapidly to antigenic 
variants and thus a recrudescence arose. If this is the case, T cells act as helpers for 
antibody production, and immunity to P. c. chabaudi CB is mediated by humoral 
mechanisms. This is a direct contradiction of the results of Cavacini et al. (1990) who 
demonstrated that immunity to the CB strain is Ab-independent.
Non-humoral mechanisms appear to resolve infection in some rodent models of 
malaria (Jayawardena et al.y 1982; Brinkmann et al., 1985; Cavacini et al.y 1986). 
Brinkmann et al. (1985) demonstrated that the reconstitution of nude mice with naive 
T cells, but not with naive B cells, restored a protective immune response in recipient 
animals. In the case of P. c. adami, infected athymic mice develop a high-grade, 
fulminating infection; T cell but not B cell enriched naive or immune spleen cells 
suppress challenge infection in otherwise susceptible nude mice (Cavacini et al. 
(1986). In this study, T cells from 21 DPI were more effective at transferring 
immunity to P. c. chabaudi CB than the same number of B cells. Titration of the 
number of T lymphocytes necessary to confer a sterilising immunity showed that 
while no difference in the reduction or remission of the primary parasitaemia occurred 
as the number of T cells decreased, a smaller number of T cells did not prevent a 
recrudescence from arising. It is possible, therefore, that the immunity conferred by 
enriched B cells was in fact due to the presence of a proportion of contaminating T 
cells. However, 5% contaminating T cells would be the equivalent of 106 T cells and 
the protection achieved by such a number of T cells follows a different pattern than 
that produced upon transfer of B cells.
An attempt at analysing the function of the 21 DPI T cells was made. This was 
done by measuring Ab titres and nitrate levels during the course of infection, as well 
as looking at the production of IFN-y from spleen cells around the peak of infection. 
The antibody levels in the recipient mice were significantly higher than those of naive 
T cell recipients, although the transfer of a smaller number of cells did not 
significantly affect the level or pattern of antibody production. It appears, therefore, 
that a more rapid antibody response occurs in recipients of 21 DPI T cells, but 
following this there is no further difference in the Ab levels. NO and IFN-y 
production are indicators of a Th I response. The levels of nitrate in the serum of 
infected mice did not differ significantly in the recipients of 21 DPI T cells or naive T 
cells. However, there was a more prolonged and earlier production of IFN-y in the 21 
DPI T cell recipients than in the naive cell recipients. The results, therefore, indicate 
that a mix of Th I and Th2 cells was probably contained within the transferred 21 DPI 
T cell population.
Legorreta-Herrera et al. (1993) have described the successful transfer of 
protection aginst P. c. chabaudi AS with anti-Thy-1 treated, irradiated spleen cells.
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This not only suggests that the protective activity of immune spleen celts lies outwith 
the T cell fraction, but that a radioresistant cell population confers immunity. It is 
also possible, therefore, that within the recipients used in this study protection may 
also have been conferred by radioresistant cells. The different pattern of protection 
conferred by T and B cells may have been due to a difference in cooperation with 
ndioresistant cells. Although both T and B cells are lost after irradiation, a 
proportion of T cells (Nossal & Pike, 1973), and B cells (Pilarski & Cunningham, 
1574) are relatively radioresistant. Macrophages are relatively radioresistant as far as 
some macrophage functions are concerned and sensitive with regard to others (Geiger 
& Galiily, 1974).
Faster parasite remission occurs in mice treated with chloroquine at peak 
pirasitaemia. Consequently, subpatency occurs 14 DPI and a recrudescence follows 
qjickly. Because this stage of infection represented the first point of parasite 
remission in these animals, an adoptive transfer was carried out to compare the level 
of immunity transferred from this point of infection with that transferred from 
sibpatency in naturally recovering mice (21 DPI). Significant reduction of the peak 
pirasitaemia was observed in the recipients of the different 14 DPI cell populations. 
Compared to the transfer of naive cells, transfer of 14 DPI cells resulted in a faster 
remission of the parasitaemia. Recrudescences, however, followed in all the groups 
o: recipients. A difference, therefore, was demonstrated in the level of immunity 
conferred by splenic lymphocytes from the subpatent period of naturally recovering 
nice aaid those from the subpatent period of mice treated with chloroquine. One 
reason for this may not be due to a specific defect in the T cell repertoire but simply 
that the lymphocytes from chloroquine treated mice 14 DPI were not as 
inmunologically mature as those from naturally recovered mice 21 DPI. Another 
reason may have been that chloroquine treatment in vivo resulted in the suppression of 
lymphocyte activation and proliferation. In vitro studies have demonstrated that 
clloroquine suppresses the proliferation of lymphocytes in a dose-dependent manner 
(Hurvitz & Hirschhom, 1965; Panush, 1975; Gery & Eidinger, 1977; Trist & 
Weatherall, 1981; Salmeron & Lipsky, 1983). To exclude this in the present study the 
pioliferative response of naive spleen cells following in vivo chloroquine treatment 
was investigated. No difference in the response of spleen cells to Con A was 
observed following several regimes of chloroquine treatment. It would appear that 
the dose of chloroquine used at peak parasitaemia was not sufficient to cause 
inmunosuppression. Indeed, Bygbjerg & Flachs (1986) demonstrated that the 
immunosuppressive effects by chloroquine were dose-related as only high 
concentrations of chloroquine profoundly suppressed the proliferation of mitogen- 
ard antigen-stimulated lymphocytes.
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That no recrudescences were observed in the recipients of 21 DPI T cells was 
somewhat surprising. The patent parasitaemias of donor mice from this stage of 
infection are expected to recrudesce and, therefore, assuming antigenic variation is a 
feature of P. c. chabaudi CB infection, mice would not be primed to all the variant- 
specific Ags during a course of infection. The subpatent period is poorly defined for 
the CB strain of P. c. chabaudi so individual donor mice may have experienced 
different antigenic variants such that sufficient cells reactive to the different variants 
were included in the transferred T cell population. Alternatively, if recrudescences 
arise as a result of a decline in the effector arm of the immune response during 
remission of the primary parasitaemia then it is also surprising that T cells from 
subpatency transferred a sterilising immunity.
The experiments described in the next chapter examine the phenomenon of 
antigenic variation in P. c. chabaudi CB in both naturally recovering and chloroquine 
treated mice, as a direct result of the different patterns of protection described here.
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CHAPTER FIVE
PASSIVE TRANSFER OF IMMUNITY AND ANALYSIS OF 
RECRUDESCENT PARASITE POPULATIONS
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5.1 Introduction
Chapter four demonstrated that effective immunity could be transferred with 
enriched populations of spleen cells. The aims of the experiments described in this 
chapter were twofold: firstly, to determine if passive transfer of serum from donor 
mice 21 DPI or 14 DPI could confer protection upon parasite challenge, and secondly, 
to investigate antigenic variation by serum sensitivity, as described for P. c. chabaudi 
AS (McLean et al., 1982b), in recrudescent parasite populations collected from 
naturally recovering and chloroquine treated mice. This method tests the ability of 
serum collected from mice during the subpatent period of infection to protect against 
a challenge infection with either the infecting parasite population or recrudescent 
parasites. It was considered important to investigate the ability of serum, and 
presumably Ab, to transfer protection since one report (Cavacini et al., 1990) suggests 
that immunity to P. c. chabaudi CB is independent of Ab.
Numerous investigators have used the method of passive Ab transfer to define 
more specifically the nature of protective Ab production, to evaluate ways for 
increasing the level of protective Ab formation, to establish the isotype of protective 
Abs, and to characterise further protective humoral immunity (Stechschulte et al., 
1969; Zuckerman & Golenzer, 1970; Phillips & Jones, 1972; Lourie & Dunn, 1972; 
Brown & Phillips, 1974; Golenzer et al., 1975; Wells & Diggs, 1976). The majority 
of these studies examined blood-induced P. berghei infection in rats or mice. In 
general, the results showed that the passive transfer of serum at the same time as 
infection resulted in a delayed onset in detectable parasitaemia, reduced peak 
parasitaemias and enhanced the survival of challenged animals (Zuckerman & 
Golenzer, 1970; Phillips, 1970; Phillips & Jones, 1972; Brown & Phillips, 1974; 
Golenzer et al., 1975; Lourie & Dunn, 1972). The transfer of hyperimmune sera to P . 
berghei-infected mice resulted in delayed parasitaemia but the animals generally 
succumbed to the disease (Stechschulte et al., 1969; Brown & Phillips, 1972; Wells & 
Diggs, 1976). The transfer of hyperimmune sera was considerably better than sera 
from animals with an ongoing or chronic infection (Stechschulte et al., 1969; Phillips 
& Jones, 1972) or sera from an animal that had recovered from a single infection 
(Diggs & Oster, 1969; Zuckerman & Golenzer, 1970). Levels of protective activity 
change rapidly during the course of infection, therefore, with regard to serum 
protection, the timing of serum collection is crucial (R.S. Phillips, personal 
communication).
Antigenic variation in the asexual erythrocytic stages of malaria parasites has 
been well documented. This phenomenon was first described in P. berghei by Cox 
(1962), and subsequently in P. knowlesi (Brown & Brown, 1965; Brown, 1973; 
Howard et al., 1984), P. cynomolgi bastianelli (Voller & Rossan, 1969), P. c. 
chabaudi AS (McLean et al.y 1982b; 1986a; Gilks et al., 1990), P. falciparum in vivo
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(Hommel et al., 1983) and in vitro (Biggs et al., 1991; Roberts et al., 1992), and P. 
fragile (Handunnetti et al., 1987). It is now considered likely that antigenic variation 
is a feature of most, if not all, malaria parasites. Using a passive transfer protection 
system, recrudescences of P. c. chabaudi AS have been shown to be antigenically 
different from the cloned infecting parental population (McLean et al., 1982b), and 
appear to contain a mix of variant antigenic types (McLean et al., 1986a).
This chapter describes the results of a passive transfer experiment and 
demonstrates that protection can be transferred with serum collected during the 
subpatent period of infection (herein referred to as 'immune subpatent serum') from 
both naturally recovering and chloroquine treated mice. In addition, it describes the 
difference in serum sensitivity of recrudescent parasites collected from both these 
groups of mice. Using a triple-layered indirect fluorescent antibody test on live, 
schizont-infected erythrocytes as described by McLean et al. (1986b) these 
recrudescent parasite populations were evaluated further for the occurrence of 
antigenic variation.
5.2 Serum antibody titres during the course of infection
Two groups of six age-matched female mice were infected with 5 x 104 pRBCs 
P. c. chabaudi CB and the course of infection followed. One group of mice was 
treated with 50 mg/kg chloroquine at the peak of infection (10 DPI). Small volumes 
of serum were collected from the tails of two mice in each group at two day intervals 
during the course of infection. The antibody levels in the sera of these mice were 
determined using a slide IFAT on fixed parasite material.
The mean Ab titres in sera collected during the course of infection (Figure 5.2.1) 
rose during the first wave of patent parasitaemia in both groups of mice, a low titre of 
Ab being detected as early as 4 DPI. Following chloroquine treatment (Figure 5.2.1b) 
the Ab levels in these mice continued to rise with no apparent effect on the pattern of 
Ab production induced by subcurative doses of chloroquine. Maximal Ab was 
detected immediately following the recrudescence in both naturally recovering and 
chloroquine treated mice (Figure 5.2.1a and Figure 5.2.1b) respectively. At 
subpatency, the mean Ab titres for these groups of mice were 1: 960 and 1: 640, 
respectively but there was no significant difference (p>0.05) between these two 
values.
5.3 Passive transfer of immunity
Two groups of twenty five mice were infected with 5 x 104 P. c. chabaudi CB 
pRBCs and the course of infection followed in ten mice chosen at random. 10 DPI 
one group of mice was treated with chloroquine. When the patent parasitaemia had 
declined to 0.01% or less in both groups, 14 DPI for the chloroquine treated mice and
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FIGURE 5.2.1 Serum antibody levels during the course of P. c. chabaudi CB infection in: 
(a) naturally recovering mice, and (b) chloroquine treated mice.
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21 DPI for the naturally recovering mice, all but five mice in each group were killed 
and bled by cardiac puncture. The blood was pooled within each group and the serum 
collected and stored at -20°C. The parasitaemias in the remaining mice were 
followed until patent recrudescences appeared. For chloroquine treated mice this was 
21 DPI and for naturally recovering mice this was between 26 and 32 DPI. 
Recrudescent parasites from the individual mice were collected and subpassaged, and 
stabilates prepared when the parasitaemia in individual recipient mice was between 5 
and 10%. The stabilates were designated a WEP number and are referred to as such 
in the text.
Four groups of twelve age-matched female mice were infected with 5 x 104 
pRBCs i.v. of either the infecting parasite population (WEP 1224), recrudescent 
parasites from naturally recovering mice (WEP 1265) or recrudescent parasites from 
chloroquine treated mice (WEP 1278). Within 1 hr of parasite challenge six of the 
mice in each group received 0.65 ml NMS i.v. or 0.65 ml of the respective immune 
subpatent serum. Before passive transfer each serum pool was dialysed overnight 
against large volumes of PBS to remove any remaining chloroquine. The course of 
infection was monitored in serum recipients. Protection was measured as a delay in 
the onset of a patent parasitaemia compared with the controls; this delay was 
quantified as the increased average time for the mean parasitaemia of the mice 
receiving subpatent serum to reach a parasitaemia of 2% compared to the recipients of 
NMS. Two groups of mice provided the NMS, one was chloroquine treated and the 
other left untreated. In each case, however, the serum pools were dialysed against 
PBS.
Figures 5.3.1 and 5.3.2 show the results of the passive transfers for naturally 
recovering and chloroquine treated mice respectively. Mice receiving day 21 
subpatent serum and infected with the infecting population (referred to as parent) of 
P. c. chabaudi CB showed a significant (p<0.01) delay in reaching 2% parasitaemia 
(6.7 DPI) compared to mice receiving NMS (5.1 DPI) (Figure 5.3.1a). Similarly, 
Figure 5.3.2a shows that mice that received subpatent 14 DPI serum from chloroquine 
treated mice which were infected with the parent parasites showed a significant 
(p<0.05) delay in reaching 2% parasitaemia (5.9 DPI) compared to NMS recipients 
(5.3 DPI). Figure 5.3.1b shows that 21 DPI serum was also effective at delaying the 
2% parasitaemia in mice infected with recrudescent parasites collected from naturally 
recovering mice compared to mice receiving NMS. 2% parasitaemia was delayed by 
one day (7.2 DPI compared to 6.2 DPI, p<0.01). Conversely, 14 DPI serum from 
chloroquine treated mice could not protect mice infected with recrudescent parasites 
compared to mice receiving NMS (Figure 5.3.2b). The mean day of 2% parasitaemia 
for recipients of 14 DPI serum or NMS was 7.5 or 7.4 DPI, respectively; p>0.05.
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FIG U R E 5.3.1
Delay in reaching 2% parasitaemia (days) in mice receiving either 21 DPI 
serum or NMS (no chloroquine treatment), challenged with (a) 5 x 104 
pRBCs of the infecting population or (b) 5 x 104 recrudescent parasites of P. 
chabaudi CB.
* indicates significant difference (p<0.05)
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FIG U RE 5.3.2
Delay in reaching 2% parasitaemia (days) in mice receiving either 14 DPI 
serum or NMS, challenged with (a) 5 x 104 pRBCs of the infecting 
population or (b) 5 x 104 recrudescent parasites, from chloroquine treated 
mice, of P. chabaudi CB.
* indicates significant difference (p<0.05)
116
These results show that subpatent sera from both naturally recovering and 
chloroquine treated mice are protective upon challenge with parent parasites. They 
also show that subpatent serum from naturally recovering mice can protect against 
challenge with recrudescent parasites, while subpatent serum is not protective against 
challenge with recrudescent parasites collected from chloroquine treated mice. This 
indicates that these recrudescent parasites are insensitive to the antiparasite activity of 
14 DPI subpatent serum. This suggests that antigenic variation, as manifest by serum 
sensitivity, is demonstrable during P. c. chabaudi CB infection only following 
subcurative chloroquine treatment.
5.4 Analysis of recrudescent parasite populations
The recrudescent parasite populations collected from naturally recovered and 
chloroquine treated mice were analysed further by following their behaviour, with 
respect to the course of infection, in vivo, and by using a live IF AT to analyse the 
antigenic composition of the uncloned recrudescent parasites.
Three groups of six age-matched female mice were infected with 5 x 104 pRBCs 
P. c. chabaudi CB of either the infecting parasite population, recrudescent parasites 
collected from naturally recovering mice or recrudescent parasites from chloroquine 
treated mice. The parasites used were the same stabilates as those used in the passive 
transfer experiment. The course of infection in each of the groups was followed and 
is illustrated in Figure 5.4.1. Both recrudescent populations behaved very similarly to 
the infecting parasite population. There was no obvious increase or decrease in 
virulence, the peak parasitaemia occurring 9 DPI at approximately 40% in each 
group, and the course of the primary parasitaemia was not significantly different 
(p>0.05) in any of the groups until after 20 DPI. Mice infected with recrudescent 
parasites from chloroquine treated animals, however, showed a delayed onset in the 
appearance of a recrudescence. The peak of this recrudescent patency was 
significantly depressed (p<0.05) compared to the other two groups (Figure 5.4.1c). 
This provides further evidence that subcurative chloroquine treatment of P. c. 
chabaudi CB results in the expression of antigenic variation that cannot be detected 
during the course of infection in naturally recovering mice.
Table 5.4.1 shows the results of a live IF AT using subpatent sera from naturally 
recovering mice and chloroquine treated mice against all of the recrudescent parasites 
collected from these groups of mice. Those parasites used in the passive transfer 
experiment are highlighted in bold. The reciprocal antibody titres for 21 DPI and 14 
DPI subpatent sera against the infecting population were 320 and 160 respectively. 
The 21 DPI serum reacted with all the recrudescent parasites collected from naturally 
recovered mice, but the antibody titres varied. The titres for WEP 1267 and WEP 
1283 recrudescent parasites (collected 32 DPI and 25 DPI respectively) were low and
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FIGURE 5.4.1 The courses of infection in NIH mice receiving 5 x 10 4 pRBCs of (a) infecting 
parasite population, (b) recrudescent parasites from naturally recovering mice or (c) recrudescent 
parasites from chloroquine treated mice.
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PARASITE RECIPROCAL A]VTIBODY TITRE
(WEP No.) DAY 21 SERUM a DAY 14 SERUM b
1224
(Infecting population) 320 160
l
1265
1266 
1267 
1283
160
160
10*
80*
N/D
N/D
N/D
N/D
2
1278
1284
1263 (pooled from 4  m ice)
N/D
N/D
N/D 10*
a Subpatent serum collected from naturally recovering mice
b Subpatent serum collected from chloroquine treated mice
1 Recrudescent parasites collected from naturally recovering mice
2 Recrudescent parasites collected from chloroquine treated mice
* Indicates very few positive pRBCs (<5% positive pRBCs compared to positive controls 
(hyperimmune serum))
N/D = Not done
TABLE 5.4.1 - Positive titres in live IF AT of subpatent sera against recrudescent 
parasite populations of P. c. chabaudi CB collected from naturally recovered and 
chloroquine treated mice.
in each case <5% pRBCs showed positive fluorescence compared to the positive 
controls (hyperimmune serum - not shown). The level and proportion of reactivity of 
hyperimmune serum (40-50%) was the same for all populations tested. The lack of 
reactivity in some recrudescent populations, therefore, was specific for that pool of 
subpatent serum. WEP 1265 (used in the passive transfer) and WEP 1266, however, 
collected 24 and 28 DPI respectively, reacted with 21 DPI serum with a titre almost 
the same as the infecting population. 14 DPI serum from chloroquine treated mice
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did not react with either WEP 1278 or WEP 1284, but showed slight positive 
fluorescence at a titre of 1:10 to WEP 1263.
All the recrudescent parasite populations collected from chloroquine treated 
mice, therefore, appeared to be antigenic variants of the infecting population. Only, 
two out of four recrudescences from naturally recovering mice, however, appeared by 
IF AT to be antigenically different from the infecting parasites. These IF AT results 
indicate that antigenic variation does occur in mice naturally recovering from P. c. 
chabaudi CB infection but was only demonstrated in two of the collected recrudescent 
populations.
55 Discussion
The results described in this chapter have demonstrated that subpatent serum 
from both naturally recovering and chloroquine treated mice is successful in 
transferring immunity to naive, immunocompetent recipients. Protective activity in 
the passively transferred serum was seen as a delay in the onset of the patent 
parasitaemia. The pattern of the patent parasitaemias in the mice receiving protective 
serum was, however, similar to that in recipients of normal serum (data not shown). 
A previous report by McLean et al. (1982a) demonstrated that the passive transfer of 
immunity to P. c. chabaudi AS with sera collected from mice at different times during 
the course of infection gave a measure of the changing level of protective activity in 
the serum. Their results demonstrated that the level of serum protective activity 
against the infecting population at the time that the primary parasitaemia had almost 
been reduced to subpatent levels was significantly higher than the level recorded at 
the time that the first recrudescent parasitaemia became patent.
Although the antimalarial Ab levels detected by slide IF AT were very similar in 
naturally recovering or chloroquine treated mice during the respective subpatent 
periods, IF AT, however, will measure a large proportion of antibodies that are not 
protective. No attempt was made to fractionate the serum used in passive serum 
transfers in this study. The major part of the protective activity of the serum probably 
lies in the immunoglobulin fraction of the serum. Diggs & Osier (1969) demonstrated 
that the protective activity of anti-P. berghei hyper-immune serum could be removed 
with anti-rat Ig antiserum. Likewise, Phillips & Jones (1972), Green & Kreier (1978) 
and Reese & Motyl (1979) showed that'the protective activity of malaria immune 
serum was confined to the immunoglobulin fraction. It is unlikely that the protective 
activity observed in these passive transfer experiments was due to soluble non 
antibody factor(s) which may be produced in acutely infected mice and lead to 
intracellular killing of the parasites (Clark eta l.y 1976; 1979; Allison & Eugui, 1982). 
There have been no direct reports that this factor can be transferred in serum, but 
nitric oxide produced during malaria infection (see chapter 6) can react with the
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oxygen anion radical 02-* to form a peroxynitrite anion which decays rapidly once 
protonated to form the reactive hydroxyl radical OH* and the stable free radical nitric 
oxide N02* (Liew & Cox, 1991). This may be active upon passive transfer (F.E.G. 
Cox, personal communication). The protective activity of 14 DPI serum from 
chloroquine treated mice, however, was only demonstrated against the infecting 
parasite population while recrudescent parasites were unaffected by this serum. 
Soluble non-Ab factors would be expected to affect all recrudescences, as well as 
heterologous parasite challenge. Moreover, dialysis of the serum pools would 
probably elute non-Ab factors, including the nitric oxide free radical described above.
The difference in serum sensitivity of infecting parasites and recrudescent 
parasites of 14 DPI or 21* DPI mice could be due to changing in vivo antimalarial 
activity during the course of infection in chloroquine treated or untreated mice. 
During the subpatent period, before the recrudescence of P. c. chabaudi AS emerges, 
there is a marked decline in the ability of mice to control a large challenge of 
homologous parasites (R.S. Phillips, personal communication; McLean, 1985). 
Indeed, a large P. c. chabaudi CB parasite challenge on day 20 in chloroquine treated 
mice or naturally recovering mice resulted in very high parasitaemias in the former, 
where the recrudescence was ascending, with a more controlled parasitaemia resulting 
in the latter (prior to subpatency) (R.S. Phillips, personal communication). An 
investigation of the proportion of Ig secreting spleen cells would be of interest to 
more easily quantify the levels of Abs present in each serum pool.
In mice receiving 14 DPI serum and infected with recrudescent parasites, no
protection was observed. This indicated that antigenic variation was occurring in P.
c. chabaudi CB infection following subcurative chloroquine treatment. In contrast,
21 DPI serum from naturally recovering mice was equally effective at delaying
parasitaemia in mice challenged with both parent parasites and recrudescent parasites.
*
This raises two questions: (i) are there specific Abs in 21 DPI subpatent serum to both 
infecting and recrudescing parasites? and/or (ii) are recrudescent parasites in naturally 
recovering mice not undergoing antigenic variation? The former point is more easily 
reconciled, and due to the unpredictable course of P. c. chabaudi CB infection it is 
likely that the serum collected had experienced recrudescent parasites. This probably 
accounts for the differences in the passive transfer experiment and the live IF AT. 
Ideally, to answer these questions more fully it would be necessary to repeat the 
passive transfers using each of the collected recrudescent parasites and correlate the 
results of these with the results of the live IF AT. However, Brannan /et al. (1993) 
showed that it was difficult to correlate passive transfer experiments with the live 
IF AT, since the number of antigenic variants determined for recrudescences of P. c. 
chabaudi AS was greater than that determined by passive transfer (McLean et al.,
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1986a). It must also be stressed that the populations of recrudescent parasites tested 
were uncloned populations, presumably containing a mix of antigenic types (McLean 
et al., 1986a).
Antigenic variation, however, was evident in both groups of mice using a live 
IF AT. Nevertheless, all recrudescent parasites from chloroquine treated mice were of 
a different antigenic composition than the parent parasites, while it appeared that only 
under certain circumstances could antigenic variation be detected in the 
recrudescences from naturally recovering mice.
Antigenic variation has been shown to occur in both the ascending (Brannan et 
al., 1994) and descending (McLean et al., 1990) phases of the primary parasitaemia of 
P, c. chabaudi AS infection. That antigenic variation was not demonstrated (by 
serum sensitivity) in the recrudescences of some of the mice naturally recovering 
from CB strain infection may be due to variant antigenic types present in the 
ascending and declining primary parasitaemia being the major component of the 
recrudescent, uncloned, parasite population. It must then be assumed that, if these 
parasites were present in the recrudescence, the protective immune response was 
inactive against them, or that the immune response was declining during the onset of 
recrudescence. Differences in the composition of the recrudescent populations may 
explain why the uncloned recrudescent parasites varied in their reactivity in the live 
IFAT. In addition, as mentioned above, 21 DPI serum may have experienced some of 
the recrudescent parasites present in the collected parasite populations and was, 
therefore, reactive with some of the populations tested by live IFAT.
Speculatively, chloroquine may induce a more easily observed antigenic 
variation by inhibiting ThI cell responses (see Chapter 6) thereby allowing induction 
of a Th2 response. There have been some indications that Ab may induce antigenic 
variation (Brown, 1973; Brown & Hills, 1974). Since Tn2-derived cytokines regulate 
B cell differentiation, and therefore, indirectly, antibody secretion, it may be that Tjj2 
cells are involved in the induction of antigenic variation. The sequential appearance 
of ThI and Th2 cells observed during P. c. chabaudi AS infection may be a parasite 
immune evasion mechanism, such that a parasite induced Th2 response is generated 
to evade ThI dependent, cell-mediated parasite destruction. In mice rendered B cell- 
deficient by anti-|i treatment, however, P. c. chabaudi AS infection is controlled but 
the parasitaemia is not totally eliminated (Von der Weid & Langhome, 1993b; 
Taylor-Robinson & Phillips, 1994b). Such anti-|i treated mice maintain a T hI cell 
response, sufficient to control but not eliminate parasitaemia, suggesting that 
depletion of B cells reduces the generation of the Th2 cell subset. Whether antigenic 
variation occurs in these B-cell depleted mice, lacking detectable antimalarial Ab, has 
yet to be determined. Detailed analyses of Ig isotypes and cytokine production during
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the course of infection should provide more information on the dynamics of the 
immune response developing in naturally recovering or chloroquine treated mice.
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CHAPTER SIX
THE ROLE OF NITRIC OXIDE DURING THE COURSE OF INFECTION
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6.1 Introduction
Nitric oxide (NO), a simple and unstable free radical, has recently been 
identified as a potent mediator produced by and acting on many cells of the body. NO 
is derived from molecular oxygen and the guanidino nitrogen of L-arginine, in a 
reaction catalysed by NO synthase. Most mammalian cells constitutively produce a 
low level of NO and a number of cell types, when activated by immunological 
stimuli, produce large amounts of NO which is an important effector in the 
destruction of pathogens and tumours and in potentially damaging immune responses 
(Moncada et al., 1991; Clark etal., 1992).
Pathogens reported to be inhibited by NO and its derivatives include herpes 
simplex virus (Sethi, 1983), Cryptococcus neoformans (Granger et al., 1988; 1990), 
Leishmania major (Green et al., 1990a,b), Schistosoma mansoni (James & Glaven, 
1989), Trypanosoma cruzi (Gazzinelli et al., 1992; Petray et al., 1994), T. brucei 
gambiense, T. b. brucei (Vincendeau etal., 1992) anti.Plasmodium liver stages (Green 
et al., 1990a,b; Mellouk et al., 1991; Nussler et al., 1991b). A role for reactive 
nitrogen intermediate (RNI) killing in vivo has also been demonstrated for Leishmania 
major (Liew et al., 1990) and Toxoplasma gondii (Adams et al., 1990). In addition, 
killing of Plasmodium falciparum in vitro by NO derivatives has been demonstrated 
(Rockett et al, 1991).
A role for NO has been indicated in P. c. chabaudi AS infection (Taylor- 
Robinson et al., 1993). During the course of infection in NIH mice a sharp peak of 
nitrate is detected in the sera of mice which consistently coincides with the peak 
parasitaemia. Inhibiting the production of NO by L-NMMA results in mice 
developing a significantly elevated and extended primary parasitaemia. The results of 
this indicate that NO is produced and can control a rapidly escalating primary 
parasitaemia either by direct parasite killing or indirectly by causing blood vessel 
vasodilation leading to less efficient parasite sequestration (Taylor-Robinson et al.,
1993). These workers have also shown that ThI malaria-specific cloned T cell lines 
protect mice upon adoptive transfer by a NO dependent mechanism, activating 
macrophages to produce NO or producing NO themselves (Taylor-Robinson et al.,
1994).
The experiments described in this chapter were designed to evaluate the ability 
of cells from mice infected with the more virulent strain, P. c. chabaudi CB to 
produce NO, and a detailed analysis of NO (measured as nitrate production) over the 
peak of the primary parasitaemia is described. In addition, differences in the level of 
production of NO were measured in mice given a number of subcurative chloroquine 
treatment regimes. The effect of chloroquine in vitro on the production of NO by a 
murine macrophage cell line is also described and the results discussed with reference 
to the use of chloroquine as an anti-malarial disease therapy.
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6.2 Production of nitric oxide during the course of infection
Two groups of twenty age-matched female NIH mice were infected with 5 x 104 
pRBCs P. c. chabaudi CB and the course of infection monitored by examination of 
Giemsa's stained thin blood smears. To determine if collection of serum or 
chloroquine treatmerit affected the blood picture or level of nitrate a further two 
groups of three uninfected mice were included: one group was chloroquine treated 
and the other left untreated. On day 10 post infection (12.45 pm) one group of 
infected mice was treated with 50 mg/kg chloroquine. Sera were collected by tail 
bleeding from two mice from each group on days 4, 6 and 8 post infection. During 
the peak parasitaemia from 4.00 pm 9 DPI to 8.00 am 10 DPI serum was taken at four 
hourly intervals by exsanguinating two mice on each occasion. From the latter 
occasion until 2.00 pm 11 DPI serum was collected in the same way every six hours. 
Thereafter, serum collection continued every two days. Differential parasite counts 
were carried out on blood smears which were prepared at the same time as the serum 
collections around peak parasitaemia. All serum samples were analysed for nitrate 
using the chemiluminescence method.
Figure 6.2.1 shows the mean serum nitrate levels from individual mice during 
the course of infection. Nitrate levels reflect the NO levels in the serum of infected 
mice (Moncada et al., 1991) and were compared by the Student’s t test. The nitrate 
levels plotted 9 to 11 DPI for each group represent the mean values for all samples 
collected on that day. In both naturally recovering and mice treated with chloroquine 
10 DPI a peak of nitrate was detected in the sera of infected mice (620 ±155 and 541 
± 179 nmol/ml, respectively) which coincided with the peak of the primary 
parasitaemia. There was no significant difference between these two values (p>0.05) 
but both were significantly higher than those on any other day of infection (p<0.01). 
In both groups of mice the peak of nitrate declined rapidly and had returned to 
background levels by 8.00 am 11 DPI. The peak parasitaemias of naturally 
recovering and chloroquine treated mice were 32.0% and 31.8% respectively and 
there was no significant difference between these values (p>0.05). Chloroquine 
treatment at the peak of infection, however, resulted in rapid parasite remission 
(Figure 6.2.1b) with all mice subpatent by 14 DPI. A recrudescence occurred 
immediately after, and peaked at a parasitaemia of 3.0% 21 DPI. In naturally 
recovering mice (Figure 6.2.1a) the primary parasitaemia was not cleared to subpatent 
levels until 21 DPI and the recrudescence that followed peaked at 0.9% 31 DPI. In 
both cases, however, there was no indication of a further NO increase associated with 
the recrudescences.
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FIGURE 6.2.1 Serum nitrate levels during the course of infection in (a) naturally 
recovering mice and (b) chloroquine treated mice. Mice were infected with 5 x 104 
pRBCs P. c. chabaudi CB.
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Figure 6.2.2 shows the nitrate levels of individual mice on day 10 post infection 
correlated with the percentage of ring stage parasites calculated from each time point. 
Although the data are presented as nitrate levels in naturally recovering (Figure 
6.2.2a) or chloroquine treated (Figure 6.2.2b) mice the latter did not receive 
chloroquine treatment until three out of the five measurements were complete. Both 
graphs show that higher nitrate levels were detected when a large proportion of the 
parasites were at the ring-stage. The largest proportion of ring stage parasites were 
detected after midnight, the time at which schizogony occurred; as the parasites 
completed their 24 hour growth cycle and the % of rings decreased so too did the 
nitrate level in the sera of infected mice. Spearmann-Rank correlations were 
performed for each of the data. The correlation for the data presented in Figure 6.2.2a 
was 0.705, p<0.02; however, the correlation for chloroquine treated mice (Figure 
6.2.2b) was somewhat less (0.462, p>0.05) and there was no significant difference 
detected for these values. Combining both sets of data, however, resulted in a 
correlation value of 0.643, p<0.05 but >0.02. A significant correlation, therefore, 
indicated that the highest nitrate levels at the peak parasitaemia were obtained at the 
earliest stage of parasite development, i.e., immediately after schizogony.
The data described in this section have shown that NO is produced in response 
to infection with P. c. chabaudi CB. Mice naturally recovering from infection or 
those treated with chloroquine on day 10 post infection produced significant levels of 
nitrate in their sera, the peak of which coincided with the peak of primary 
parasitaemia. Levels declined rapidly thereafter and remained at background levels 
throughout the course of infection. There were no differences in the levels of nitrate 
produced in naturally recovering mice or in mice following chloroquine treatment on 
day 10 post infection, despite differences in the course of infection. Chloroquine 
treated mice rapidly cleared the primary parasitaemia before a recrudescence of 3% 
occurred, while naturally recovering mice showed an extended primary parasitaemia 
and a recrudescence of less than 1%. No increase in nitrate levels was demonstrated 
during either recrudescence, indicating that NO is only involved in controlling the 
primary parasitaemia.
The measurement of nitrate levels in a narrow time range through the peak of 
infection showed that the initial rise in nitrate occurred just after midnight 9/10 DPI 
with levels significantly correlated with ring-stage parasites over the next 24 hour 
period. It appears, therefore, that preceding the peak of infection, nitrate is released 
during schizogony, which occurs around midnight in a normal cycle of infection, 
when merozoites are released into the blood stream and declines during the following 
period of parasite development.
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FIGURE 6.2.2
Correlation of individual serum nitrate levels from timed intervals 10 DPI (peak 
parasitaemia) with the percentage of ring-stage parasites for (a) naturally recovering 
mice and (b) chloroquine treated mice. Chloroquine treated (10 DPI, 12.45 pm) 
mice did not differ from naturally recovering mice for three out of the five 
measurements.
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6.3 The effect of chloroquine treatment preceding peak parasitaemia on the 
production of nitric oxide.
Five groups of six age-matched female NIH mice were infected with 5 x 104 
pRBCs P. c. chabaudi CB and the course of infection followed. One group of mice 
was treated with chloroquine two days prior to the peak parasitaemia, another group 
was treated one day prior to the peak and a third group was treated on the day of the 
peak parasitaemia. The other two groups consisted of untreated mice or uninfected 
controls. Sera were collected by tail bleeding from two mice in each group every two 
days during the course of infection and every day around the peak parasitaemia and 
during the recrudescences. The sera were analysed for nitrate by chemiluminescence.
Figure 6.3.1 shows the levels of serum nitrate during the course of infection in 
the groups of mice. The peak parasitaemia occurred 8 DPI in untreated mice. 
Chloroquine, therefore, was administered 6, 7 or 8 DPI. In mice treated with 
chloroquine before the peak of parasitaemia the levels of nitrate in the sera remained 
at basal levels throughout the course of infection. In mice that were treated on the day 
of peak parasitaemia, or those that were untreated, a sharp peak of nitrate occurred on 
the same day as peak parasitaemia (688 ± 11 or 690 ± 21 nmol/ml nitrate, 8 DPI, 
respectively). No further elevation of nitrate levels was detected in any mice during 
the rest of the infection. Mice treated with chloroquine 6 DPI (parasitaemia=13.2%) 
or 7 DPI (parasitaemia=30.3%) quickly showed a reduction in parasitaemia but 
subpatency was not reached before a recrudescence occurred. In each case the 
parasitaemia of the recrudescence peaked at 3.4% or 3.1% respectively but with no 
associated rise in nitrate. It appears, therefore, that early chloroquine treatment 
resulting in a rapid decline in parasitaemia prevents any rise in serum nitrate levels 
during the course of infection, even when an appreciable recrudescence occurs.
To investigate this phenomenon further, the experiment was repeated and the 
levels of IFN-y, a cytokine known to induce macrophages to produce NO, in Con A 
stimulated spleen cell supernatants were assessed. Mice were infected with 5 x 104 
pRBCs P. c. chabaudi CB as before, and the course of infection monitored. The peak 
parasitaemia occurred 10 DPI, so chloroquine treatment was administered 8 or 9 DPI. 
7, 8, 9, 10 and 11 DPI spleen cell? were prepared from individual infected mice or 
from naive controls and stimulated with Con A. 48 hours later, supernatants were 
collected and assayed for IFN-y by ELISA. Spleen cells from chloroquine treated 
mice were prepared two hours following treatment.
Figure 6.3.2 shows the results. Throughout the measurements naive spleen 
cells consistently produced between 20 and 60 U/ml of IFN-y when stimulated with 
Con A. In contrast, 7 DPI infected, untreated mice produced 147.3 ± 35.8 U/ml,
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FIGURE 6.3.2 Interferon-gamma production by Con A stimulated spleen cells from 
chloroquine treated (8 or 9 DPI) or untreated mice infected with 5 x 104 pRBCs P. c. 
chabaudi CB. The peak parasitaemia occurred 10 DPI at 38.5% in untreated animals.
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significantly higher (p<0.01) than naive controls. 8 DPI mice that were treated with 
chloroquine on that day showed no difference in the production of IFN-y compared to 
untreated mice (142.3 ± 37.7 and 133.2 ± 23.3 U/ml, respectively). Both values were 
significantly higher than for naive controls (p<0.01). By 9 DPI levels of IFN-y had 
dropped off in untreated mice and again there were no differences in mice treated 
with chloroquine 8 DPI or 9 DPI compared to untreated mice. This pattern remained 
through to 11 DPI with no significant differences detected between any groups, 
including naive mice.
These data show that although chloroquine treatment before the peak 
parasitaemia results in reduced NO production, no effect is observed on the 
production of IFN-y. IFN-y levels peaked over days 7 and 8 post infection, before 
chloroquine was administered, consistent with previous findings of Slade & 
Langhome (1989) and Stevenson et al. (1990c). These investigators demonstrated 
that IFN-y in serum and spleen cell supernatants respectively peaked approximately 
two days before the peak parasitaemia.
6.4 Chloroquine induced inhibition of nitric oxide in vitro
Following the results of early chloroquine treatment in vivo on the production of 
NO, the ability of chloroquine to inhibit NO production in vitro was investigated. 
J774 macrophage-like cells can be induced to produce NO upon stimulation with LPS 
and IFN-y (Stuehr & Marietta, 1987). Macrophages were treated with various 
amounts of chloroquine either 24 hrs or 2 hrs before, or at the same time as 
stimulation with LPS and IFN-y. The results are illustrated in Figure 6.4.1. These 
show that chloroquine, at doses above 1 pM, inhibits NO production by macrophages 
in a dose-dependent manner, and this was observed at all times when chloroquine was 
added to the cultures. The viability of the J774 cells remained at >90% during 
chloroquine treatment, so NO inhibition was not due to a cytotoxic effect on the cells, 
although following 48 hrs of stimulation some culture wells (those producing highest 
NO levels) looked grainy but maintained >65% viability. This is a usual consequence 
of NO production from these cells (C.A. O'Donnell, personal communication). 
Inhibition of NO synthesis was evident when chloroquine was added to macrophages 
at the same time as stimulation but was most effective when chloroquine was added to 
macrophages prior to stimulation. At each of the chloroquine pretreatment times, 1 
|iM chloroquine did not significantly inhibit NO production (p>0.05). Two hours 
preincubation with chloroquine (>10 pM) before stimulation was enough to obtain a 
significant decrease in NO production. Preincubation of macrophages 24 hrs prior to 
stimulation caused a reduction of 25% in NO production with a dose of 10 pM  
chloroquine (p<0.003), 36% with 100 pM chloroquine (p<0.0001) and 58% with 
1000 pM chloroquine (p<0.0001).
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FIGURE 6.4.1 Chloroquine-induced inhibition of NO production from J774 macrophages 
stimulated with LPS and rIFN-y. macrophages were pretreated with chloroquine for (a) 24 
hours, (b) 2 hours before stimulation, or (c) treated at the same time as stimulation.
* indicates a significant difference compared to control well (0 pM chloroquine)
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6.5 Discussion
The results reported in this chapter have demonstrated that NO is produced 
during infection with P. c. chabaudi CB with the same pattern as that observed during 
infection with the AS strain (Taylor-Robinson et al., 1993). A significant peak of 
nitrate occurs in the serum of infected mice that coincides with the peak of 
parasitaemia. No further increase of nitrate is demonstrated throughout the rest of 
infection. This indicates that NO is produced to control the ascending primary peak 
parasitaemia but has no effect later in the course of infection (Taylor-Robinson et al., 
1993). This also supports the view of a sequential activation of T hI cells early in 
infection followed by Tjj2 cells later in infection (Langhorne et al., 1989; Taylor- 
Robinson & Phillips, 1992; 1993; 1994a). NO involvement may be mediated by ThI 
secretion of IFN-y which may activate macrophages to produce large amounts of NO 
(Marietta et al., 1988; Stuehr & Nathan, 1989) to kill parasites directly. In addition, 
malaria-specific cloned ThI cell lines have recently been shown to synthesise NO 
themselves (Taylor-Robinson et al., 1994) and may add to direct parasite killing. 
Indirectly, NO may have an effect by causing blood vessel vasodilation (Knowles & 
Moncada, 1992) leading to less efficient parasite sequestration in deep tissue 
capillaries, allowing removal of the parasites by macrophages (Taylor-Robinson et 
al., 1993).
NO and RNI may react in several ways to cause cell death. Once the oxides of 
nitrogen have diffused into erythrocytes, the formation of nitrosothiol groups on 
proteins could lead to the inactivation of enzymes or changes in protein function. 
These groups can react further to cross-link sulphydryl groups (Rockett et al., 1991), 
one effect of which would be to oxidise glutathione and so reduce the parasite oxidant 
defense capacity. This process may create more nitrosothiol groups rather than form 
nitrite and nitrate (Mima & Hoffmann, 1969) and thus initiate a chain reaction. S- 
nitrosothiol derivatives of cysteine and glutathione have been shown to be potent 
compounds in the in vitro killing of P. falciparum  (Rockett et al., 1991). In an 
erythrocyte, one target for RNI attack is oxyhaemoglobin. Nitrite reacts with this 
molecule to form either nitrosothiolhaemoglobin (Westenberger et al., 1990) or 
methaemoglobin (Wallace & Caughey, 1975), and one product of the latter reaction is 
hydrogen peroxide, itself toxic to malaria parasites (Clark & Hunt, 1983; Dockrell & 
Playfair, 1983). This property of RNI to reduce metal ions is consistent with the 
concept that exposure of Fe-S groups to NO results in iron-nitrosyl complex 
formation (Hibbs et al., 1988) causing the inactivation and degradation of Fe-S 
prosthetic groups of aconitase and complex I and II of the mitochondrial electron 
transport chain. In addition, NO and RNI can also form toxic alkylating agents by 
reacting with secondary amines (Iyengar et al., 1987).
The results described herein, demonstrated that NO was released/detected in the
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serum of infected mice during schizogony on the night preceding peak parasitaemia. 
Differential counts of blood smears showed that the highest nitrate levels occurred 
when parasites were at the early ring-stage. This probably indicates that NO is most 
active when merozoites are released from schizonts, free in the blood stream. The 
selectivity of target destruction may be explained by the fact that the NO molecule is 
very short-lived, and therefore its reactivity would necessarily be directed towards 
targets with which the activated macrophage is in close contact. Sequestration of the 
malaria parasite at sites such as the liver, would provide a microenvironment where 
endothelial cells, hepatocytes and kupffer cells are all in close proximity to the 
parasite; NO produced by these cells could destroy merozoites as they are released 
from schizonts (R.S. Phillips, personal communication).
Cytokines are involved in the induction of NO synthesis (Ding et al, 1988; 
Steuhr & Marietta, 1987). There is now general agreement that levels of TNF are 
increased in the sera of human malaria patients (Grau et al., 1989c; Kern et al., 1989; 
Kwiatkowski et al., 1990) and mouse models of malaria (Curfs et al., 1989; Grau et 
al., 1989b). Increase in RNI caused by TNF could contribute to the antimalarial 
effects of TNF in vivo (Clark et al., 1987b) and the antiparasite effect may be a direct 
result of NO alone or RNI in synergy with oxygen radicals known to be toxic to 
malaria parasites (Clark & Hunt, 1983; Dockrell & Playfair, 1983). Alternatively, 
nitric oxide may go on to form chemical species that are even more toxic, such as 
peroxynitrite (Blough & Zafiriou, 1985; Gryglewski et al., 1986) or hydroxyl radicals 
(Beckman, et al., 1990). Since a number of cell types produce NO, particularly 
endothelial cells, this mechanism could explain how P/J mice, whose macrophages 
have poor oxidative capacity, can kill P. chabaudi as effectively as can normal mice 
(Cavacini e ta l ., 1989).
ThI cell secretion of IFN-y activates macrophages to produce large amounts of 
NO (Marietta et al., 1988; Stuehr & Nathan, 1989). Taylor-Robinson et al. (1994) 
proposed that the protection upon adoptive transfer of a T hI cloned cell line was 
mediated by IFN-y induced NO production. Inhibition of NO by L-NMMA elevated 
IFN-y production, but increased parasitaemia. This is consistent with the idea that the 
effect of IFN-y is mediated predominantly through NO production. Several earlier 
reports, however, have shown that IFN-y production directly contributes to resistance 
to asexual blood stage malaria (Clark et al., 1987a; Bienzle et al., 1988; Shear et al., 
1989; Meding et al., 1990; Curfs et al., 1993). Furthermore, IFN-y enhances the 
effect of antimalarial chemotherapy (Kremsner et al., 1991) in P. vinckei infection. In 
a recent report by Curfs et al. (1993) treatment with IFN-y of P. berghei K173- 
infected mice temporarily reduced body temperature, delayed patency, inhibited 
proliferation of the parasites, and also prevented development of cerebral lesions, 
depending on the regimen used. Anti-IFN-y antibody caused increased proliferation
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of the parasite. The mechanism of this protection may be due to the activation of ROI 
(Clark etal., 1987a; Shear etal., 1989) or NO (Taylor-Robinson et al., 1993; 1994).
Clark et al. (1991; 1992) hypothesised a role for NO in the development of 
cerebral malaria. Overproduction of NO would cause brain vessel dilatation, 
responsible in turn for the increased intracranial pressure seen in cerebral malaria 
patients (Newton et al., 1991). In addition, NO might be involved in another process 
expressed at the neuron level. NO could diffuse through the brain parenchyma and 
could activate the guanylate cyclase in neurons causing a disruption of the regulation 
of glutamate-induced neural NO. Senaldi et al. (1992), Asensio et al. (1993) and 
Kremsner et al. (1993), however, have reported recently that there is no influence of 
NO inhibitors on the development of cerebral malaria in the mouse model, P. berghei 
ANKA, even upon intracranial administration. Conversely, treatment with anti-IFN-y 
antibody has been reported to prevent the development of the cerebral complication in 
P. berghei ANKA-infected CBA/Ca mice (Grau et al., 1989a) when given before and 
during infection. A continuous delivery of IFN-y, however, prevented the 
development of cerebral malaria in a recent study by Curfs et al. (1993), possibly 
downregulating its own production or that of TNF release. Distinct mechanisms of 
IFN-y and NO protection may, therefore, exist.
Mice treated with chloroquine at the peak of infection did not show any 
differences in the production of nitrate following the resolution of the primary 
parasitaemia, despite the increase in parasitaemia of the recrudescence. Treatment of 
mice, however, before the peak parasitaemia resulted in a rapid parasite remission and 
although a high recrudescence followed quickly, no NO was detected in the serum of 
infected mice throughout the whole course of infection. Peak IFN-y levels after Con 
A stimulation were detected in spleen cell supernatants of mice 7 and 8 DPI. In 
untreated mice levels had fallen off by day 9 post infection and chloroquine treatment 
8 or 9 DPI did not affect the IFN-y levels in any way. Slade & Langhome (1989) and 
Stevenson et al. (1990c) have previously demonstrated similar kinetics in IFN-y 
production in AS infected mice, that is peak levels occurring one or two days prior to 
the peak parasitaemia. In activated ThI cells the peak NO synthase activity occurs 12 
hrs after activation (Taylor-Robinson et al., 1994) and in infected mice peak NO 
occurs at the peak parasitaemia. This indicates that perhaps some factor other than 
IFN-y is involved in activating macrophages and ThI cells to produce NO. This may 
be TNF, as mentioned above, which is detectable during a primary infection with P. c. 
chabaudi AS (Stevenson et al., 1990b). Resolution of primary parasitaemia and 
recrudescence following subcurative chloroquine treatment occurred in all groups of 
mice regardless of the level of NO produced. NO may only be produced above a 
certain threshold of parasitaemia. Preventing the parasitaemia from reaching a critical
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value by chloroquine treatment may be the reason for blocking the elevation of NO 
normally observed at the peak of infection.
Despite the occurrence of a peak of NO, in some cases the primary parasitaemia 
still took some time to be resolved. This indicates that other immune mechanisms 
that are NO (and IFN-y) independent are operative to control the primary 
parasitaemia. A more detailed analysis of the kinetics of both ThI and Th2 cytokine 
production would be of interest to evaluate further the role of both Ab-independent 
and Ab-dependent immune mechanisms during resolution of infection. Ab titres as 
measured by IF AT show that significant specific anti-malaria Ab are detected by day 
7 post infection. By measuring the Ab isotypes that occur during infection and the 
effect of exogenous cytokines on these titres would provide useful evidence as to the 
mechanisms eliciting protection to P. c. chabaudi CB. Chloroquine treatment of mice 
at the peak parasitaemia (10 DPI) does not significantly alter the IF AT Ab levels in 
the serum of infected mice until after the recrudescence when the larger Ag 
stimulation in these mice causes an increase in the Ab titre.
In vitro, chloroquine was shown to inhibit the synthesis of LPS and IFN-y 
induced NO from a murine macrophage cell line in a dose-dependent manner. 
Chloroquine easily penetrates into macrophages (Picot et al., 1993) and has 
previously been shown to inhibit D-l secretion, presentation of antigens by accessory 
cells, to depress mitogen responsiveness and natural killer cell cytotoxicity and to 
display anti-inflammatory properties (Krogstad & Schlessinger, 1987). In addition, 
the action of prophylactic doses of chloroquine has been shown to inhibit the 
phagocytosis of IgG-coated sheep red blood cells (Osorio et al., 1992). Recent 
observations by Picot et al. (1991; 1993) have shown that chloroquine also inhibits 
TNF and 11-6 production. This observation, combined with the inhibition of NO 
described herein, may be clinically relevant and chloroquine used at pharmacological 
concentrations could inhibit cytokine over-production in vivo. Although the pH was 
strictly controlled in all cultures containing chloroquine, elevated pH is a consequence 
of chloroquine accumulation in acidic intracellular compartments including 
lysosomes and endosomes. This in turn can cause alterations in intracellular 
trafficking, affecting receptor-mediated endocytosis, intralysosomal digestion, 
exocytosis and the biosynthesis of secretory proteins (Maxfield, 1982). However, 
reacidification of lysosomes occurs only three hours after chloroquine treatment 
(Tietz et al., 1990), providing evidence that chloroquine-dependent TNF inhibition 
(Picot et al., 1991; 1993) and NO inhibition is not due to the weak base properties of 
chloroquine. Picot et al. (1993) have hypothesised that chloroquine inhibits TNF 
secretion by disrupting iron haemostasis outside lysosomal compartments.
NO and TNF have both been postulated as mediators responsible for morbidity
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and mortality associated with cerebral malaria (Clark et al., 1991; 1992; Grau et al., 
1989b, c; Kwiatkowski et al., 1990). Regardless of the effect on parasite killing by 
chloroquine, maintaining levels of these mediators below certain threshold levels at 
which cerebral manifestations occur, provides an approach for the continued use of 
chloroquine despite the rapid emergence of drug-resistance.
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CHAPTER SEVEN 
IN  VITRO  PROPAGATION OF MALARIA SPECIFIC T CELL LINES
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7.1 Introduction
The previous chapters have reported, through depletion of T cells in vivo and to 
an extent by adoptive transfer experiments, that the immune response to the 
erythrocytic stages of the CB strain of P. c. chabaudi is absolutely dependent on the 
presence of CD4-bearing T cells. This confirms the work of Suss et al. (1988), 
Podoba & Stevenson (1991) and Taylor-Robinson (1991) working with P. c. 
chabaudi AS, and Vinetz et al. (1990) working with P. yoelii. These reports 
supported the pioneering work of Jayawardena et al. (1982), who implicated a role for 
CD4+ but not CD8+ T cells in acquired resistance to blood stage malaria parasites, a 
view which was later contradicted by Mogil et al. (1987). Working with the same 
strain of P. yoelii (17X) the discrepancy between the results of these investigators was 
thought to be due to attempts to dissect the contribution of the two subsets of T 
lymphocytes using enriched, but nevertheless heterogeneous populations of cells for 
adoptive transfer. This problem has been overcome through the recent advances in 
the methodology for propagating and maintaining Ag-specific T cell lines and clones 
in vitro (Gillis & Smith, 1977; Fathman & Fitch, 1982). Following Ag recognition, T 
cells secrete 11-2 and express high-affinity 11-2 receptors at their cell surface. The 
combination of 11-2 with its receptor and subsequent signal transduction allows Ag- 
stimulated T cells to undergo clonal expansion (Smith, 1984). Thus, it has become 
possible to establish enriched populations of antigen-specific CD4+ or CD8+ T cells 
by repeated cycles of Ag stimulation followed by expansion either with 11-2 or with 
mAb against the CD3 T cell receptor (Van Wauve et al., 1980). These cells may be 
maintained as a polyclonal population, or, following cloning, as cells with a unique 
Ag specificity. Recognition of Ag by T lymphocytes may then be assayed by a 
variety of techniques including cytokine release (Kappler et al., 1980) and T cell 
proliferation (Seeger & Oppenheim, 1970). Using this technology, malaria specific T 
cell lines have been generated by a number of workers. Gross et al. (1984) have 
demonstrated that the transfer of a T cell line raised to P. berghei provides protection 
in rats to parasite challenge. Similarly, lines produced to P. c. adami infections in 
BALB/c mice (Brake et al., 1986) also transfer protection. In this latter study, one of 
the CD4+ cell lines was cloned with no loss of adoptive protection (Brake et al., 
1988). More recently, Taylor-Robinson (1991) and Taylor-Robinson & Phillips 
(1992, 1993, 1994a) have described the generation of T hI and Th2 cell lines and 
clones specific for P. c. chabaudi AS which are protective upon adoptive transfer and 
have been characterised in much detail with respect to their function.
The adoptive transfer experiments described in Chapter 4 demonstrated the 
effectiveness with which T cells could transfer protection to mice challenged with P. 
c. chabaudi CB. It was therefore decided to attempt to raise T cell lines with spleen 
cells isolated from donor animals at time points similar to those used for the adoptive
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transfers. Table 7.1.1 shows the time points chosen. It was hoped that these lines, if 
generated successfully, would have a similar immunological status as the enriched T 
cell populations used in the transfers, but would have the advantage of being 
cultivated in vitro as relatively homogeneous populations suitable for further 
investigation such as cytokine secretion and B cell helper activity. In addition, these 
lines could be cultured in bulk to provide sufficient cell numbers to facilitate adoptive 
transfer into syngeneic recipient mice. Thus, the generation of these lines in mice 
primed to P . c. chabaudi CB to different degrees, and therefore, being of varying 
immunological competence, would allow the study of specific cellular responses 
during the course of infection.
The work described in this chapter outlines the preparation of Th cell lines from 
different time points during a P. c. chabaudi CB infection in NIH mice and following 
subcurative chloroquine treatment. Although the generation of these cell lines proved 
problematic, the initiation and maintenance of one cell line is detailed. The ability of 
the cultured Th cells to respond to specific antigenic stimulation is described as is the 
adoptive transfer of this line into immunocompromised syngeneic mice.
NATURALLY RECOVERING MICE CHLOROQUINE TREATED MICE
16 DPI 
21 DPI (subpatency) 
31 DPI 
60 DPI (WEP 1153) 
After 1 reinfection 
After 2 reinfections
14 DPI (subpatency) 
30 DPI 
60 DPI 
After 1 reinfection 
After 2 reinfections
TABLE 7.1.1 Selected time points for generation of T cell lines from naturally 
recovered and chloroquine treated mice.
7.2 Optimisation of T cell line culture conditions
The preparation of responder T cells, with APCs, for long-term culture requires 
rigorous attention to conditions necessary for optimal lymphocyte proliferation. 
Therefore, the number of responder cells, the concentration of APCs as well as 
inhibition of APC proliferation, and the concentration of antigen for cell stimulation 
must be assessed before initiation of specific T cell lines. Within this study, 
optimisation of these conditions was carried out in consultation with Dr A.W. Taylor- 
Robinson. Features such as the number of responder cells and APCs remained as 
predetermined by Taylor-Robinson & Phillips (1992). The dose of gamma irradiation 
for inhibition of those cells in the APC population capable of proliferation was 
maintained at 30 Gy (3000 rads) - a dose which has no adverse effects on the capacity
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of the APCs to present Ag in a suitable manner for recognition and activation of 
responder cells, but does completely abrogate cellular proliferation.
At the outset of this investigation two sources of antigen were used for 
stimulation of T cells in vitro. These were whole pRBCs and a crude solubilised 
lysate of pRBCs of P. c. chabaudi CB. To elucidate whether both these Ag 
preparations could provide a suitable source of antigenic stimulus/determinants 
against which a cellular response could be mounted, assays were performed to 
demonstrate a specific proliferative response of spleen cells to these Ags. These also 
determined the optimum number of pRBCs or the optimum protein concentration of 
the lysate necessary to elicit the maximal level of lymphocyte proliferation. In 
addition, the use of nRBCs and a nRBC lysate was included to determine if 
lymphocyte growth was in response to parasite-specific Ag(s).
The Ag concentration assays were performed on spleen cell suspensions from 
mice recently recovered (60 DPI) from infection with 5 x 104 pRBCs P. c. chabaudi 
CB. These cells were cultured at 2 x 10^ cells/well in a 96 well microtitre plate and 
assayed for proliferation by the incorporation of methyl [3H] thymidine. The 
proliferative response of the cells to both sources of antigen is shown in Figure 7.2.1 a 
& b. In each case the response is dose-dependent and the activation induced by either 
pRBC preparation was significantly greater than that induced by nRBCs (p<0.001), 
indicating that the stimulus for cell growth was parasite specific and not due to a 
common determinant on all RBCs (compare to response seen later with cultured T 
cells, 7.5). Maximal proliferation was attained with 1 x 106 pRBCs/ml or 250 |ig/ml 
pRBC lysate; figures 7.2.1a and 7.2.1b respectively. Therefore, for routine 
stimulation of T cell lines in vitro, cultures were stimulated with the above 
concentrations of the respective Ag.
7.3 Initiation and maintenance of helper T cell lines
Having determined the optimum Ag concentration as described above, it was 
possible to attempt to generate helper T cell lines in vitro. These could then be 
analysed both in vitro and in vivo for an anti-P. c. chabaudi CB immune response. 
The lines established in vitro were raised by the protocol described in Chapter 2. 
Table 7.1.1 shows the stages of infection from which it was attempted to prepare T 
cell lines. At the outset, cultures were set up in parallel, stimulated with either whole 
pRBCs or the pRBC lysate. As the study progressed it became apparent that cell 
growth was not supported by the lysate preparation. This has been reported 
previously (Khansari et al., 1981; Gross & Frankenburg, 1989; Riley et al., 1989b) 
and therefore, it was decided to use whole infected pRBCs as the sole source of Ag. 
Several splenic lymphocyte lines were raised, but only one was successively
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FIGURE 7.2.1
Proliferative response of post-infective splenic lymphocytes to (a) pRBCs, and 
(b) lysate preparations of P. c. chabaudi CB, to determine optimum Ag 
concentrations for T cell line stimulation.
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maintained. This was prepared from naturally recovered mice at 60 DPI and was 
designated WEP 1153. The other lines succumbed to contamination or simply would 
not grow after the second or third stimulation in vitro. Following cryopreservation, 
none of the lines responded to stimulation upon recovery from liquid nitrogen.
7.4 Surface phenotyping of WEP 1153
The successfully generated T cell line was phenotyped by immunofluorescence 
(2.30). After 5 rounds of antigenic stimulus with pRBCs the cell line was tested 
against a panel of mAbs specific for CD4 and CD8 surface determinants, and a 
monoclonal to the lymphocyte marker Thy-1.2. By this method, WEP 1153 contained 
96% CD4+ and 4% CD8+ T cells, all possessing the Thy-1.2 marker.
7.5 Antigen specific T cell proliferation
In vitro studies must include a Th cell proliferation assay to measure the ability 
of cultured Th cells to respond to specific antigenic stimulation, to demonstrate that 
the T cell line generated was primed to the asexual erythrocytic stages of P. c. 
chabaudi CB to which it was raised. This assay was used not only to confirm the 
antigenic reactivity of the newly generated T cell line, but also to examine the 
maintenance of specificity during long-term culture. Cellular proliferation was 
measured by the incorporation of [^H-T] and the methodology is described in detail in 
section 2.31. Careful attention was paid to the inclusion of negative control wells, for 
statistical analysis and enumeration of background responses.
Figure 7.5.1 shows the proliferative response of WEP 1153. Proliferation was 
measured after 6 cycles of stimulation, 5 days after the last addition of Ag (Figure 
7.5.1a) or after 7 cycles of stimulation, 7 days after the last stimulus (Figure 7.5.1b). 
In the former assay high background counts were observed with cells + Ag and cells 
+ APCs (Figure 8.5.1a) indicating that the cells were still responding to residual Ag 
from previous stimulation in culture and/or that APCs were still able to present fresh 
Ag to the responding WEP 1153 cells. The assay was, therefore, repeated with cells 
that had been deprived of Ag for longer before the assay was carried out (Figure 
7.5.1b). Here, the background responses were negligible, although a significant 
response was seen with cells + APCs (p<0.05) compared to cells alone or medium 
alone wells. However, this response was significantly lower (p<0.01) than all other 
test wells.
In both assays, a trend was observed, with a dose dependent response to pRBCs: 
the greatest response seen with 2.5 x 106 pRBCs/ml; maximal cellular growth, 
therefore, being achieved by a greater number of pRBCs than that used to give 
optimal proliferation of unffactionated 60 DPI spleen cells (Figure 7.2.1). This was 
only significant (p<0.01) for the second assay (Figure 7.5.1b). However, for both
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FIGURE 7.5.1
Proliferative response of WEP 1153 T lymphocytes to antigenic stimulation with 
pRBCs of P. c. chabaudi CB. Cells were deprived of antigen for either (a) 5 days 
or (b) 7 days before the assay. 
nRBCs (1) = 2.5 x l^ /m l 
nRBCs (2) = 2.5 x l^ /m l
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assays, the greatest proliferative response was to nRBCs, (2.5 x 106/ml) showing a 
significant difference to control wells (p<0.001) but this response was not 
significantly different to that obtained with the highest concentration of pRBCs. At a 
lower concentration of red cells (nRBCs (2) - Figure 7.5.1b) the response was not as 
great, although it was comparable to those cells responding to the lower doses of 
pRBCs and to pRBC lysate (250 fig/ml). These responses strongly suggest that the 
proliferation of the established cell line WEP 1153 was not due entirely to stimulation 
by cocultured parasite-determined antigenic determinants, but to a nRBC/altered red 
cell Ag. Throughout the assay, as the number of pRBCs increased so too did the 
number of nRBCs within the preparation and this was perhaps the reason for the 
apparent dose response seen with pRBCs. The response to pRBCs, soluble pRBC 
lysate or nRBCs, however, was dependent on the availability of APCs, since no 
proliferation was observed when T cells were stimulated without APCs (Figure 
7.5.1b).
7.6 Adoptive transfer of WEP 1153 T cell line to immunocompromised 
recipients
Following pRBC Ag stimulation in vitro, the effect of adoptive T cell transfer of 
host resistance to a primary infection with P. c. chabaudi CB in sublethally irradiated, 
syngeneic mice was assessed. The study documented herein was carried out to assess 
if in vitro lymphoproliferation correlated with in vivo protection against parasite 
challenge.
WEP 1153 was propagated in vitro in bulk cultures prior to adoptive transfer to 
gain sufficient viable lymphocytes for inoculation. Enough cells were harvested, 
while the cells were still dividing logarithmically, to inoculate 5 age-matched female 
NIH mice with 2 x 107 viable cells, i.v.. These mice had been exposed, on the same 
day of transfer, to 4 Gy (400 rads) y irradiation. A control group of irradiated mice 
received the same size inoculum of enriched T cells prepared from non-immune naive 
donor mice. All animals were infected with 1 x 104 pRBCs P. c. chabaudi CB 
immediately after adoptive transfer, and the consequent course of infection monitored 
by examination of daily blood smears.
The resultant course of infection in both groups of mice is shown in Figure 
7.6.1. Detectable protection against parasite challenge after adoptive transfer was 
observed with WEP 1153. This was manifested as a delay in onset of patency and a 
lower peak parasitaemia, the peak occurring 13 DPI in both groups, the mean 
parasitaemia being 29.9% and 39.1% for WEP 1153 and naive T cell recipients 
respectively. These features, however, were not significant (p>0.05). However, there 
was a much more rapid parasite remission in recipients of WEP 1153, p<0.05 on days
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FIGURE 7.6.1 The course of infection in 4Gy irradiated recipients of 2 x 107 WEP 
1153 T cells. Mice were challenged with 1 x 104 pRBCs P. c. chabaudi CB.
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16, 17, 18 and 19 post infection. The recrudescence observed in WEP 1153 recipients 
was significantly lower (p<0.05) than that observed in naive T cell recipients.
7.7 Discussion
This chapter describes the successful initiation and propagation of one T cell 
line, WEP 1153, raised from splenic T lymphocytes taken from donor mice at 60 DPI. 
By immunofluorescent staining, this line was predominantly of the CD4+ phenotype. 
An attempt was made to generate other lines at the selected time points shown in 
Table 7.1.1. However, these were unsuccessful due either to contamination or 
difficulties in maintaining a P. c. chabaudi CB specific proliferation in vitro.
WEP 1153 was raised by stimulating the cultures with pRBCs as the source of 
Ag, due to the unresponsiveness of the T cells to proliferate in bulk culture to lysate 
preparations. Possible reasons for this include factors associated with the lysate that 
may downregulate T-cell proliferation (Gross & Frankenburg, 1989; Khansari et al., 
1981; Riley et al., 1989b), act directly as T-cell toxins or induce nonspecific 
cytotoxicity, eg. by altering the pH or osmolality of the medium (Wasserman et al., 
1993). Wasserman et al. (1993) have shown that the responsiveness of malaria 
specific T lymphocyte lines is markedly enhanced by the use of syngeneic APCs that 
have preprocessed an antigen lysate and subsequently washed prior to culture with T 
cells in vitro. Thus, this provides a possible new method for the successful initiation 
of malaria-specific T cell lines, with the immediate availability of preprocessed Ags 
for the stimulation of T cells enhancing T-cell responsiveness, as has been described 
for other systems (Unanue, 1989; Corradin, 1990; Cresswell, 1990). Brake et al. 
(1988) found that coculturing APCs, with the same soluble Ag as that used to 
stimulate proliferation, for 3hrs before irradiation gave the highest cell growth 
response. Furthermore, Chemtai et al. (1984a,b) showed an increased proliferative 
response to P. c. chabaudi pRBC lysate using lysate-fed macrophages. However, 
APC sensitisation has been shown to reduce the radiosensitivity of the APCs 
(Ashwell etal., 1988).
Previous findings using T cell lines raised against P. berghei (Gross et al., 1984; 
Gross & Frankenburg, 1988), P. c. adami (Brake et al., 1986; 1988) and P. c. 
chabaudi AS (Taylor-Robinson, 1991; Taylor-Robinson & Phillips, 1992, 1993, 
1994a) have shown that lymphocyte lines (and daughter clones) retain their Ag 
specificity in vitro, as evidenced by the fact they proliferate in response to parasite 
stimulation but not to nRBC preparations. These studies indicated that parent 
lymphocyte lines could be established from mice at a variety of times after infection; 
Taylor-Robinson (1991) and Taylor-Robinson & Phillips (1992; 1993; 1994a) 
demonstrating that anti-malaria lines could be raised as early as 16 DPI after 
challenge of the donor animals with P. c. chabaudi AS. Chemtai et al. (1984a) had
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previously raised lymph node cell lines specific for the virulent IPPCI strain of P. c. 
chabaudi from mice primed for either 8 or 14 days. The proliferative response of 
these established lines was parasite specific. Langhome & Simon (1989) using a 
limiting dilution assay of undefined splenic lymphocytes measured a specific 
response as early as 7 DPI. The above information was encouraging in attempting to 
generate P. c. chabaudi CB specific T cell lines from donor mice at different times 
throughout infection. Interestingly, Chemtai et al. (1984a) found no difference 
between the ability of whole or lysed pRBCs to induce lymphocyte activation, as was 
found in this study. These latter workers, however, failed to establish pRBC-specific 
lines in vitro using splenic lymphocytes.
Preliminary investigations to determine the optimal conditions for in vitro 
culture resulted in the use of whole, unlysed pRBCs at 1 x 106/ml. This was in 
agreement with other experimenters (Gross et al., 1984; Brake et al., 1986; 1988). 
The APC concentration used in this study was 1-2 x 106 APCs/ml, a value close to 
that of 106 peritoneal macrophages/ml quoted by Chemtai et al. (1984a) but differing 
from those of Gross et al. (1984) using 6 x 106 spleen cells/ml and Brake et al. (1986;
1988) using only 2 x 105 spleen cells/ml. This may reflect the difficulty in generating 
T cell lines in this study, but the variation in numbers used successfully above is more 
difficult to explain. Spleen cell concentration is probably not a direct measure of 
APC concentration, rather, the functional frequency of cells which fulfill the role of 
APC to different types of responder cells may vary according to such factors as the 
state of purification or differentiation of the T lymphocyte population. The variation 
in numbers, however, is probably not critical, the magnitude of Ag-induced T cell 
proliferation in one study not being affected directly by APC frequency (Goodacre et 
al. (1987).
The in vitro proliferative response of WEP 1153 unusually showed maximal 
response to a high number of nRBCs (2 x 106/ml) and a positive response was also 
demonstrated with a lower concentration of nRBCs (2.5 x 105/ml). This has not been 
documented previously and it appears that the WEP 1153 T cell line produced was 
raised to a pRBC Ag that cross-reacted with a nRBC/altered red cell Ag. Sherman & 
Winograd (1990) proposed that changes to the surface proteins of the red cells on 
infection with P. falciparum were parasite-induced modifications to host proteins. 
They suggested that changes to naturally occurring host red cell proteins, especially 
band 3, result in subtle changes to the antigenicity of infected red cells. There is 
evidence that alterations in band 3, the principal membrane protein of the red cell, do 
occur and contribute to changes in the antigenicity of parasitised cells. 
Intramembranous band 3 particles are specifically redistributed in the region of a P. 
falciparum-induced knob (Allred et al., 1986) and immunoelectron microscopic 
studies have shown that band 3 is clustered in the region of knobs (Sherman et al.,
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1989). Autoantibodies to band 3 occur naturally (Winograd et al., 1989) and have 
been used to immunoprecipitate a surface iodinatable protein of >240 kDa (PfEMPl, 
a P. falciparum vaccine candidate, is exposed on the surface of the infected red cell 
and is >240 kDa), which by peptide mapping has been shown to be a truncated form 
of band 3 (Winograd & Sherman, 1989). Another truncated form of band 3, of 85 
kDa, can be immunoprecipitated by a mAb that specifically reacts with the surface of 
live knobby cells, but not uninfected cells (Winograd & Sherman, 1989). 
Cytoadherence, may also be affected by band 3 modifications (Winograd & Sherman, 
1989; Crandall & Sherman, 1994). A 65 kDa altered form of band 3 present in a 
knobless cytoadherent line of parasites is recognised by a mAb that also blocks 
cytoadherence (Winograd & Sherman, 1989).
It is debatable whether this information helps to explain the occurrence of 
maximal proliferation of WEP 1153 to nRBCs. It is possible, however, that the 
dominant response of the T cell line was to such an altered nRBC component and that 
within the proliferation assays, the concentration of red cells was high enough that 
proliferation was induced. That there was a dose response to pRBCs may be due to 
the presence of the altered Ag itself as well as an increase in the number of uninfected 
cells in the stimulating preparation. Such a large number of uninfected red cells (or 
FCS within the system) may also act as mitogens increasing proliferative responses. 
Con A, a T cell mitogen, has been shown to recognise sugar residues on band 3, and 
addition of Con A to knobby pRBCs in vitro enhances the agglutination of such cells 
(Sherman & Greenan, 1986). It is possible that FCS or nRBCs in the microtitre assay 
recognise band 3 and cause an alteration in antigenicity. Further studies on these 
responses were, however, impossible as WEP 1153 suffered contamination problems 
and would not grow upon recovery from liquid nitrogen.
That the cell line became unresponsive after recovery from liquid N2 may have 
been due to the T cells becoming anergic. If the APC concentration was too low for 
the responding cells, the T cells may act as APCs, but following this they cannot 
respond to subsequent specific antigenic challenge (Prof. R. Lechler, personal 
communication). If the T cells become anergic they may act as Ag-specific 
suppressor cells, or consume either exogenous or endogenous 11-2 preventing 
proliferation of responsive T cells (Prof. R. Lechler, personal communication).
The adoptive transfer of WEP 1153 T cells resulted in protection against 
challenge with P. c. chabaudi CB in recipient immunocompromised mice. Gross et 
al. (1984), Brake et al. (1986) and Taylor-Robinson (1991), raised T cell lines against 
P. berghei, P. c. adami and P. c. chabaudi AS respectively, and showed that these 
lines were protective upon adoptive transfer. These workers used a variety of 
recipient mice, from naive to irradiated, CD4 depleted and congenitally T cell- 
deficient nude mice. The use of sublethally irradiated hosts in this study was to tally
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with the previous adoptive transfer experiments, and served to amplify the protection 
conferred. After a slight delay in onset of patency which was not significant 
compared to recipients receiving naive T cells, the ascending parasitaemia of WEP 
1153 cell recipients did not differ from the control animals. It would appear, 
therefore, that the transferred cells did not function immediately as effector cells, but 
rather that they took time for expansion to numbers necessary to affect the course of 
infection, or that they activated other mechanisms within the irradiated but recovering 
host, or possibly elsewhere in the donor population, to effect resolution of infection. 
Such activation is probably a result of cytokine activation, as first proposed by Brake 
et al. (1986). Unfortunately, this study did not permit the characterisation of cytokine 
secretion of WEP 1153 and it is impossible to tell whether the T cell line was 
predominantly T jjl or Th2.
Control animals in this adoptive transfer experiment received a population of 
enriched naive T cells. A more rigorous control would have been to include mice 
receiving CD4 enriched cells, since a population of naive T cells will include a 
significant proportion of CD8+ cells. These may exert an effect by suppressing the 
development of immunity to P. c. chabaudi CB. It is unlikely, however, that such a 
contribution by these cells would exist, since the removal of CD8+ cells by mAb 
treatment (Chapter 3) did not alter the course of a normal infection.
The protection demonstrated by the transfer of WEP 1153 was much less than 
that observed with the transfer of enriched splenic T cells from donor mice 75 DPI 
(Chapter 4). In the latter case protection was manifested as a significant reduction in 
the peak parasitaemia, rapid parasite remission and no recrudescences of infection. 
WEP 1153 induced protection was exhibited by a more rapid parasite remission 
compared to control animals, but a recrudescence did occur although it was 
significantly lower than in control mice. This probably reflects the difference in 
transferring a heterogeneous population of cells, albeit enriched populations, in the 
case of the adoptive transfer experiments described in Chapter 4, and the transfer of in 
vitro propagated Ag-specific T cell lines. The former populations of cells always 
contained an undefined proportion of contaminating cells which may either have been 
activated by the T cells within the population or contributed to immunity by 
themselves.
Although the cellular events occurring during the prepatent period are not 
known, it was assumed that the trigger for the activation of the transferred WEP 1153 
T cells was P. c. chabaudi CB. However, this cannot be stated with certainty due to 
the proliferative response observed in vitro; while a pRBC response was 
demonstrated, which may have been maintained in vivo, it is difficult to explain the 
results to include the proliferation to nRBCs. Proliferation, however, demonstrated in 
vitro to pRBCs is likely to be maintained in vivo. Spasmodic regrowth of donor
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tumour specific T cells has been reported by Chen et al. (1990) with the number of 
lymphocytes of donor origin maintained at the same or greater level for longer than a 
month. There is no reason why such a proliferative response in vivo should not occur 
with transferred T cells through a natural P. c. chabaudi CB infection (R.S. Phillips, 
personal communication). The homing patterns of the transferred cells are important 
although they have not been studied within this experiment. Lymphocyte migration 
patterns have been examined for the host lymphocyte reservoir during malaria 
infection (Kumararatne et al., 1987), but no similar studies have been performed on 
the distribution of lymphoid cells introduced by artificial means into a malaria- 
challenged animal. Such a study would reveal the homing patterns of inoculated cells 
after their introduction into the host blood stream, and show whether or not they have 
the capacity to migrate to appropriate sites. Transferred effector lymphocytes, if they 
still possess markers associated with activation, will probably home to the the tissue 
of their origin (Mackay, 1993). Many cloned T cells, however, when injected 
intravenously, display aberrant trafficking patterns, a phenomenon that may be due, in 
part, to the loss of the MEL-14 homing receptor (Gallatin et al., 1986). In the case of 
malaria, it is thought that a small subpopulation of the cultured anti-P. c. adami T cell 
lines (Brake et al., 1986) may still express the MEL-14 cell surface Ag (Weidanz & 
Long, 1988) and thus distribute to immunologically critical sites. As the spleen is 
critical in the resolution of malaria infections, it is important that the grafted 
lymphocytes reach the spleen, and perhaps even microenvironments within it, in order 
to fulfill their protective capacity.
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CHAPTER EIGHT 
GENERAL DISCUSSION
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The work reported in this thesis has demonstrated the importance of T 
lymphocytes in the development of protective immunity to the asexual blood stages of 
Plasmodium chabaudi chabaudi CB. Depletion of specific subsets by mAb treatment 
showed that the CD4+ T cell subset is absolutely critical in the resolution of infection 
(Chapter 3). CD4+ T cells can be separated into two major subsets, ThI and Th2, 
based upon the repertoire of cytokines secreted following stimulation, with the 
distinct cytokine profiles that they display indicating their function (Mosmann & 
Coffman, 1987). Both subsets of lymphocytes, for the P. c. chabaudi CB/NIH mouse 
system, will recognise plasmodial peptides which have been processed and presented 
on H-2 class II molecules of APCs (Chapter 7). ThI cells produce 11-2, IFN-y and 
TNF-P and through these activate macrophages and mediate delayed-type 
hypersensitivity responses. Th2 cells produce 11-4,11-5,11-6 and 11-10 and provide 
help for B-cell Ab production (Mosmann & Coffman, 1987; 1989). Hence, T hI and 
T h 2 cells mediate qualitatively distinct immune responses, containing largely 
nonoverlapping cell-mediated and humoral elements. Infection of mice with the AS 
strain of P. c. chabaudi generates a host protective immune response which involves 
CD4+ T cells of both the ThI and Th2 phenotypes (Langhome, 1989). The relative 
contributions of these two subsets change during the course of infection (Langhome 
et al., 1989a, b; Taylor-Robinson & Phillips, 1992; 1993; 1994a) such that T hI cells 
predominate during the primary parasitaemia, while Th2 cells predominate during the 
later stages of infection and reinfection.
The adoptive transfer experiments described in Chapter 4 indicated that 
immunity could be transferred with enriched splenic T cell populations prepared from 
donor mice at different stages of malarial infection. Although a detailed analysis of 
the function of the cells was not carried out it was apparent that both subsets of Th 
cells were involved in eliciting immunity. Increased levels of malaria-specific Abs 
were detected in the sera of mice that received ’immune1 T cells from all the stages of 
infection from which spleen cell populations were prepared. A prolonged secretion of 
IFN-y from Con A stimulated spleen cells was observed in mice receiving 21 DPI T 
cells (Chapter 4). An attempt at generating P. c. chabaudi CB specific T cell lines 
(Chapter 7) was undertaken with the aim of obtaining homogeneous cell lines of 
either the T hI or Th2 phenotype, to characterise further the T cell responses present 
during different stages of malarial infection.
When ThI cells are activated they secrete amongst other cytokines, IFN-y. IFN- 
y is a potent activator of macrophages, which leads to their expression of increased 
levels of MHC class II determinants (King & Jones, 1983; Femandez-Botran et al.,
1988). They, thereby, become more efficient APCs (Zlotnik et al., 1983). 
Macrophage activation also results in enhanced phagocytosis (Zlotnik et al., 1983)
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and in the release of cytokines such as TNF, II-1 and 11-6 (Dockrell & Playfair, 1983, 
reviewed by Stevenson et al., 1990b), reactive oxygen intermediates (Clark et al., 
1987a) and reactive nitrogen intermediates (Green et al., 1990a). All these effects of 
macrophage activation have been noted as contributing towards clearance of malaria 
pRBCs. Activated macrophages phagocytose effectively Plasmodium-infected RBCs 
(Ockenhouse & Shear, 1983; Shear, 1984). TNF, II-1 and 11-6 can induce fever which 
may be directly damaging to parasites (Dinarello, 1989; Kwiatkowski, 1989), 
influence the production of acute phase proteins (Dinarello, 1989), and enhance 
further cell-mediated and Ab responses by activating T cells, B cells and 
macrophages, sometimes by acting in a synergistic manner (Titus et al., 1991). These 
cytokines also contribute to the pathology of malaria.
TNF-a can be induced in macrophages by direct stimulation with erythrocytic 
stages of the parasite (Bate et al., 1988; 1989; Taveme et al., 1990). This cytokine is 
also detectable during a primary infection with P. c. chabaudi, P. vinckei, P. berghei 
and P. yoelii, both in the plasma and in the supernatants of splenic cells taken from 
infected animals and cultures in vitro (Stevenson et al., 1990c; Taveme et al., 1986; 
Grau et al., 1987). Treatment with exogenous TNF-a at the beginning of infection 
protects against an otherwise lethal infection of P. c. chabaudi in susceptible strains 
of mice (Stevenson & Ghadirian, 1989), and delays patency and reduces peak 
parasitaemias in P. c. adami infections (Clark al., 1987b).
Mice infected with P. berghei have elevated serum levels of 11-6 and the 
production of 11-6 can be modulated by injection of infected mice with an Ab against 
IFN-y and TNF-a (Grau et al., 1990). Although serum levels of II-1 have not been 
found to be elevated in malaria infection, II-1 has important immunoregulatory 
activities (Arai et al., 1990; Beutler & Cerami, 1988; Snick, 1990). Some subsets of 
CD4+ T cells have receptors for II-1 (Kaye et a l , 1984; Greenbaum et al., 1988; 
Lichtman et al., 1988; Munoz et al., 1990; Taylor-Robinson & Phillips, 1994c) and 
thus may be preferentially expanded in the presence of this cytokine. Indeed, Taylor- 
Robinson & Phillips (1994c) have shown that the expression of the II-1 receptor 
discriminates Th2 from ThI cloned T cells specific for P. c. chabaudi AS, providing 
a possible marker for phenotyping, depletion or selection of CD4+ T cells of either the 
ThI or Th2 subset.
Oxygen intermediates and NO released from activated macrophages are toxic 
for intraerythrocytic parasites in vitro (Dockrell & Playfair, 1983; Clark & Hunt, 
1983; Rockett et al., 1991) and may be important for killing parasites in vivo (Rockett 
etal., 1992; Taylor-Robinson etal., 1993). Free oxygen radicals may be important in 
killing parasites evidenced by mice treated with the free radical scavenger butylated 
hydroxyanisole during P. c. adami infection having higher parasitaemias than
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untreated mice (Clark et al., 1987a). In contrast, however, P/J mice which are 
defective in macrophage activation and production of oxygen intermediates are able 
to resolve P. c. chabaudi infections (Cavacini et al., 1989). The importance of NO in 
vivo has been demonstrated by Taylor-Robinson et al. (1993), T h I T cell clones 
specific for P. c. chabaudi, upon adoptive transfer, protect in vivo by a NO dependent 
mechanism. In vivo production of NO has also been demonstrated during infection 
with P. c. chabaudi CB (Chapter 6).
ThI CD4+ lymphocytes, through their synthesis and secretion of IFN-y (and NO 
(Taylor-Robinson et al., 1994)) are, therefore, effective initiators of Ab-independent 
pathways of cell-mediated immunity involving non-specific toxic effector molecules. 
The levels of IFN-y detectable in the circulation of P. c. chabaudi AS-infected mice 
are maximal prior to peak parasitaemia (Slade & Langhome, 1989, Stevenson et al., 
1990a). Experiments described in Chapter 4 and Chapter 6 demonstrated that IFN-y 
production in mice infected with P. c. chabaudi CB was also produced maximally one 
or two days prior to the peak parasitaemia. This concurs with reports that ThI cells 
predominate during the resolution of the primary parasitaemia and that this resolution 
is independent of specific Ab production, probably through the synthesis of NO 
(Taylor-Robinson et al., 1993; 1994). It also demonstrates that the kinetics of the 
immune response to infection with P. c. chabaudi CB are similar to those of the AS 
strain. The Ab levels during the course of infection (Chapter 5) show that although 
detectable Abs appear early in infection, peak Ab titres occur following resolution of 
the primary parasitaemia. ThI lymphocytes are thought to be unable to stimulate 
resting B cells (Boom et al., 1988) while Th2 cells, the frequency of which is very 
low in the first two weeks of P. c. chabaudi AS infection (Langhome et al., 1989a), 
can induce the activation of resting B cells. The Ab that is detectable during the 
primary parasitaemia is of the IgG2a isotype (Langhome et al., 1984; 1985), the 
synthesis of which is positively regulated by IFN-y (Snapper & Paul, 1987). IgGi 
synthesis is detected later in malarial infection, and indeed the suppressed levels of 
IgGi Abs elaborated during the primary patency (Langhome et al., 1984; 1985; 
Langhome & Asofsky, 1986; Falanga et al., 1987) are probably due to ThI-produced 
IFN-y via its antagonistic effects on Il-4-dependent responses (Rabin et al., 1986; 
Snapper & Paul, 1987; Snapper e ta l , 1988).
Studies by Langhome et al. (1989a), Taylor-Robinson (1991) and Taylor- 
Robinson & Phillips (1992, 1993,1994a) have shown that CD4+ populations specific 
for P. c. chabaudi AS obtained late in infection belonged to the Th2 subset and 
provided considerable help for specific Ab synthesis. It has also been shown that 
cloned Th2 malaria-specific cells protect immunocompromised mice upon adoptive 
transfer by the enhancement and accelerated production of specific IgGi Ab (Taylor-
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Robinson et al., 1993). Tj^-type CD4-bearing lymphocytes are activated by 11-2 and 
II- 1 secreted from activated T hI cells and activated macrophages respectively 
(Mosmann & Coffman, 1989). Following activation Th2 cells then secrete their own 
growth factor, 11-4. After stimulation with malaria Ags, Th2 cells provide help, in the 
form of 11-4 and 11-5, for B cells to produce specific Ab (Mosmann & Coffman, 
1987). Ig specific for blood stage malaria has been shown to serve several functions. 
Circulating Abs against pRBC membrane-bound determinants may cause elimination 
of infected RBCs by agglutination (Brown et al., 1970b) or complement-mediated 
lysis, or alternatively, function in a neutralising capacity by blocking reinvasion of 
merozoites into RBCs (Butcher et al., 1978). In addition, circulating Ig acts as an 
opsonin for the Fc receptor-mediated phagocytosis of pRBCs (Ockenhouse & Shear, 
1984). In turn, this signals further mononuclear phagocytic cell activation and the 
subsequent release of toxic mediators into the surrounding localities of the liver and 
spleen. Alternatively, B lymphocyte membrane-bound Ig specific for surface Ags of 
free merozoites or pRBCs may function as a reservoir for parasite material, thereby 
facilitating the uptake, processing and presentation of plasmodial Ags by available 
APCs to CD4+ T cells (Langhome, 1989). This would serve to recruit other effector 
cells to the parasite-directed immune response.
Several studies have indicated the important role played by Ab in the 
elimination of plasmodia in vivo. Successful passive transfer experiments (Chapter 5) 
have been undertaken using rodent models and immune serum (reviewed by Deans & 
Cohen, 1983). For a P. c. chabaudi AS infection, the ability to control parasitaemia 
coincides with the production of specific IgG but not IgM Abs, and the predominance 
of Th2 cells (Langhome et al., 1989b). With this in mind, it is perhaps not surprising 
that the immunity transferred by 21 DPI semm from naturally recovering mice was 
greater than that transferred with 14 DPI subpatent serum from chloroquine treated 
mice (Chapter 5), given that there is more likelihood of a greater frequency of Th2 
cells being present by 21 DPI.
As the primary infection of P. c. chabaudi AS (and presumably P. c. chabaudi 
CB) progresses there is, therefore, a clear shift in the pattern of the CD4+ T cell 
response. Host immunity appears to combine both Ab-independent and Ab- 
dependent mechanisms, ThI and Th2 cells appearing sequentially during a primary 
erythrocytic infection. The ThI response may control acute phase parasitaemias 
through Ab-independent means via macrophage activation and production of 
parasiticidal mediators. T h2 cells which appear later become the major effector 
mechanism of protective immunity by producing the appropriate cytokines for B cells 
to expand and to differentiate into malaria-specific Ab-producing cells (Langhome,
1989). The signals which differentially regulate the activation of Th I and Th2 cells
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following challenge are not completely understood. The knowledge of the signals 
which differentially regulate activation of these cells is necessary for an 
understanding of how cellular and humoral responses are generated and regulated 
during an infection and for the design of a subunit vaccine which induces the 
appropriate effector pathway.
Several lines of evidence indicate that the major controlling factors for the 
selective activation of Th subsets are secreted cytokines (Swain et al., 1991; 
Abehsira-Amar et al., 1992), the nature of the APC involved (Gajewski et al., 1991; 
DeKruyff et al., 1992; Schmitz et al., 1993), the processing of the Ag for presentation 
to the T cell (Soloway et al., 1991), and the antigenic load (DeKruyff et al., 1992; 
Mamula & Janeway, 1993). The latter may provide an explanation for the relatively 
large recrudescent patency observed in P. c. chabaudi CB-infected, chloroquine 
treated mice. In mice naturally recovering from infection, the parasitaemia is not 
resolved to subpatent levels until around 21 DPI; it is possible that the drop in 
parasitaemia may commit the immune response to Tn2-regulated mechanisms during 
the subpatent period and later stages of infection. For chloroquine treated mice the 
circulating-Ag dose is reduced quickly, perhaps providing the signal for a switch from 
the T h I to T h2 phenotype before other appropriate signals are operative, hence 
leading to an increase in parasitaemia.
Two independent in vivo studies (Von der Weid & Langhome, 1993b; Taylor- 
Robinson & Phillips, 1994b) on mice rendered B cell-deficient by life-long treatment 
with anti-fi Abs strongly suggested that the signal(s) mediating the switch from ThI 
to Th2 cells is provided by B cells. In both studies, anti-|1 mice infected with P. c. 
chabaudi AS maintained a strong T hI response throughout the whole course of 
infection. That the progression from a ThI-regulated to a Tn2-regulated immune 
response fails to occur in B cell-depleted mice, suggests that B cells are required for 
the downregulation of T hI mediated and/or the generation of Tn2-m ediated 
protective immunity to P. c. chabaudi. This hypothesis is supported by the concept 
that ThI cells respond optimally to Ag presented on macrophages whereas Th2 cells 
respond better to peptides presented on B cells (Gajewski et al., 1989; Hsieh et al., 
1992; DeKruyff etal., 1992; Schmitz etal., 1993).
Chapter 6 demonstrated that subcurative chloroquine treatment could alter the 
production of NO, a T hI cell-mediated immune mediator. Few studies have 
considered the interactions between chemotherapy and immunity to malaria although 
it is increasingly recognised that antimalarial drugs can interact in both positive and 
negative ways. Chloroquine has previously been shown to inhibit II-1 secretion, 
presentation of antigens by accessory cells, to depress mitogen responsiveness and 
natural killer cell cytotoxicity and to display anti-inflammatory properties (Krogstad
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& Schlessinger, 1987). Prophylactic doses of chloroquine have also been shown to 
inhibit the phagocytosis of IgG-coated sheep RBCs (Osorio et al., 1992). The results 
presented in this thesis and those of Picot et al. (1991; 1993) have shown that 
chloroquine, at doses achievable in vivo, is capable of inhibiting a number of 
cytokines and immune mediators. This is of great interest and warrants further 
investigation, not only because it provides an approach for the use of chloroquine as 
an anti-disease therapy for malaria and auto-immune disorders, but also because it 
may influence the balance of ThI and Th2 cells described above. This may affect the 
ability of the malaria parasite to undergo antigenic variation (Chapter 5) or induce an 
early T h 2 response, which may increase the susceptibility of a host to malaria 
infection (Stevenson & Tam, 1993).
Reiterating points made in the previous chapters and within this chapter, future 
work on P. c. chabaudi CB infection of the NIH mouse will allow factors involved in 
the interplay between cells of the two CD4+ T cell subsets to be investigated. 
Immunity to most infectious agents can be broadly categorised into a predominant 
protective response of either the T jjl or Th2 phenotype. Experimental infections 
with Leishmania, Candida and Listeria evoke a protective T hI response but a 
disease-exacerbating Th2 response. In contrast, for nematode infections, there is a 
significant relationship between Th2 responses and worm expulsion and between ThI 
responses and chronic infection (Sher & Coffman, 1992). The dichotomy of response 
during a primary infection of P. c. chabaudi infection, therefore, is an ideal system to 
study the mechanisms of immunity evoked by either/both T cell subset.
The relative contributions of each T cell subset in immunity to P. c. chabaudi 
CB could be analysed in a variety of ways. Adoptive transfer of T cell clones, if 
successfully derived from different stages of infection, as well as from different 
tissues (eg., liver, spleen and peripheral blood), will enable the mechanisms leading to 
the recipient's control of infection to be elucidated. Titration of the numbers of cells, 
as described in Chapter 4, would determine the threshold number of malaria-specific 
T cells required to confer protection. In addition, to examine any synergy between 
the two subsets in eliciting immunity, adoptive transfer of suboptimal doses of cells 
alone or in combination could be performed. Direct screening of P . c. chabaudi CB 
cDNA libraries with parasite-specific CD4+ T cell clones would identify the antigenic 
determinants to which the protective cells respond. 'Recognised' fragments could then 
be sequenced and used in protection experiments. Using the AS strain of P. c. 
chabaudi and the protective ThI and Th2 cell clones derived by Taylor-Robinson & 
Phillips (1992; 1993; 1994a), such studies are underway. A comparison between 
fragments recognised by these clones and Th clones specific for P. c. chabaudi CB 
could then be made, and the strain differences determined. This would not only help
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in the elucidation of the mechanisms of protective immunity of anti-plasmodial T cell 
clones, but would evaluate their worth with a view to subunit vaccine development
Detailed analysis of the cytokine profiles during the course of infection would 
allow the flux in levels of ThI and Th2 cells to be followed, perhaps highlighting the 
switch between these two phenotypes. Delivery of exogenous cytokines by 
Salmonella mutants, a project underway in the laboratory for AS strain infection, will 
also provide information on the roles of T hI and Th2 specific cytokines and their 
regulation to be investigated. Experiments described in this thesis demonstrated that 
chloroquine had an interesting effect on the course of infection, antigenic variation 
and NO production. Chloroquine chemotherapy could be used as a tool to investigate 
in more detail the induction of different T cell immune responses. By varying 
treatment regimes, and hence the antigenic load at any given time, the resulting 
cytokine patterns would indicate the predominant T cell responses present.
To conclude, the elucidation of the T cell-mediated immune mechanisms, with 
and without chloroquine therapy, involved in the killing or growth inhibition of 
malarial parasites could provide new avenues for therapeutic intervention as well as 
prophylactic immunisation. Studies using the mouse malaria P. c. chabaudi go some 
way to achieving this aim and allow analogies to human malaria to be made.
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CHLOROQUINE
5 mg/ml chloroquine diphosphate (Sigma) made up in PBS (pH 7.2) 
0.25 ml/mouse (each mouse weighing approx. 25-28 g)
GIEMSA'S BUFFER
3.0 g Na2HP04 
0.6 g KH2PO4
Made up to 11 with distilled water and adjusted to pH 7.4
GREISS REAGENT
The Greiss reagent is obtained by mixing in equal volumes, the following two 
solutions:
(a) 0.1% alpha-naphthyl-amine (Sigma) in distilled water
(b) 1% sulphanilamide (Sigma) in 5% phosphoric acid.
Store both solutions in the dark. Prepare fresh Greiss reagent every time.
NITRATE CONVERSION BUFFER
Stock reagents
NADPH (Sigma) 5 mg/ml in PBS or distilled water, stored at -20°C
FAD (Sigma) 41.5 mg/ml in PBS or distilled water, stored at -20°C
Nitrate reductase (Sigma) 34 mg/ml - lyophilised powder diluted in distilled
water. Aliquots of 50 pi stored at -70°C.
KH2PO4 (anhydrous) 0.5 M, pH7.5
Buffer
For 50 samples and standards in duplicate:
500 pi NADPH 
500 pi FAD 
500 pi KH2PO4 
500 pi distilled water
50 pi nitrate reductase + 450 pi distilled water to dilute enzyme
enzyme added to buffer last, then buffer is immediately added to 
samples.
PHOSPHATE BUFFERED SALINE (PBS)
Stock Solution
60.0 g Na2HP04.12H20  
13.6 g Na2HP04.2H20
8.5 g NaCl
Made up to 11 with distilled water 
Buffer
40 ml stock, made up to 11 with 0.9% saline and adjusted to pH 7.2
RPM I
RPMI Malaria Stock Medium
10.39 g RPMI 1640 powdered medium (with L-glutamine) (Gibco)
5.94 g (25 mM) N2-hydroxyethylpiperazine-N’-2 ethane sulphonic acid (HEPES) 
(Sigma)
Made up to 960 ml with distilled water and filter-sterilised (Millipore/Gelman filter 
size 0.22 pm).
RPMI Malaria Incomplete
Stock, aliquoted in 100 ml volumes to which the following supplements are added:
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4.2 ml 5% w/v NaHC03 
0.25 ml Gentamicin (Sigma)
RPMI Cell Culture Stock Medium
10.39 g RPMI 1640 powdered medium (with L-glutamine) (Gibco)
5.96 g (25 mM) N2-hydroxyethylpiperazine-N’-2 ethane sulphonic acid (HEPES) 
(Sigma)
Made up to 11 with distilled water and filter-sterilised (Millipore/Gelman filter size
0.22 (im), pH adjusted to 7.2
RPMI Cell Culture Incomplete
Stock supplemented with the following additives:
11 ml L-glutamine (Gibco)
5.5 ml NaHC03 (3.5%)
0.55 ml 2-Mercaptoethanol (.1 M)
22 ml Fungizone (Gibco)
2.2 ml Gentamycin (Sigma)
Aliquots of 85 ml dispensed into 100 ml bottles.
Both Complete media contained 10% FCS (Gibco)
SORBITOL-GLYCEROL
380 g glycerol (Sigma)
39 g sorbitol (BDH)
6.3 g NaCl
TRIS-AMMONIUM CHLORIDE
0.17 M Tris(hydroxymethyl)aminomethane (20.60 g/1)
0.16 M ammonium chloride (8.30 g/1)
10 ml Tris added to 90 ml ammonium chloride and the 0.83% stock solution adjusted 
to pH 7.4
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